
<html lang="en"     class="pb-page"  data-request-id="c47bd960-3fd0-448f-bcd9-549864a7d9b0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm900372w"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-Amino Acid N-Terminus: Discovery and Optimization of a New Series of P2−P4 Macrocycles" /></meta><meta name="dc.Creator" content="Steven  Harper" /></meta><meta name="dc.Creator" content="Marco  Ferrara" /></meta><meta name="dc.Creator" content="Benedetta  Crescenzi" /></meta><meta name="dc.Creator" content="Marco  Pompei" /></meta><meta name="dc.Creator" content="Maria Cecilia  Palumbi" /></meta><meta name="dc.Creator" content="Jillian M.  DiMuzio" /></meta><meta name="dc.Creator" content="Monica  Donghi" /></meta><meta name="dc.Creator" content="Fabrizio  Fiore" /></meta><meta name="dc.Creator" content="Uwe  Koch" /></meta><meta name="dc.Creator" content="Nigel J.  Liverton" /></meta><meta name="dc.Creator" content="Silvia  Pesci" /></meta><meta name="dc.Creator" content="Alessia  Petrocchi" /></meta><meta name="dc.Creator" content="Michael  Rowley" /></meta><meta name="dc.Creator" content="Vincenzo  Summa" /></meta><meta name="dc.Creator" content="Cristina  Gardelli" /></meta><meta name="dc.Description" content="In a follow-up to our recent disclosure of P2−P4 macrocyclic inhibitors of the hepatitis C virus (HCV) NS3 protease (e.g., 1, Chart 1), we report a new but related compound series featuring a basic..." /></meta><meta name="Description" content="In a follow-up to our recent disclosure of P2−P4 macrocyclic inhibitors of the hepatitis C virus (HCV) NS3 protease (e.g., 1, Chart 1), we report a new but related compound series featuring a basic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 22, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900372w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900372w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900372w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900372w" /></link>
        
    
    

<title>Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-Amino Acid N-Terminus: Discovery and Optimization of a New Series of P2−P4 Macrocycles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900372w" /></meta><meta property="og:title" content="Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-Amino Acid N-Terminus: Discovery and Optimization of a New Series of P2−P4 Macrocycles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0004.jpeg" /></meta><meta property="og:description" content="In a follow-up to our recent disclosure of P2−P4 macrocyclic inhibitors of the hepatitis C virus (HCV) NS3 protease (e.g., 1, Chart 1), we report a new but related compound series featuring a basic amine at the N-terminus of the P3-amino acid residue. Replacement of the electroneutral P3-amino acid capping group (which is a feature of almost all tripeptide-like inhibitors of NS3 reported to date) with a basic group is not only tolerated but can result in advantageous cell based potency. Optimization of this new class of P3-amine based inhibitors gave compounds such as 25 and 26 that combine excellent cell based activity with pharmacokinetic properties that are attractive for an antiviral targeting HCV." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900372w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900372w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900372w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900372w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900372w&amp;href=/doi/10.1021/jm900372w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4820-4837</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900314j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900610k" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-Amino Acid N-Terminus: Discovery and Optimization of a New Series of P2−P4 Macrocycles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Harper">Steven Harper</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Ferrara">Marco Ferrara</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benedetta++Crescenzi">Benedetta Crescenzi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Pompei">Marco Pompei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Cecilia++Palumbi">Maria Cecilia Palumbi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jillian+M.++DiMuzio">Jillian M. DiMuzio</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Donghi">Monica Donghi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Fiore">Fabrizio Fiore</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Koch">Uwe Koch</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+J.++Liverton">Nigel J. Liverton</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Pesci">Silvia Pesci</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Petrocchi">Alessia Petrocchi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Summa">Vincenzo Summa</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Gardelli">Cristina Gardelli</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39 06 91093444. Fax: +39 06 91093225. E-mail: <a href="/cdn-cgi/l/email-protection#36454253405358695e5744465344765b5344555d1855595b"><span class="__cf_email__" data-cfemail="f6858293809398a99e9784869384b69b9384959dd895999b">[email protected]</span></a></div><div class="corresp-fn" id="fn1">†Current address: Merck West Point, Sumneytown Pike, 19486 West Point, PA</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900372w&amp;href=/doi/10.1021%2Fjm900372w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4820–4837</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 22, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 March 2009</li><li><span class="item_label"><b>Published</b> online</span>22 July 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900372w" title="DOI URL">https://doi.org/10.1021/jm900372w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4820%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSteven%2BHarper%252C%2BMarco%2BFerrara%252C%2BBenedetta%2BCrescenzi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D15%26contentID%3Djm900372w%26title%3DInhibitors%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2BNS3%2BProtease%2Bwith%2BBasic%2BAmine%2BFunctionality%2Bat%2Bthe%2BP3-Amino%2BAcid%2BN-Terminus%253A%2BDiscovery%2Band%2BOptimization%2Bof%2Ba%2BNew%2BSeries%2Bof%2BP2%25E2%2588%2592P4%2BMacrocycles%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4837%26publicationDate%3DAugust%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900372w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1960</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900372w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-Amino Acid N-Terminus: Discovery and Optimization of a New Series of P2−P4 Macrocycles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Harper&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Ferrara&quot;},{&quot;first_name&quot;:&quot;Benedetta&quot;,&quot;last_name&quot;:&quot;Crescenzi&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Pompei&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Cecilia Palumbi&quot;},{&quot;first_name&quot;:&quot;Jillian&quot;,&quot;last_name&quot;:&quot;M. DiMuzio&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Donghi&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Fiore&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Koch&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;J. Liverton&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Pesci&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Petrocchi&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Summa&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Gardelli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4820-4837&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900372w&quot;},&quot;abstract&quot;:&quot;In a follow-up to our recent disclosure of P2−P4 macrocyclic inhibitors of the hepatitis C virus (HCV) NS3 protease (e.g., 1, Chart 1), we report a new but related compound series featuring a basic amine at the N-terminus of the P3-amino acid residue. Replacement of the electroneutral P3-amino acid capping group (which is a feature of almost all tripeptide-like inhibitors of NS3 reported to date) with a basic group is not only tolerated but can result in advantageous cell based potency. Optimization of this new class of P3-amine based inhibitors gave compounds such as 25 and 26 that combine excellent cell based activity with pharmacokinetic properties that are attractive for an antiviral targeting HCV.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900372w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900372w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900372w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900372w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900372w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900372w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900372w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900372w&amp;href=/doi/10.1021/jm900372w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900372w" /></input><a href="/doi/pdf/10.1021/jm900372w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900372w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900372w%26sid%3Dliteratum%253Aachs%26pmid%3D19624135%26genre%3Darticle%26aulast%3DHarper%26date%3D2009%26atitle%3DInhibitors%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2BNS3%2BProtease%2Bwith%2BBasic%2BAmine%2BFunctionality%2Bat%2Bthe%2BP3-Amino%2BAcid%2BN-Terminus%253A%2BDiscovery%2Band%2BOptimization%2Bof%2Ba%2BNew%2BSeries%2Bof%2BP2%25E2%2588%2592P4%2BMacrocycles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D15%26spage%3D4820%26epage%3D4837%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In a follow-up to our recent disclosure of P2−P4 macrocyclic inhibitors of the hepatitis C virus (HCV) NS3 protease (e.g., <b>1</b>, Chart 1), we report a new but related compound series featuring a basic amine at the N-terminus of the P3-amino acid residue. Replacement of the electroneutral P3-amino acid capping group (which is a feature of almost all tripeptide-like inhibitors of NS3 reported to date) with a basic group is not only tolerated but can result in advantageous cell based potency. Optimization of this new class of P3-amine based inhibitors gave compounds such as <b>25</b> and <b>26</b> that combine excellent cell based activity with pharmacokinetic properties that are attractive for an antiviral targeting HCV.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: HCV, hepatitis C virus; NS, nonstructural; HATU, azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; TBTU <i>O</i>-benzotriazole-1-yl-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate; NOESY, nuclear Overhauser enhanced spectroscopy; RCM, ring closing metathesis; RP-HPLC, reversed phase high performance liquid chromatography; po, per os; iv, intravenous.</p></div> is a human pathogen from the flaviviridae family of positively stranded RNA viruses and infects around 200 million individuals worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Chronic infections of HCV are initially asymptomatic but can ultimately lead to serious liver disorders such as hepatocellular carcinoma and cirrhosis. HCV is consequently a leading cause of liver transplantation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The current standard of care for HCV infections is based on subcutaneous injection of a modified interferon-α usually combined with ribavarin. Such treatment regimens are inconvenient, poorly tolerated, and only successful at curing HCV infection in around 50% of patients. New therapies targeting virally encoded enzymes are under investigation,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> but to date, no direct-acting antiviral agent has reached the market.</div><div class="NLM_p">Replication of HCV occurs predominantly in hepatocytes where the genome is translated into a polyprotein that is subsequently cleaved to produce the structural components of HCV, as well as the nonstructural proteins that constitute the viral replication machinery. Four out of the five polyprotein cleavages that occur in the nonstructural region are mediated by the virally encoded heterodimeric NS3/NS4A (NS3) enzyme.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This enzyme is a serine protease that has been shown to be essential for viral replication and that has been studied intensively as a target for direct antivirals. BILN-2061, a reversible P1−P3 macrocyclic “product-like” inhibitor<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> of NS3 was the first compound for which clinical proof of concept was achieved, validating the NS3 protease as an excellent target for drug intervention. Subsequently related noncovalent inhibitors<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (e.g., ITMN-191 and TMC435350) and serine-trap based covalent compounds<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (e.g., VX-950 and Sch503034) have elicited strong clinical reductions in viral titers, further illustrating the potential benefit to human health from development of drugs against NS3. Toward this goal, we have recently described the design and initial evaluation of a novel series of P2−P4 macrocyclic inhibitors of the HCV NS3/NS4A protease.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These compounds (e.g., <b>1</b>, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) demonstrated strong inhibition of the NS3 enzyme, had robust cell-based potency, and showed promising preliminary pharmacokinetic profiles. The evolution of this compound class to bismacrocyclic analogues (e.g., <b>2</b>) and to a clinical candidate MK-7009 has also been disclosed.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> As part of our continuing effort in this area, we report here an exploration of structure−activity relationships in the linker group that tethers the nitrogen atom of the P3-amino acid to the heterocyclic group attached to the hydroxyproline residue in P2.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This work led to the finding that basic alkylamine functionality at the N-terminus of active-site P1−P3 peptidomimetic inhibitors of NS3 is not only tolerated but can be beneficial in terms of enhanced cell based potency or improved pharmacokinetic properties.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. P2−P4 Macrocyclic Inhibitors of the HCV NS3 Protease Enzyme</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compounds were assessed for activity (<i>K</i><sub>i</sub>) against recombinant NS3 protease using a time-resolved fluorescence assay.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Inhibition of subgenomic HCV RNA replication was measured in HUH-7 cells using modifications<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> of the procedure described by Bartenschlager;<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> reported data were generated using cellular HCV RNA as the assay readout and were confirmed (results not shown) in an independent assay using a monoclonal antibody against the viral NS3 protease as the readout. Cell-based activity (EC<sub>50</sub>) in the replicon assay was measured routinely in the presence of 10% fetal bovine serum; high serum conditions refer to data collected in the presence of 50% normal human serum. Enzyme inhibition data and replicon potencies were generated against genotype 1b HCV. Preliminary pharmacokinetic studies were conducted through oral administration of compounds to male Sprague−Dawley rats at 5 mg/kg using PEG<sub>400</sub> as vehicle. In these studies plasma exposure was determined from the area under the plasma concentration/time curve between 0 and 4 h, and liver tissue concentrations were determined at the 4 h time point. Follow-up pharmacokinetic studies were conducted for compound <b>25</b> in both male Sprague−Dawley rat and male beagle dog. The dosing parameters used were the following: dog, intravenous (iv) 1 mg/kg (DMSO/PEG<sub>400</sub>/H<sub>2</sub>O, 20%:60%:20% as vehicle); dog, per os (po) 5 mg/kg (PEG<sub>400</sub>/H<sub>2</sub>O, 80%:20% as vehicle); rat, iv 5 mg/kg (DMSO/PEG<sub>400</sub>/H<sub>2</sub>O 20%:60%:20% as vehicle); rat, po 5 mg/kg (PEG<sub>400</sub> as vehicle). Pharmacokinetic parameters were determined from the area under the plasma concentration/time curve between 0 and 24 h (or to the last point at which compound levels were quantifiable). Liver tissue concentrations were determined (in rat) at the 24 h time point.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The P2−P4 macrocyclic amine compounds described (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were assembled using the modular approach outlined in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. This route relied on ring closing metathesis (RCM) methodology to construct the central P2−P4 macrocyclic ring (<b>10)</b> followed by installation of the P1−P1′ functionality by amide coupling with the known amino acid acylsulfonamide fragment <b>11</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The RCM precursors <b>9</b> were available through amide coupling between a <i>trans</i>-4-hydroxyproline methyl ester derivative (<b>4</b>−<b>7</b>) functionalized with the required P2-heterocyclic group, and the N-alkylated P3-amino acid derivatives <b>8</b>. A vinyl group on the P2-heterocycle in compounds <b>4</b>−<b>7</b> served as a partner for the RCM step with the terminal olefin in the functionalized amino acids <b>8</b>.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General retrosynthetic analysis of P2−P4 macrocyclic amine inhibitors <b>12</b>−<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. P2−P4 Macrocyclic Amine Inhibitors Containing a Trifluoroethylamine Amide Isostere (<b>12a</b>,<b>b</b>) and Early Structural Analogues (<b>13</b>−<b>15</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0016.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center">R</th><th class="rowsep1" align="center">R<sub>1</sub></th><th class="rowsep1" align="center">R<sub>2</sub></th><th class="rowsep1" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" char=".">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>3</b></td><td colspan="3" align="left">See Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>.</td><td align="left">0.04 ± 0.01</td><td align="char" char=".">12</td></tr><tr valign="top"><td align="left"><b>12a</b></td><td align="left">H</td><td align="left">CF<sub>3</sub></td><td align="left">H</td><td align="left">1.1 ± 0.1</td><td align="char" char=".">18</td></tr><tr valign="top"><td align="left"><b>12b</b></td><td align="left">H</td><td align="left">H</td><td align="left">CF<sub>3</sub></td><td align="left">5.7 ± 0.3</td><td align="char" char=".">470</td></tr><tr valign="top"><td align="left"><b>13a</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">H</td><td align="left">Me</td><td align="left">H</td><td align="left">0.27 ± 0.07</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>13b</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">H</td><td align="left">H</td><td align="left">Me</td><td align="left">1.7 ± 0.5</td><td align="char" char=".">40</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">0.51 ± 0.2</td><td align="char" char=".">7</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">0.35 ± 0.01</td><td align="char" char=".">14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values in this and subsequent tables are quoted as the arithmetic mean ± standard error (or half-range where <i>n</i> = 2) for two to nine independent determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">EC<sub>50</sub> values are measured in the presence of 10% fetal bovine serum.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">The absolute stereochemistry of compounds <b>13a</b> and <b>13b</b> is assigned by analogy to <b>12a</b>,<b>b</b> (see ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a> for further details).</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Most Significant NOE<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Intensities for Compounds <b>12a</b> and <b>12b</b> in Comparison with Predicted Interatomic Distances from Molecular Modeling</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0017.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="" /></col><col align="char" char="." /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center"> </th><th class="rowsep1" colspan="2" align="center" char="."><b>12a</b> (12<i>-S</i>)</th><th class="rowsep1" colspan="2" align="center" char="."><b>12b</b> (12<i>-R</i>)</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">proton</th><th class="rowsep1" align="center" char=".">calculated (Å)</th><th class="rowsep1" align="center">measured<a class="ref internalNav" href="#t2fn2" aria-label="a">a</a></th><th class="rowsep1" align="center" char=".">calculated (Å)</th><th class="rowsep1" align="center">measured<a class="ref internalNav" href="#t2fn2" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="left">H<sub>12</sub>−H<sub>10</sub></td><td align="char" char=".">2.9</td><td align="char">s</td><td align="char" char=".">3.6</td><td align="char">m</td></tr><tr valign="top"><td align="left">H<sub>12</sub>−H<sub>1(centroid)</sub></td><td align="char" char=".">3.5</td><td align="char">m</td><td align="char" char=".">6.2</td><td align="char">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup>a</sup><p class="last">NOE intensities determined from NOESY experiments: w = weak; m = medium; s = strong; nd = not detected.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structural Changes to the P3-Amino Acid Residue and Their Effect on Rat Pharmacokinetic Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0001.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compd</th><th class="rowsep1" align="center">bond</th><th class="rowsep1" align="center">P<sub>3</sub></th><th class="rowsep1" align="center">R</th><th class="rowsep1" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="rowsep1" align="center" char=".">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" char=".">AUC<sub>po</sub> (μM·h)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="rowsep1" align="center" char=".">Liver (μM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>13a</b></td><td align="left">single</td><td align="left">Val</td><td align="left">H</td><td align="left">0.27 ± 0.07</td><td align="char" char=".">1</td><td align="center" char="."><0.1</td><td align="center" char="."><0.1</td></tr><tr valign="top"><td align="left"><b>17a</b></td><td align="left">double<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td align="left">C<sub>5</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">0.29 ± 0.07</td><td align="char" char=".">0.5</td><td align="center" char="."><0.1</td><td align="char" char=".">0.26</td></tr><tr valign="top"><td align="left"><b>17c</b></td><td align="left">single</td><td align="left">C<sub>5</sub>H<sub>9</sub></td><td align="left">H</td><td align="left">0.1 ± 0.03</td><td align="char" char=".">0.7</td><td align="center" char="."><0.1<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td align="center" char="."><0.1<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>18a</b></td><td align="left">single</td><td align="left">C<sub>6</sub>H<sub>11</sub></td><td align="left">H</td><td align="left">0.06 ± 0.01</td><td align="char" char=".">2</td><td align="center" char="."><0.1</td><td align="char" char=".">1.04</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">single</td><td align="left">C<sub>6</sub>H<sub>11</sub></td><td align="left">Me</td><td align="left">0.35 ± 0.01</td><td align="char" char=".">3</td><td align="center" char="."><0.1<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td align="char" char=".">0.56<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values were measured in the presence of 10% fetal bovine serum.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Area under the plasma concentration/time curve between 0 and 4 h following oral administration of the compounds (5 mg/kg) to Sprague−Dawley rats.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Rat liver concentrations are measured 4 h after oral administration (5 mg/kg) to Sprague−Dawley rats.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last"><i>E</i>-Olefin geometry.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">4 mg/kg oral dose.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activity and Preliminary Rat Pharmacokinetic Profile for P2−P4 Macrocyclic Amine Inhibitors: SAR at the P2 Heterocyclic Group and Evaluation of an Acyclic Analogue <b>38</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0002.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0003.gif" alt="" id="fx8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values were measured in the presence of 50% normal human serum.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Area under the plasma concentration/time curve between 0 and 4 h following oral administration of the compounds (5 mg/kg) to Sprague−Dawley rats.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Rat liver concentrations are measured 4 h after oral administration (5 mg/kg).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">nd = not determined.</p></div></div></div><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> illustrates the synthesis of the P3-amino acid derivatives <b>8</b> that were employed herein. Treatment of the known oxazolidine <b>27</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with 6-bromohex-1-ene afforded a mixture of the amino alcohols <b>28a</b>,<b>b</b>. The diastereomeric ratio was 7:1, and the individual isomers were separated by reversed phase high performance liquid chromatography (RP-HPLC). Oxidation of these compounds with Jones reagent furnished the corresponding carboxylic acids <b>8a</b>,<b>b</b>. The remaining P2−P4 linking fragments <b>8c</b>−<b>j</b> were prepared by reductive amination using the appropriate amino ester derivative. Thus, reaction of 7-octen-2-one <b>29</b> with the methyl esters of valine, cyclopentylglycine, or cyclohexylglycine afforded (after methyl ester hydrolysis) the functionalized amino acids <b>8c</b>−<b>e</b>. The reductive amination step proceeded with a diastereomeric ratio of around 1:1, and compounds <b>8c</b>−<b>e</b> were used as mixtures in the subsequent coupling reactions (see Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). A reductive amination/ester hydrolysis sequence also proceeded in efficient yield with the aldehydes <b>30</b>, <b>31</b>, and <b>32</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> giving <b>8f</b>−<b>j</b>. 2,2-Difluoro-6-heptenal <b>31</b> (which was used in the preparation of <b>8g</b>) was obtained by fluorination of <b>30</b> with <i>N</i>-fluoro-<i>N</i>-(phenylsulfonyl)benzenesulfonamide using racemic proline as the organocatalyst.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) 6-bromohex-1-ene, Mg, Et<sub>2</sub>O; (ii) RP-HPLC; (iii) Jones reagent, Me<sub>2</sub>CO; (iv) NaBH<sub>3</sub>CN, ZnCl<sub>2</sub>, MeOH; (v) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (vi) (PhSO<sub>2</sub>)<sub>2</sub>NF, <span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>-proline, THF.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> illustrates the construction of compound <b>12a</b>. Thus, TBTU mediated amide coupling between <b>4</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and <b>8a</b> furnished the RCM precursor <b>9a</b> as a single diastereoisomer, and this material was smoothly cyclized to <b>10a</b> using Zhan I<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> as catalyst. Direct hydrogenation of the crude product from the RCM reaction gave the saturated macrocyclic compound <i>sat</i>-<b>10a</b> (62% yield from <b>9a</b>). The synthesis was completed by LiOH·H<sub>2</sub>O mediated hydrolysis of the proline methyl ester followed by TBTU mediated amide coupling with <b>11</b>. Compound <b>12a</b> was isolated following purification by RP-HPLC. In identical fashion as outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, the inhibitor <b>12b</b> (which is a diastereoisomer of <b>12a</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was accessed from <b>4</b> and <b>8b</b>. The intermediates (not shown) were <b>9b</b> (RCM precursor) and <b>10b</b> (P2−P4 macrocycle).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) TBTU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA then RP-HPLC; (iii) H<sub>2</sub>(g), Pd/C; (iv) LiOH.H<sub>2</sub>O, THF/H<sub>2</sub>O; (v) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) TBTU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA, then RP-HPLC; (iii) RP-HPLC; (iv) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (v) H<sub>2</sub>(g), Pd/C; (vi) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC; (vii) HCHO, NaBH<sub>3</sub>CN, ZnCl<sub>2</sub>, MeOH, then RP-HPLC.</p></p></figure><div class="NLM_p">The construction of compounds <b>13a</b>,<b>b</b>, <b>17a</b>−<b>c</b>, and <b>18a</b>,<b>b</b> is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Although the P3 fragments <b>8c</b>−<b>e</b> used contain both a free amine and a carboxylic acid group (which have the potential to undergo a homocoupling reaction), their reaction with <b>4</b> was successfully accomplished using HATU as the peptide reagent. The RCM precursors <b>9c</b>−<b>e</b> were isolated in 43−76% yield. The amine functionality in <b>9c</b>−<b>e</b> was deactivated as a TFA salt and in this form did not impede the Zhan I mediated RCM reaction (45−73% yield). Macrocycles <b>10c</b>−<b>e</b> (each a mixture of diastereoisomers at the chiral center adjacent to the P3-N atom) were purified by RP-HPLC to give the individual 12-<i>R</i> and 12-<i>S</i> isomers; only <i>E</i>-olefins were isolated from the ring closing metathesis reaction. The individual diastereoisomers<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (<i>R</i>)-<b>10c</b>−<b>e</b> and (<i>S</i>)-<b>10c</b>−<b>e</b> were elaborated separately through the final steps of the synthesis. Thus, hydrolysis of the proline methyl ester and a hydrogenation step set up the final TBTU-mediated coupling with <b>11</b>. Compounds <b>13a</b>, <b>17c</b>, and <b>18a</b> (from (<i>R</i>)-<b>10c</b>, (<i>R</i>)-<b>10d</b>, and (<i>R</i>)-<b>10e</b>, respectively) and compounds <b>13b</b> and <b>18b</b> (from (<i>S</i>)-<b>10c</b> and (<i>S</i>)-<b>10e</b>, respectively) were isolated following RP-HPLC purification. In a similar vein <b>17a</b> and <b>17b</b> were obtained from (<i>R</i>)-<b>10d</b> and (<i>S</i>)-<b>10d</b> by omitting the catalytic hydrogenation step. Compound <b>19</b> was prepared by direct reductive-formylation of <b>18a</b>, which was smoothly achieved (55% yield following RP-HPLC purification) in the presence of a Lewis acid (ZnCl<sub>2</sub>) using NaBH<sub>3</sub>CN as the reducing agent.</div><div class="NLM_p">An analogous reaction sequence as has already been described was used to access compounds <b>14</b> and <b>15 (</b>Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Thus, coupling of <b>4</b> with the P3 fragments <b>8f</b> or <b>8g</b> gave the RCM precursors <b>9f</b>,<b>g</b> and Zhan I mediated RCM furnished the olefins <b>10f</b>,<b>g</b>. Hydrogenation, proline ester deprotection, and amide coupling with <b>11</b> again completed the synthesis.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) TBTU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA, then RP-HPLC; (iii) H<sub>2</sub>(g), Pd/C; (iv) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (v) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><div class="NLM_p">The macrocyclic amine compounds <b>20</b>−<b>26</b> were prepared (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) from the <i>trans</i>-4-hydroxyproline heterocyclic derivatives <b>5</b>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a><b>6</b>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and <b>7</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> together with the P3-amino acid fragments <b>8h</b>−<b>j</b>. HATU mediated coupling of <b>8h</b> or <b>8i</b> with <b>6</b> gave the ring closing metathesis precursors <b>9h</b>,<b>i</b> from which Zhan I catalyzed RCM generated the <i>trans</i>-olefins <b>10h</b>,<b>i</b>. Following removal of the proline methyl ester, the corresponding carboxylic acids were elaborated either to <b>22</b>/<b>24</b> by direct coupling with <b>11</b> or to <b>23</b>/<b>25</b> by a hydrogenation/coupling sequence. Likewise, reaction of <b>8j</b> with <b>5</b> or of <b>8h</b> with <b>7</b> afforded the macrocycles <b>20</b>−<b>21</b> or <b>26</b>, respectively.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) HATU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA; (iii) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (iv) H<sub>2</sub>(g), Pd/C; (v) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><div class="NLM_p">Having been unable to obtain functionalized amino acids <b>8</b> through reductive amination of aldehydes such as <b>30</b> with sterically hindered amino acids, compound <b>16</b> was accessed as outlined in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Coupling of <b>4</b> with (<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Boc-trifluoromethylglycine followed by <i>N</i>-Boc deprotection furnished <b>33</b>. Reductive amination between this compound and <b>30</b> was possible but gave <b>9l</b> as a single diastereoisomer in modest yield (17%). Following elaboration of <b>9l</b> to <b>16</b> as has previously been described, the P3-amino acid residue was confirmed to have the desired (<i>R</i>)-configuration by <sup>1</sup>H,<sup>1</sup>H NOESY experiments.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) (<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Boc-trifluoromethylglycine, HATU, NMM; (ii) 4 N HCl in 1,4-dioxane; (iii) <b>30</b>, NaBH<sub>3</sub>CN, then RP-HPLC; (iv) Zhan I, DCE, TFA; (v) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (vi) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><div class="NLM_p">The acyclic tripeptide analogues <b>38</b> and <b>39</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. The intermediates <b>35a</b>,<b>b</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> containing the P2-proline residue from BILN-2061 were elaborated either at the N-terminus to furnish the P2−P3 fragment <b>37</b> or at the carboxylic acid to give the P1−P2 dipeptide analogue <b>36</b>. Coupling of <b>36</b> with <b>34</b> (which was available following reductive amination of cyclohexylglycine methyl ester and 3,3-dimethylbutanal followed by routine protecting group manipulations) led after <i>N</i>-Boc-deprotection to the amine <b>38</b>. TBTU mediated coupling of <b>37</b> with <b>11</b> provided the urethane capped tripeptide analogue <b>39</b>.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) NaBH<sub>3</sub>CN, ZnCl<sub>2</sub>, MeOH; (ii) Boc<sub>2</sub>O, Et<sub>3</sub>N, MeOH; (iii) LiOH·H<sub>2</sub>O, THF/dioxane/H<sub>2</sub>O; (iv) TBTU, DIEA, DMAP; (v) TFA/CH<sub>2</sub>Cl<sub>2</sub>, then RP-HPLC; (vi) Boc-Chg-OH, HATU, Et<sub>3</sub>N; (vii) <b>11</b>, TBTU, DIEA, DMAP.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peptidomimetic inhibitors that span the P1−P3 region (or P1′−P3 region) of the NS3 protease enzyme are ubiquitous in the HCV literature. Compound series based upon both acyclic structures<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and several classes of P1−P3 macrocycles<a onclick="showRef(event, 'ref7 ref8 ref26'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref26">(7, 8, 26)</a> have been reported. More recently, P2−P4 macrocycles<a onclick="showRef(event, 'ref9 ref10 ref27'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref27">(9, 10, 27)</a> have been shown to be a viable class of tripeptide mimetics that strongly inhibit HCV replication. A structural feature of almost all HCV inhibitors from these classes<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> is an electroneutral capping group at their P3 N-terminus, most usually an alkyl (or cycloalkyl) amide, urea, or urethane. The role of the capping group may be seen as twofold; the lipophilic alkyl group generates binding energy through interaction toward the S4 subsite of NS3, while the P3-amidic NH group can engage in a hydrogen bonding interaction with the backbone carbonyl of Ala157.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In light of these considerations we were attracted to a recently reported<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> trifluoroethylamine isostere for an amide bond and questioned whether in the context of our P2−P4 macrocyclic inhibitors (e.g., <b>3</b>, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) this might provide a viable alternative to the urethane functionality found in this compound class to date. We envisioned that the alkyl chain of the tether between the P2 and P3 residues might still engage S4, while the nonbasic amine group of the P3-amino acid would retain the potential to act as a hydrogen bond donor. The suitability of this hypothesis was borne out by molecular modeling studies<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> on <b>3</b> and the trifluoroethylamine analogues <b>12a</b>,<b>b</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) which have opposite configuration at the CF<sub>3</sub> substituted carbon α to the P3-N atom. Superposition of <b>3</b> with <b>12b</b> (which has <i>R</i>-configuration at the α-CF<sub>3</sub> group) suggested that a steric clash between the enzyme and the CF<sub>3</sub> group would result in significant distortion of the P2−P4 region of the ligand and ultimately diminish interaction with the NS3 enzyme. In contrast, the isomer based on (<i>S</i>)-configuration at the α-CF<sub>3</sub> group (<b>12a</b>) overlaid well with urethane <b>3</b>. For this isomer the CF<sub>3</sub> group is oriented away from the enzyme surface, allowing the ligand to interact with NS3 in a manner similar to that of the (predicted) bioactive conformation of <b>3</b>.</div><div class="NLM_p">Compounds <b>12a</b>,<b>b</b> were prepared as is outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and then tested in our NS3 enzyme and cell based replicon assays. Results showed that although both compounds caused somewhat lower inhibition of the NS3 enzyme than the urethane <b>3</b>,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> they nonetheless retained potency in the low nanomolar range (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Furthermore, in the cell based replicon assay a comparable response for the more active trifluoroethylamine <b>12a</b> (EC<sub>50</sub> = 18 nM) as for urethane <b>3</b> (EC<sub>50</sub> = 12 nM) was measured, highlighting the suitability of a trifluoroethylamine based linker in the context of a P2−P4 macrocycle.</div><div class="NLM_p">The absolute stereochemistry at C<sub>12</sub> for <b>12a</b> and <b>12b</b> was assessed by NMR analysis. Significantly different interatomic distances between H<sub>12</sub> and both H<sub>10</sub> and the H<sub>1</sub> centroids were expected for the two diastereoisomers on the basis of molecular modeling, and these predictions were confirmed by <sup>1</sup>H,<sup>1</sup>H-NOESY experiments<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> performed on both compounds. As reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, a strong match was observed between the calculated distances and the measured NOE intensities for both epimers, indicating (<i>S</i>)-configuration at C<sub>12</sub> for the more active isomer <b>12a</b> and (<i>R</i>)-configuration for <b>12b</b>. Both compounds had similar <i>Z</i>-conformations at their proline amide bonds. Thus, the stronger biochemical potency that is predicted (and observed) for compound <b>12a</b> with respect to <b>12b</b> together with measured NMR data and molecular modeling make a strong case for the assignment of (12<i>S</i>)-configuration at the α-CF<sub>3</sub> group in <b>12a</b>.</div><div class="NLM_p">A feature that distinguishes <b>12a</b> from previously reported cathepsin K inhibitors that incorporate a trifluoroethylamine isostere of an amide is the p<i>K</i><sub>a</sub> of the amine functionality β to the CF<sub>3</sub> group. The predicted<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> p<i>K</i><sub>a</sub> of this N-atom in <b>12a</b> is 6.3, around 3 log units higher than that reported for trifluoroethylamine amide isosteres in the cathepsin K area. The strong enzyme inhibition shown by <b>12a</b> was notable given that a precipitous drop in activity (of around 3 orders of magnitude) was observed in the cathepsin area when an amine with p<i>K</i><sub>a</sub> above 6 was employed as the amide isostere.<a onclick="showRef(event, 'cit30b'); return false;" href="javascript:void(0);" class="ref cit30b">(30b)</a> Although <b>12a</b> would be expected to be around 90% unprotonated at the physiological pH of the biological assays, a significant amount of the protonated form would still be present in the assay media. To assess the contribution to enzyme inhibition from this protonated species and to further probe the role of amine p<i>K</i><sub>a</sub>, the α-methyl branched compounds <b>13a</b>,<b>b</b> (which aside from amine p<i>K</i><sub>a</sub> have strong structural similarity to <b>12a</b>,<b>b</b>) were evaluated. Remarkably, the more active of these α-methyl diastereoisomers, <b>13a</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> had enzyme inhibition that was <i>enhanced</i> over the CF<sub>3</sub> compound <b>12a</b>. While it cannot be excluded that modification of the CF<sub>3</sub> group to the sterically less demanding CH<sub>3</sub> may be favorable, the presence of a basic amine likely improves potency through electrostatic interaction with the acidic residue D168 which lies close to the P3 amino acid (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). A further attraction of amine <b>13a</b> was that it elicited a much stronger cell based response (EC<sub>50</sub> = 1 nM) than either <b>12a</b> or the original urethane <b>3</b>. The cell based potency of <b>13a</b> was especially attractive when the replicon assay was conducted in the presence of human plasma. Under these conditions, which may be considered to be more physiologically relevant,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>12a</b> and <b>13a</b> had EC<sub>50</sub> values of 320 and 3 nM, respectively. The improved cell-based potency of <b>13a</b> is in line with reduced affinity for serum albumin when a basic amine (which renders the inhibitor formally zwitterionic) is present.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In vitro binding experiments with <b>12a</b> and <b>13a</b> showed that their free fractions in human plasma are 1.9% and 10.6%, respectively.</div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Superposition of urethane inhibitor <b>3</b> (green) with trifluoroethylamine analogues <b>12a</b> (cyan, A) and <b>12b</b> (pink, B) and the proposed binding orientation for compound <b>12a</b> (cyan, C). Inhibitors were minimized and docked into the active site of the genotype 1b NS3/peptide4A crystal structure. The enzyme surface and individual amino acid residues are shown in white (with the exception of the side chain of residue D168 which is shown in red in parts A and B). Potential hydrogen bonding interactions between the ligand and enzyme are shown as broken lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of these initial findings, a research campaign to optimize P2−P4 linked macrocyclic amine inhibitors was initiated. The first target was evaluation of structurally simplified inhibitors devoid of the chiral center resulting from the branching functionality α to the P3-amine group. Compound <b>14</b> fulfills this goal and demonstrates that removal of the branch can be achieved without significant loss of biological activity; <b>14</b> showed similar intrinsic potency and cell based efficacy to the α-branched analogue <b>13a</b>. Two simplified analogues of <b>12a</b>, both of which retained a P3 N-terminal nonbasic amine, were also evaluated. The P3-trifluoromethylglycine compound <b>16</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>) retained enzyme inhibition comparable to <b>12a</b> (<i>K</i><sub>i</sub> values for <b>16</b> and <b>12a</b> are 1.8 and 1.1 nM, respectively) but showed much reduced efficacy in the cell based assay (EC<sub>50</sub> of 160 nM vs 18 nM). In contrast, the <i>gem</i>-difluoro compound <b>15</b> had somewhat improved biochemical potency over the prototype trifluoroethylamine inhibitor <b>12a</b> and demonstrated comparable cell based efficacy as either <b>12a</b> or <b>14</b>. However, the absence of a basic amine group in <b>15</b> again resulted in a less favorable serum shift than for <b>13a</b> or <b>14</b>; when assayed in the presence of human serum, <b>15</b> was around a 100 nM inhibitor of HCV replication.</div><div class="NLM_p">Rat pharmacokinetic studies were performed on all compounds (<b>12a</b>−<b>15</b>) in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. After oral administration consistently low exposure of these compounds in rat plasma was measured. AUC values ranged from zero (compound <b>14</b> was undetectable in rat plasma following administration at 4 mg/kg) to 0.05 μM·h (compound <b>12a</b>). Low compound levels were also detected in rat liver tissue 4 h post-administration,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> the highest concentration being measured for compound <b>13b</b> (0.22 μM). The combination of low plasma and liver levels was viewed as a limitation for these macrocyclic amines given that their main target is the suppression of HCV replication in hepatocytes. The low observed plasma exposure and liver tissue concentration likely reflects modest absorption and uptake of the inhibitors from the gastrointestinal tract. It has been reported<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> that in the carbamate series a change of side chain in the P3 α-amino acid residue had a profound effect on uptake, suggesting that an approach to improving pharmacokinetics of the current inhibitors might be to evaluate changes at P3. The results in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> reflect our efforts in this direction and further emphasize that for P2−P4 macrocycles very subtle changes in the structure of the P3-amino acid side chain can strongly influence the pharmacokinetic profile of the inhibitor. Thus, little benefit came from the presence of a cyclopentylglycine residue in P3, with compound <b>17c</b> showing a profile similar to that of its direct P3-valine analogue <b>13a</b>. Somewhat improved liver tissue levels were recorded when a benzylic double bond was present in the P2−P4 linker group (compound <b>17a</b>), but a stronger improvement was noted for ring expanded cyclohexyl analogue <b>18a</b>. The liver levels of this compound were at least 100 times higher than for initial macrocyclic amine inhibitors such as <b>13a</b>. The N-methylated compound <b>19</b>, which interestingly demonstrated that tertiary amine functionality at the P3 N-terminus of these inhibitors is tolerated, showed a similarly improved concentration in rat liver. Ultimately, however, although liver concentrations were improved for the cyclohexyl analogues <b>18a</b> and <b>19</b>, the lack of plasma exposure remained an issue that could not be addressed via changes to the P3 residue alone.</div><div class="NLM_p">As a result of the unpredictable effect of minor changes in chemical structure on pharmacokinetic parameters, the early optimization of all our P2−P4-macrocyclic compound series relied heavily on in vivo studies run on closely related analogues. Analysis of the data generated from these studies (which were conducted on compounds from across a range of subseries differing in structure at the P3 amino acid residue, the P2−P3 linker group, and the P2-heterocycle) was subsequently performed with a view to establishing trends. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> illustrates an interrogation of this early rat pharmacokinetic data set aimed at establishing relationships between oral plasma exposure and liver levels as a function of structural changes to the P2 heterocyclic group. This plot of dose normalized plasma vs dose normalized liver levels makes a clear illustration that the choice of P2-heterocycle alone is insufficient to ensure either strong plasma exposure or liver levels in the micromolar range. However, a trend suggesting that ether linked 2-isoquinoline P2-heterocyclic compounds (indicated in yellow) tend to be more profitable emerges, and the presence of additional functionality on the isoquinoline ring, such as a methoxy group at the 6-position (blue), can apparently bring a further improvement in plasma exposure. In contrast, while compounds based on the isoindoline carbamate P2-heterocycle (which was a feature of our early macrocyclic amine compounds and which are indicated in grey) do on occasion achieve high liver concentrations (>10 μM), they consistently fail to provide plasma exposure above 0.5 μM·h.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0008.jpeg" id="fx1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacokinetic data for P2−P4 macrocyclic compounds measured following oral administration to Sprague−Dawley rats at doses between 3 and 5 mg/kg. Plasma exposure (<i>x</i>-axis, μM·h) was measured as the area under the plasma concentration/time curve between 0 and 4 h; liver concentrations (<i>y</i>-axis, μM) were measured at 4 h. Data are colored according to the heterocycle attached to the P2-hydroxyproline residue, as indicated below the graph. Exposure values and liver concentrations for compounds that were administered at doses below 5 mg/kg are normalized by linear adjustment to 5 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Changes to the P2-heterocyclic group were consequently explored as an approach toward remedying the poor rat pharmacokinetics of early P2−P4 macrocyclic amine inhibitors. Disappointingly, and for reasons not clearly understood, inhibitors based on an unsubstituted 1,7-linked 2-isoquinoline P2-heterocycle (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <b>20</b>, <b>21</b>) tended to lack potency against the NS3 enzyme. Macrocyclic amine inhibitors based on this P2-heterocycle are also modest inhibitors in the cell based assay (e.g., <b>21</b> EC<sub>50</sub> = 410 nM), and compounds of this type were not further pursued. In contrast 1,7-linked 3-phenyl-4-quinoline based inhibitors showed excellent potency. Compounds <b>22</b> and <b>23</b> highlight this, both showing subnanomolar enzyme blockade and strong efficacy in the replicon assay when it was conducted under high serum conditions (EC<sub>50</sub> values were in the 20 nM range). The presence of a 6-OMe substituent on the P2 heterocycle of <b>22</b> and <b>23</b> (a structural feature that had appeared to favor plasma exposure in a related series; see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) did not strongly benefit PK properties; no improvement in plasma exposure or rat liver levels was achieved with respect to previous P3-cyclohexylglycine compounds such as <b>18a</b>. However, a strong improvement was achieved by installation of <i>gem</i>-dimethyl functionality into the linker group that joins the P2 and P3 amino acids. This change again highlights how subtle structural features can dramatically impact pharmacokinetics; compounds <b>24</b> and <b>25</b> were among our first macrocyclic amine inhibitors that following oral administration to rat achieved plasma exposure significantly higher (∼0.5 μM·h) than detection limits together with high compound concentrations in liver (5.6 and 13.7 μM for <b>24</b> and <b>25</b>, respectively). As projected on the basis of the analysis in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, further augmented plasma levels came from inhibitors based on a 6-methoxy-2-isoquinoline heterocycle at P2. Gratifyingly this change also restored biochemical and cell based potency to a more attractive, low nanomolar level (compare <b>21</b> and <b>26</b>). Compound <b>26</b> had excellent plasma exposure in rat (7 μM·h following a 5 mg/kg dose), and although the liver concentration of this inhibitor was not as high as had been achieved with compounds <b>24</b> and <b>25</b>, it was nonetheless detected at a level more than 2 orders of magnitude above its replicon EC<sub>50</sub>.</div><div class="NLM_p">Although there have been occasional reports in the patent literature relating to tripeptide based inhibitors of NS3 that feature an amine group at their N-terminus,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> the inhibitors described here are to the best of our knowledge the first potent compound series to be based on this feature. The rareness of protease inhibitors featuring an amine at P3 is probably a reflection of early work in the NS3 area, where enzyme bound crystal structures were used toward the design of smaller and more druglike inhibitors. The presence of a hydrogen bonding interaction between Ala157 and the (neutral) P3 NH group of the ligand is a feature in these X-ray structures, and retention of this structural element during subsequent phases of optimization is understandable.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, the compounds described show that neutral functionality is not a strong requirement at the N-terminus, and in fact, benefits in terms of cell based potency or pharmacokinetic properties can come from its replacement with basic amine functionality. Thus, compound <b>13a</b> showed around a 100-fold stronger cell based response (when assayed under high serum conditions) than the closely related P3-urethane compound <b>3</b>. During the optimization of <b>13a</b> a degree of cell based potency could be sacrificed to favor inhibitors with pharmacokinetic properties that are attractive in an antiviral targeting HCV. Compound <b>25</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) highlights this approach. Although the cell-based potency of this inhibitor is not superior to the carbamate analogue <b>40</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>; the compounds are equipotent in our cell based assays), it does reach somewhat higher levels in rat liver (13.7 μM vs 9.9 μM) following oral administration of a 5 mg/kg dose and also has improved plasma exposure (0.45 μM·h vs 0.15 μM·h). Compound <b>25</b> was 44% bioavailable in rat, with moderate plasma clearance (27 mL/min/kg); the half-life was 3.3 h. Plasma levels were not quantifiable 24 h after oral administration, but the compound was still detected in liver at a concentration (0.3 μM) well above its replicon EC<sub>50</sub>, suggesting at least the potential for prolonged suppression of HCV replication in the target organ. Significantly higher exposure was also measured in dog for the amine based inhibitor <b>25</b> vs <b>40</b> (68.8 μM·h vs 5.7 μM·h). The overall pharmacokinetic profile of <b>25</b> in dog was attractive, with the compound showing low clearance (1 mL/min/kg), a reasonable plasma half-life (3 h), and 92% bioavailability.</div><div class="NLM_p last">To demonstrate that the tolerance for amine functionality at the P3 N-terminus is not limited to P2−P4 macrocyclic protease inhibitors (where constraint of the P3-capping group into a ring may render it more permissive toward modification), compounds <b>38</b> and <b>39</b> that are based on the P2 heterocycle found in BILN-2061 were prepared. Amine analogue <b>38</b> showed marginally weaker inhibition (4-fold) than the corresponding P3-urethane analogue <b>39</b> but nonetheless retained subnanomolar inhibition of the NS3 enzyme. In line with the results described for the P2−P4 macrocyclic compounds, amine <b>38</b> showed a similar response as urethane <b>39</b> in the cell-based assay. These results confirm that the tolerance for simple amine functionality at the P3-amino acid N-terminus is not confined to P2−P4 macrocyclic inhibitors of the NS3 protease.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary we have described the discovery and optimization of a series of P2−P4 macrocyclic amine inhibitors of the HCV NS3 protease. The starting point for this work was <b>12a/13a</b>, which showed promising cell based potency but had poor pharmacokinetic properties in rat. Through optimization of the P2 heterocycle, the P3 amino acid, and the P2−P3 linking group, these issues were addressed to generate inhibitors with attractive properties for anti-HCV agents. Basic amine functionality at the P3 N-terminus of HCV NS3 inhibitors has been shown to be generally tolerated, and optimized inhibitors that incorporate this structural feature have cell-based potency and pharmacokinetic profiles that compare favorably with their related P3-N-capped (urethane) analogues.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Solvents were obtained from commercial suppliers (Fluka, puriss. grade) and were used without further purification. Organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> (Merck). Flash chromatography purifications were performed on Biotage prepacked silica gel columns using Biotage Horizon and SP2 instruments. NMR spectra were recorded on Bruker Avance spectrometers and, unless otherwise stated, were acquired at 300 K. Proton chemical shifts are reported in parts per million (δ) and are referenced to the residual proton signal of the deuterated solvent (DMSO-<i>d</i><sub>6</sub> at 2.50 ppm, CDCl<sub>3</sub> at 7.26 ppm, CD<sub>3</sub>OD at 3.31 ppm). Carbon chemical shifts are referenced to the solvent signal of DMSO-<i>d</i><sub>6</sub> at 39.5 ppm. Compounds were assessed for purity under two independent RP-HPLC conditions and were judged >95% pure by peak area (UV detection at 254 nm); for the purity of specific compounds, see below. RP-HPLC was performed on Waters Alliance instruments (analytical scale) or Waters preparative-scale instrument equipped for automated mass or UV-triggered collection. In all cases mixtures of MeCN and H<sub>2</sub>O (each buffered with 0.1% TFA) were used as the mobile phase. The following conditions were employed. Conditions A: stationary phase, Waters Symmetry C<sub>18</sub>, 7 μm, 19 mm × 300 mm; flow rate of 20 mL/min; gradient of 40% MeCN for 4 min and then from 40% to 90% MeCN over 16 min. Conditions B: same as for conditions A but using the following gradient, 20% MeCN for 4 min and then from 20% to 70% MeCN over 16 min. Conditions C: stationary phase, Atlantis C<sub>18</sub>, 5 μm, 3 mm × 150 mm; flow rate of 1 mL/min; gradient of 20% MeCN for 1 min and then from 20% to 80% MeCN over 7 min. Conditions D: stationary phase, X-Bridge 5 μm, 4.6 mm × 50 mm; flow rate of 1 mL/min; gradient of 20% MeCN for 1 min and then from 20% to 100% over 4 min. Conditions E: stationary phase, X-Bridge C<sub>18</sub>, 5 μm, 19 mm × 100 mm; flow rate of 20 mL/min; gradient of 20% MeCN for 1 min and then from 20% to 80% MeCN over 16 min. Low resolution mass spectrometry data were generated on Waters ZQ micromass systems. High resolution data were collected on Waters Synapt Q-tof instruments.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Methyl <i>N</i>-[(1<i>S</i>)-1-(Trifluoromethyl)hept-6-en-1-yl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9a</b>)</h3><div class="NLM_p last">A solution of <b>8a</b> (82 mg, 0.29 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL) was treated with DIEA (112 μL, 0.64 mmol) and TBTU (112 mg, 0.35 mmol). The mixture was stirred for 5 min and then treated with <b>4</b> (113 mg, 0.32 mmol). The mixture was stirred for 14 h and then diluted with aqueous HCl (1 N). The organic layer was separated and washed with saturated aqueous NaHCO<sub>3</sub> and brine and then dried. Removal of the volatiles gave a residue that was purified by flash chromatography on silica gel (EtOAc/petroleum ether gradient from 5:95 to 15:85) to furnish the title compound (50 mg, 30%) as a white foam. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz; 9:1* mixture of rotamers about the proline amide bond and a 1<sup>#</sup>:1<sup>##</sup> mixture of rotamers about the isoindoline urethane bond) δ 7.48 (dd, <i>J</i> = 7.8, 2.4 Hz, 1H), 7.30 (t, <i>J</i> = 7.8 Hz, 1H), 7.26<sup>#</sup> and 7.14<sup>##</sup> (d, <i>J</i> = 7.8 Hz, 1H), 6.73<sup>##</sup> and 6.62<sup>#</sup> (dd, <i>J</i> = 17.5, 11.1 Hz, 1H), 5.82−5.68 (m, 1H), 5.76 (d, <i>J =</i> 17.5 Hz, 1H), 5.38<sup>#</sup> and 5.33<sup>##</sup> (d, <i>J</i> = 11.1 Hz, 1H), 5.30−5.26 and 5.22−5.17* (m, 1H), 5.04−4.86 (m, 2H), 4.83−4.77* and 4.55−4.48 (m, 1H), 4.74−4.56 (m, 4H), 3.91 and 3.86* (d, <i>J</i> = 11.9 Hz, <i>J</i>* = 12.1 Hz, 1H), 3.79−3.75 and 3.58−3.50* (m, 1H), 3.69* and 3.64 (s, 3H), 3.26 and 2.97* (d, <i>J</i> = 7.8 Hz, 1H), 2.90−2.82* and 2.81−2.74 (m, 1H), 2.61−2.54* and 2.49−2.42 (m, 1H), 2.41−2.36* and 2.19−2.12 (m, 1H), 2.07−1.90 (m, 3H), 1.73−1.67 (m, 1H), 1.44−1.35 (m, 3H), 1.29−1.19 (m, 3H), 0.91 (d, <i>J</i> = 6.8 Hz, 3H), 0.90 (d, <i>J</i> = 6.8 Hz, 3H); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, two rotamers with relative intensity 9:1* are observed) δ −77.0, −77.5*; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 580 (M + H)<sup>+</sup>.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Methyl <i>N</i>-[(1<i>R</i>)-1-(Trifluoromethyl)hept-6-en-1-yl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9b</b>)</h3><div class="NLM_p last">Following the procedure described for <b>9a</b>, treatment of <b>8b</b> (250 mg, 0.89 mmol) with <b>4</b> furnished the title compound (89 mg, 17%) as a solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>; a 1:1* mixture of rotamers about the isoindoline urethane bond and a >95:5 mixture of rotamers about the proline amide bond were observed; only the major isomer is assigned) δ 7.47 (d, <i>J</i> = 7.8 Hz, 1H), 7.30 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 and 7.17* (d, <i>J</i> = 7.8 Hz, 1H), 6.73 and 6.63* (dd, <i>J</i> = 17.5, 11.1 Hz, 1H), 5.80−5.71 (m, 2H), 5.37 and 5.35−5.25* (d and m*, <i>J</i> = 11.1 Hz, 1H), 5.32−5.25 (m, 1H), 4.97 (d, <i>J</i> = 17.2 Hz, 1H), 4.92 (d, <i>J =</i> 10.1 Hz, 1H), 4.74−4.41 (m, 5H), 3.92 and 3.90* (d, <i>J</i> = 12.0 Hz, 1H), 3.75−3.68 (m, 1H), 3.63 and 3.62* (s, 3H), 3.51 and 3.46* (dd, <i>J</i> = 8.0, 5.3 Hz, 1H), 3.19−3.09 (m, 1H), 2.47−2.38 (m, 1H), 2.14−2.05 (m, 2H), 2.04−1.91 (m, 2H), 1.78−1.68 (m, 1H), 1.51−1.28 (m, 6H), 0.95 and 0.94* (d, <i>J</i> = 6.8 Hz, 3H), 0.80 and 0.78* (d, <i>J</i> = 6.8 Hz, 3H); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub><i>6</i></sub>; two rotamers with relative ratio 1:1 are observed) δ −74.3, −74.4; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 580 (M + H)<sup>+</sup>.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Methyl <i>N</i>-[(2<i>R</i> and 2<i>S</i>)-Oct-7-en-2-yl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-ethenyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate Trifluoroacetate (<b>9c</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b>, treatment of <b>8c</b> (467 mg, 2.06 mmol) with <b>4</b> furnished a solid that was further purified by RP-HPLC (conditions B) to give a 3:2 mixture of diastereoisomers of the title compounds (999 mg, 76%) as a white powder. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 526 (M + H)<sup>+</sup>.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (3<i>R</i>,5<i>S</i>)-1-{(2<i>S</i> and 2<i>R</i>)-2-Cyclopentyl-2-[oct-7-en-2-ylamino]acetyl}-5-(methoxycarbonyl)pyrrolidin-3-yl 4-ethenyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>9d</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b>, treatment of <b>8d</b> (324 mg, 1.28 mmol) with <b>4</b> furnished the title compounds (301 mg, 43%) as an oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 1:1* mixture of diastereoisomers) δ 7.54−7.43 (m, 1H), 7.36−7.24 (m, 2H), 7.36−7.24 and 7.20* (m and t*, <i>J</i>* = 9.7 Hz, 1H), 6.80−6.61 (m, 1H), 5.84−5.63 (m, 1H), 5.42−5.19 (m, 2H), 5.02−4.82 (m, 2H), 4.77−4.36 (m, 6H), 4.01−3.87 (m, 1H), 3.83−3.67 (m, 1H), 3.65 (s, 3H), 3.31−3.17 (m, 1H), 2.33−0.96 (m, 19H), 0.79 (br d, <i>J</i> = 6.9 Hz, 3H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 552 (M + H)<sup>+</sup>.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (3<i>R</i>,5<i>S</i>)-1-[(2<i>S</i> and 2<i>R</i>)-2-Cyclohexyl-2-(oct-7-en-2-ylamino)acetyl]-5-(methoxycarbonyl)pyrrolidin-3-yl 4-ethenyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>9e</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b>, treatment of <b>8e</b> (1.51 g, 5.0 mmol) with <b>4</b> furnished the title compound (1.28 g, 45%) as an oil. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 566 (M + H)<sup>+</sup>.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Methyl <i>N</i>-(Hept-6-en-1-yl)-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-ethenyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9f</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b>, treatment of <b>8f</b> (990 mg, 3.96 mmol) with <b>4</b> furnished the title compound (1.82 g, 90%) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 512 (M + H)<sup>+</sup>.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Methyl <i>N</i>-(2,2-Difluorohept-6-en-1-yl)-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-ethenyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9g</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b> (HATU used in place of TBTU), treatment of <b>8g</b> (286 mg, 1.15 mmol) with <b>4</b> furnished the title compound (247 mg, 39%) as a foam. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 548 (M + H)<sup>+</sup>.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl (4<i>R</i>)-1-[(2<i>S</i>)-2-Cyclohexyl-2-(hept-6-en-1-ylamino)acetyl]-4-[(7-methoxy-2-phenyl-6-vinylquinolin-4-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9h</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b> (HATU used in place of TBTU), treatment of <b>8h</b> (269 mg, 1.06 mmol) with <b>6</b> (375 mg, 0.925 mmol) furnished the title compound (512 mg, 35%) as an oil. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 640 (M + H)<sup>+</sup>.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Methyl (4<i>R</i>)-1-{(2<i>S</i>)-2-Cyclohexyl-2-[(4,4-dimethylhept-6-en-1-yl)amino]acetyl}-4-[(6-ethenyl-7-methoxy-2-phenylquinolin-4-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9i</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b> (HATU used in place of TBTU), treatment of <b>8i</b> (293 mg, 1.04 mmol) with <b>6</b> (402 mg, 0.99 mmol) furnished the title compound (308 mg, 47%) as an oil. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 668 (M + H)<sup>+</sup>.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl (4<i>R</i>)-1-[(2<i>S</i>)-2-Cyclopentyl-2-(hept-6-en-1-ylamino)acetyl]-4-[(7-ethenylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9j</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b> (HATU used in place of TBTU), treatment of <b>8j</b> (263 mg, 1.10 mmol) with <b>5</b> (345 mg, 1.15 mmol) furnished the title compound (466 mg, 82%) as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.97 (br s, 1H), 7.94 (d, <i>J</i> = 5.9 Hz, 1H), 7.81 (br d, <i>J</i> = 8.5 Hz, 1H), 7.69 (d, <i>J</i> = 8.5 Hz, 1H), 7.22 (d, <i>J</i> = 5.9 Hz, 1H), 6.83 (dd, <i>J</i> = 17.4, 10.9 Hz, 1H), 5.89−5.85 (m, 1H), 5.89 (d, <i>J</i> = 17.4 Hz, 1H), 5.74−5.63 (m, 1H), 5.38 (dd, <i>J</i> = 10.9, 1.2 Hz, 1H), 4.94−4.85 (m, 3H), 4.17 (d, <i>J</i> = 11.8 Hz, 1H), 4.00 (br d, <i>J</i> = 11.8 Hz, 1H), 3.79 (s, 3H), 3.12 (d, <i>J</i> = 8.5 Hz, 1H), 2.79−2.71 (m, 1H), 2.39−2.30 (m, 2H), 2.09−1.98 (m, 3H), 1.88−1.71 (m, 4H), 1.59−1.24 (m, 5H), 1.19−1.07 (m, 4H), 1.01−0.81 (m, 2H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 520 (M + H)<sup>+</sup>.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Methyl (4<i>R</i>)-1-[(2<i>S</i>)-2-Cyclohexyl-2-(hept-6-en-1-ylamino)acetyl]-4-[(6-methoxy-7-vinylisoquinolin-1-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9k</b>)</h3><div class="NLM_p last">Following the general procedure described for <b>9a</b> (HATU used in place of TBTU), treatment of <b>8h</b> (222 mg, 0.88 mmol) with <b>7</b> (320 mg, 0.88 mmol) furnished the title compound (280 mg, 57%) as an oil. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 564 (M + H)<sup>+</sup>.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Methyl 3,3,3-Trifluoro-<i>N</i>-(hept-6-en-1-yl)-<span class="smallcaps smallerCapital">l</span>-alanyl-(4<i>R</i>)-4-{[(4-ethenyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>9l</b>)</h3><div class="NLM_p last">A solution of <b>34</b> (730 mg, 1.65 mmol) in THF (3 mL) was treated with <b>30</b> (186 mg, 1.65 mmol) and NaCNBH<sub>3</sub> (312 mg, 4.96 mmol). The mixture was stirred for 1 h, and then the volatiles were evaporated in vacuo. The resulting residue was purified by RP-HPLC (conditions B) to furnish the title compound (155 mg, 17%) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 538 (M + H)<sup>+</sup>.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>,17<i>E</i>)-10-Isopropyl-3,9-dioxo-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxylate (<b>10a</b>). General Procedure for Ring Closing Metathesis</h3><div class="NLM_p last">A solution of <b>9a</b> (100 mg, 0.17 mmol) in DCE (10 mL) was treated with Zhan catalyst I (17 mg, 0.026 mmol), and the mixture was heated under reflux for 1 h. The solution was cooled and filtered, and then the volatiles were evaporated under reduced pressure. The residue obtained contained the title compound and was used without further purification in the following reaction step. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.27 (t, <i>J =</i> 7.5 Hz, 1H), 7.21 (d, <i>J =</i> 7.5 Hz, 1H), 7.14 (d, <i>J =</i> 7.5 Hz, 1H), 6.40 (d, <i>J =</i> 16.1 Hz, 1H), 5.88 (ddd, <i>J =</i> 16.1, 7.4, 6.7 Hz, 1H), 5.42 (t, <i>J =</i> 3.2 Hz, 1H), 4.77 (d, <i>J =</i> 15 Hz, 1H), 4.70−4.60 (m, 2H), 4.55 (d, <i>J =</i> 15 Hz, 1H), 4.49 (dd, <i>J =</i> 10.6, 7.3 Hz, 1H), 3.97 (dd, <i>J =</i> 11.7, 1.4 Hz, 1H), 3.73 (dd, <i>J =</i> 11.7, 3.1 Hz, 1H), 3.62 (s, 3H), 3.26 (t, <i>J =</i> 8 Hz, 1H), 2.91−2.82 (m, 1H), 2.41−2.35 (m, 1H), 2.28−2.16 (m, 2H), 2.11 (br s, 1H), 2.05 (ddd, <i>J =</i> 13.4, 10.8, 3.9 Hz, 1H), 1.73−1.66 (m, 1H), 1.64−1.59 (m, 2H), 1.57−1.50 (m, 1H), 1.47−1.39 (m, 1H), 1.38−1.30 (m, 1H), 1.26−1.18 (m, 1H), 0.91 (d, <i>J =</i> 6.6 Hz, 6H); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −78.2; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 552 (M + H)<sup>+</sup>.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i> or <i>S</i>,17<i>E</i>)-10-Isopropyl-3,9-dioxo-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxylate (<b>10b</b>)</h3><div class="NLM_p last">Treatment of <b>9b</b> (89 mg, 0.154 mmol) as described in the general procedure for <b>10a</b> furnished the title compound that was used directly in the subsequent step. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 552 (M + H)<sup>+</sup>.</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>,17<i>E</i>)-10-Isopropyl-7-(methoxycarbonyl)-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosin-11-ium Trifluoroacetate ((<i>R</i>)-<b>10c</b>)</h3><div class="NLM_p last">A sealed vial was charged with a solution of <b>9c</b> (448 mg, 0.70 mmol) and Zhan catalyst I (93 mg, 0.14 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (45 mL). The mixture was heated under microwave irradiation at 100 °C for 40 min and then cooled and filtered. The volatiles were removed under reduced pressure and the residue was purified by RP-HPLC (conditions B) to furnish in the first fractions (<i>t</i><sub>R</sub> = 14.58 min) the title compound<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (160 mg, 37%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30−7.23 (m, 1H), 7.16−7.09 (m, 2H), 6.36 (d, <i>J</i> = 16.2 Hz, 1H), 5.82 (dt, <i>J</i> = 16.2, 5.7 Hz, 1H), 5.32−5.27 (br s, 1H), 4.83−4.65 (m, 4H), 4.59 (d, <i>J</i> = 14.6 Hz, 1H), 4.11−4.06 (br s, 1H), 3.96−3.81 (m, 2H), 3.78 (s, 3H), 2.93 (dd, <i>J</i> = 15.1, 8.3 Hz, 1H), 2.87−2.78 (m, 1H), 2.58−2.09 (m, 4H), 1.86−0.97 (m, 12H), 1.47 (d, <i>J</i> = 6.3 Hz, 3H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 498 (M + H)<sup>+</sup>. The later fractions (<i>t</i><sub>R</sub> = 15.12 min) were freeze-dried to give (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>,17<i>E</i>)-10-isopropyl-7-(methoxycarbonyl)-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosin-11-ium trifluoroacetate ((<i>S</i>)<b>-10c)</b> (155 mg, 36%) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30−7.22 (m, 2H), 7.15 (d, <i>J</i> = 7.1 Hz, 1H), 6.22 (d, <i>J</i> = 16.4 Hz, 1H), 5.95 (dt, <i>J</i> = 16.4, 6.3 Hz, 1H), 5.62−5.57 (br s, 1H), 4.82−4.70 (m, 3H), 4.64 (d, <i>J</i> = 14.7 Hz, 1H), 4.49 (d, <i>J</i> = 14.7 Hz, 1H), 4.11−4.07 (br m, 1H), 3.92−3.79 (m, 2H), 3.79 (s, 3H), 2.88−2.80 (m, 1H), 2.66 (dd, <i>J</i> = 14.2, 7.8 Hz, 1H), 2.60−2.51 (m, 1H), 2.38−2.13 (m, 3H), 1.88−1.73 (m, 2H), 160−0.97 (m, 4H), 1.40 (d, <i>J</i> = 6.6 Hz, 3H), 1.21 (d, <i>J</i> = 7.0 Hz, 3H), 1.10 (d, <i>J</i> = 6.6 Hz, 3H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 498 (M + H)<sup>+</sup>.</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>,17<i>E</i>)-10-Cyclopentyl-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxylate trifluoroacetate ((<i>R</i>)-<b>10d</b>)</h3><div class="NLM_p last">Following the procedure described for <b>10c</b>, treatment of <b>9d</b> (300 mg, 0.54 mmol) and TFA (54 μL, 0.71 mmol) gave a residue that was purified by RP-HPLC (conditions B) to afford in the first fractions (<i>t</i><sub>R</sub> = 14.81 min) the title compound<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (93.2 mg, 27%) as a white powder. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 524 (M + H)<sup>+</sup>. The later fractions (<i>t</i><sub>R</sub> = 15.37 min) were freeze-dried to give methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>,17<i>E</i>)-10-cyclopentyl-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxylate trifluoroacetate ((<i>S</i>)<b>-10d</b>) as a white powder (101.5 mg, 29%). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 524 (M + H)<sup>+</sup>.</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>)-10-Cyclohexyl-7-(methoxycarbonyl)-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosin-11-ium trifluoroacetate ((<i>R</i>)-<b>10e</b>)</h3><div class="NLM_p last">Following the procedure described for <b>10c</b>, treatment of <b>9e</b> (1.39 g, 2.05 mmol) gave a residue that was purified by RP- HPLC (conditions B) to afford in the first fractions the title compound<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (410 mg, 31%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.60 (br s, 2H), 7.35−7.15 (m, 3H), 6.27 (d, <i>J</i> = 16.4 Hz, 1H), 6.07 (dt, <i>J</i> = 16.4, 5.7 Hz, 1H), 5.42 (br s, 1H), 4.89−4.54 (m, 4H), 4.46 (d, <i>J</i> = 14.8 Hz, 1H), 4.40−4.31 (m, 1H), 4.26 (d, <i>J</i> = 12.2 Hz, 1H), 3.76−3.60 (m, 4H), 2.95−2.77 (m, 1H), 2.47−2.40 (m, 1H, partially obscured by residual DMSO signal), 2.30−2.03 (m, 3H), 2.01−1.71 (m, 6H), 1.70−0.97 (m, 14H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 538 (M + H)<sup>+</sup>. The later fractions were freeze-dried to afford (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>)-10-cyclohexyl-7-(methoxycarbonyl)-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosin-11-ium trifluoroacetate (<i>S</i>)-<b>10e</b> (190 mg, 14%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.46 (br s, 2H), 7.33−7.15 (m, 3H), 6.35 (d, <i>J</i> = 16.2 Hz, 1H,), 6.04 (dt, <i>J</i> = 16.2, 5.8 Hz, 1H), 5.19 (br s, 1H), 4.80 (d, <i>J</i> = 15.5 Hz, 1H), 4.73−4.50 (m, 3H, partially obscured by residual water), 4.49−4.39 (m, 1H), 4.34 (d, <i>J</i> = 11.7 Hz, 1H), 3.74 (dd, <i>J</i> = 12.4, 4.0 Hz, 1H), 3.69−3.60 (m, 3H), 2.87 (bs, 1H), 2.74−2.58 (m, 1H), 2.42−2.02 (m, 3H), 2.01−1.46 (m, 7H), 1.45−0.94 (m, 14H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 538 (M + H)<sup>+</sup>.</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,17<i>E</i>)-3,9-Dioxo-10-(propan-2-yl)-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxylate trifluoroacetate (<b>10f</b>)</h3><div class="NLM_p last">Treatment of <b>9f</b> (2.24 g, 3.58 mmol) as described in the general procedure for <b>10a</b> furnished a residue that was crystallized (petroleum ether/EtOAc, 8:2) to furnish the title compound (1.3 g, 78%) as a pale solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 484 (M + H)<sup>+</sup>.</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,17<i>Z</i>)-13,13-Difluoro-10-isopropyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxylate (<b>10g</b>)</h3><div class="NLM_p last">Following the procedure described for <b>10c</b>, treatment of <b>9g</b> (247 mg, 0.45 mmol) gave a residue that was purified by flash chromatography on silica gel (EtOAc/petroleum ether, 2:8) to furnish the title compound (154 mg, 66%) as a foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 6.30 (d, <i>J</i> = 16.3 Hz, 1H), 5.95 (dt, <i>J =</i> 16.3, 6.1 Hz, 1H), 5.39 (t, <i>J =</i> 3.3 Hz, 1H), 4.83−4.55 (m, 5H), 3.94 (d, <i>J</i> = 11.1 Hz, 1H), 3.78−3.71 (m, 1H), 3.76 (s, 3H), 3.34 (d, <i>J</i> = 6.6 Hz, 1H), 3.03 (ddd, <i>J</i> = 26.2, 13.9, 5.5 Hz, 1H), 2.87−2.66 (m, 2H), 2.51−1.72 (m, 8 H), 1.05 (d, <i>J</i> = 6.4 Hz, 3H), 1.03 (d, <i>J</i> = 6.4 Hz, 3H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 520 (M + H)<sup>+</sup>.</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclohexyl-23-methoxy-4-(methoxycarbonyl)-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13-decahydro-2H-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>10h</b>)</h3><div class="NLM_p last">Treatment of <b>9h</b> (350 mg, 0.55 mmol) and TFA (57 μL, 0.74 mmol) as described in the general procedure for <b>10c</b> afforded a residue containing the title compound. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 612 (M + H)<sup>+</sup>. Treatment of this material according to step 2 of the general procedure described for <b>12a</b> (vide infra) followed by RP-HPLC purification (conditions B) gave the corresponding carboxylic acid (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-4-carboxy-7-cyclohexyl-23-methoxy-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium trifluoroacetate (251 mg, 65% from <b>9h</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.30−12.60 (br s, 1H), 9.00−8.73 (br m, 2H), 8.28−8.18 (m, 2H), 7.99 (s, 1H), 7.70−7.48 (m, 5H), 6.72 (d, <i>J</i> = 15.7 Hz, 1H), 6.14−6.03 (m, 1H), 5.75 (br s, 1H), 4.74−4.64 (m, 1H), 4.60−4.50 (m, 2H), 3.99 (s, 3H), 3.95−3.87 (m, 1H), 3.29−3.16 (m, 1H), 2.89−2.77 (m, 1H), 2.74−2.60 (m, 1H), 2.46−2.29 (m, 2H), 2.22−2.11 (m, 1H), 2.05−1.05 (m, 17H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 598 (M + H)<sup>+</sup>.</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclohexyl-23-methoxy-4-(methoxycarbonyl)-12,12-dimethyl-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>10i</b>)</h3><div class="NLM_p last">Treatment of <b>9i</b> (307 mg, 0.46 mmol) and TFA (48 μL, 0.62 mmol) as described in the general procedure for <b>10c</b> afforded a residue containing the title compound. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 640 (M + H)<sup>+</sup>. Treatment of this material with LiOH·H<sub>2</sub>O according to step 2 of the general procedure described for <b>12a</b> (vide infra) followed by evaporation of the volatiles and trituration of the resulting residue with MeCN afforded lithium (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-cyclohexyl-23-methoxy-12,12-dimethyl-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecine-4-carboxylate (233 mg, 80% from 9i) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + TFA) δ 8.26 (s, 1H), 8.10−8.04 (m, 2H), 7.79−7.70 (m, 3H), 7.64 (s, 1H), 7.54 (s, 1H), 6.82 (d, <i>J</i> = 15.8 Hz, 1H), 6.43 (dt, <i>J</i> = 15.8, 7.9 Hz, 1H), 5.88 (br s, 1H), 4.75 (t, <i>J</i> = 8.8, 1H), 4.66 (d, <i>J</i> = 12.4 Hz, 1H), 4.48 (d, <i>J</i> = 4.8 Hz, 1H), 4.11 (s, 3H), 4.11−4.05 (m, 1H), 3.20 (td, <i>J</i> = 11.7, 5.5 Hz, 1H), 2.99−2.90 (m, 2H), 2.57−2.48 (m, 1H), 2.28−2.22 (m, 2H), 2.11−1.70 (m, 8H), 1.47−1.21 (m, 7H), 1.00 (s, 3H), 0.99 (s, 3H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 626 (M + H)<sup>+</sup>.</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclopentyl-4-(methoxycarbonyl)-6-oxo-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,2-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>10j</b>)</h3><div class="NLM_p last">Treatment of <b>9j</b> (350 mg, 0.673 mmol) and TFA (70 μL, 0.91 mmol) as described in the general procedure for <b>10c</b> afforded a residue containing the title compound that was used in the following step without further purification. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 492 (M + H)<sup>+</sup>.</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclohexyl-23-methoxy-4-(methoxycarbonyl)-6-oxo-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,2-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>10k</b>)</h3><div class="NLM_p last">Treatment of <b>9k</b> (280 mg, 050 mmol) and TFA (35 μL, 0.50 mmol) as described in the general procedure for <b>10a</b> afforded a residue containing the title compound that was purified by RP-HPLC (conditions E) to give the title compound (35 mg, 10%) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 536 (M + H)<sup>+</sup>.</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl (5<i>R</i>,7<i>S</i>,10<i>R</i>,17<i>E</i>)-3,9-Dioxo-10-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxylate (<b>10l</b>)</h3><div class="NLM_p last">Following the procedure described for <b>10c</b>, treatment of <b>9l</b> (150 mg, 0.28 mmol) gave a residue that was purified by RP-HPLC (conditions B). The fraction with <i>t</i><sub>R</sub> = 1.72 min was freeze-dried to furnish the title compound (17 mg, 12%) as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.30 (d, <i>J =</i> 7.6 Hz, 1H), 7.24 (t, <i>J =</i> 7.6 Hz, 1H), 7.17 (d, <i>J =</i> 7.6 Hz, 1H), 6.24 (d, <i>J =</i> 16.4 Hz, 1H), 6.14 (ddd, <i>J =</i> 16.4, 5.6, 5.6 Hz, 1H), 5.80−5.70 (m, 1H), 5.36 (br t, <i>J =</i> 3.4 Hz, 1H), 4.85−4.72 (m 2H), 4.63 (s, 2H), 4.61 (d, <i>J =</i> 16.0 Hz, 1H), 4.38 (d, <i>J =</i> 12.4 Hz, 1H), 3.68 (dd, <i>J =</i> 12.4, 3.4 Hz, 1H), 3.65 (s, 3H), 3.10 (ddd, <i>J =</i> 11.9, 11.9, 5.2 Hz, 1H), 2.87 (ddd, <i>J =</i> 11.9, 11.9, 5.0 Hz, 1H), 2.56 (dd, <i>J =</i> 13.9, 8.5 Hz, 1H), 2.27−2.17 (m, 3H), 1.85−1.65 (m, 2H), 1.60−1.45 (m, 2H), 1.40−1.25 (m, 2H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 510 (M + H)<sup>+</sup>.</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (5<i>R</i>,7<i>S</i>,10<i>R</i>,12<i>R</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-3,9-dioxo-10-(propan-2-yl)-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide (<b>12a</b>)</h3><div id="sec6_25_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step 1: General Procedure for Catalytic Hydrogenation. Methyl (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>)-10-Isopropyl-3,9-dioxo-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxylate (<i>sat</i>-10a)</h4><div class="NLM_p last"> A solution of <b>10a</b> (120 mg, 0.22 mmol) in MeOH (20 mL) was treated with Pd/C (10%, 20 mg). The mixture was evacuated and then stirred under an atmosphere of hydrogen for 6 h. The solution was filtered and the filtrate was concentrated in vacuo to give a residue that was purified by flash chromatography on silica gel (EtOAc/petroleum ether, gradient from 1:9 to 3:7) to afford the title compound (106 mg, 62%) as a white foam. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 554 (M + H)<sup>+</sup>.</div></div><div id="sec6_25_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Step 2: General Procedure for Proline Ester Hydrolysis. (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>)-10-Isopropyl-3,9-dioxo-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxylic Acid</h4><div class="NLM_p last">A solution of the preceding compound (105 mg, 0.19 mmol) in a 2:1 (v/v) mixture of THF and H<sub>2</sub>O (6 mL) was treated with LiOH·H<sub>2</sub>O (24 mg, 0.57 mmol). The mixture was stirred at 20 °C for 14 h and then cooled and acidified to pH 6 by addition of aqueous HCl (1 N). The mixture was diluted with EtOAc, and the organic layer was separated and dried. Removal of the solvent gave a residue that was used without further purification in the subsequent step. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 540 (M + H)<sup>+</sup>.</div></div><div id="sec6_25_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Step 3: General Procedure for Amide Couplings with <b>11</b>. (5<i>R</i>,7<i>S</i>,10<i>R</i>,12<i>R</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-3,9-dioxo-10-(propan-2-yl)-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide (<b>12a</b>)</h4><div class="NLM_p last"> To a stirred mixture of the preceding compound (89 mg, 0.165 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added DIEA (69 μL, 0.396 mmol), DMAP (10 mg, 0.082 mmol), and TBTU (64 mg, 0.198 mmol). The solution was stirred for 5 min and then treated with <b>11</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (53 mg, 0.198 mmol). The resulting mixture was stirred at 20 °C for 14 h and then diluted with saturated aqueous NaHCO<sub>3</sub> and EtOAc. The organic layer was separated, washed with brine, and dried. Removal of the volatiles gave a residue that was purified by RP-HPLC (conditions B) to furnish the title compound (42 mg, 34%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 294 K) δ 10.58 (br s, 1H), 9.22 (br s, 1H), 7.24 (t, <i>J =</i> 7.4 Hz, 1H), 7.17 (d, <i>J =</i> 7.4 Hz, 1H), 7.11 (d, <i>J =</i> 7.4 Hz, 1H), 5.67 (ddd, <i>J =</i> 17.1, 10.2, 9.2 Hz, 1H), 5.42 (br t, <i>J =</i> 3.4 Hz, 1H), 5.28 (dd, <i>J =</i> 17.1, 1.7 Hz, 1H), 5.12 (dd, <i>J =</i> 10.2, 1.7 Hz, 1H), 4.65 (s, 2H), 4.64−4.58 (m, 2H), 4.40 (dd, <i>J =</i> 11.0, 6.7 Hz, 1H), 3.96 (d, <i>J =</i> 11.9 Hz, 1H), 3.76 (dd, <i>J =</i> 11.9, 3.4 Hz, 1H), 3.30 (d, <i>J =</i> 6.5 Hz, 1H), 3.00−2.95 (m, 1H), 2.90−2.85 (m, 1H), 2.51−2.44 (m, 2H), 2.22 (dd, <i>J =</i> 13.4, 6.7 Hz, 1H), 2.16 (q, <i>J =</i> 8.8 Hz, 1H), 2.05 (ddd, <i>J =</i> 13.4, 11.0, 3.4 Hz, 1H), 1.97 (br s, 1H), 1.79−1.71 (m, 2H), 1.56−1.48 (m, 3H), 1.44−1.18 (m, 7H), 1.09−0.99 (m, 4H), 0.91 (d, <i>J =</i> 6.7 Hz, 3H), 0.82 (d, <i>J =</i> 6.7 Hz, 3H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −75.8. <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 174.1, 172.2, 169.2, 152.9, 137.1, 136.2, 135.0, 133.4, 127.9, 127.6, 126.8 (q, <i>J =</i> 228 Hz), 120.3, 117.9, 73.5, 64.8, 59.0, 58.9 (q, <i>J =</i> 26 Hz), 53.2, 52.1, 50.7, 40.8, 34.6, 33.8, 31.4, 31.2, 30.7, 28.9, 28.5, 26.4, 26.0, 23.5, 22.8, 19.1, 17.9, 5.7, 5.4. Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.84 min (peak area 98%), <i>t</i><sub>R</sub> (conditions D) 4.42 min (peak area 98%); HRMS calculated for C<sub>36</sub>H<sub>49</sub>F<sub>3</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 752.3305, found 752.3325.</div></div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)mino]carbonyl}-2-vinylcyclopropyl)-10-isopropyl-3,9-dioxo-12-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxamide (<b>12b</b>)</h3><div class="NLM_p last">Treatment of <b>10b</b> (88 mg, 0.160 mmol) as described in the general procedures for <b>12a</b> furnished the title compound (12 mg, 10%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 294 K) δ 10.73 (br s, 1H), 9.32 (br s, 1H), 7.25 (t, <i>J =</i> 7.4 Hz, 1H), 7.18 (d, <i>J =</i> 7.4 Hz, 1H), 7.12 (d, <i>J =</i> 7.4 Hz, 1H), 5.71 (ddd, <i>J =</i> 17.1, 10.2, 9.2 Hz, 1H), 5.40 (br t, <i>J =</i> 3.6 Hz, 1H), 5.30 (dd, <i>J =</i> 17.1, 1.7 Hz, 1H), 5.13 (dd, <i>J =</i> 10.2, 1.7 Hz, 1H), 4.73 (d, <i>J =</i> 14.2 Hz, 1H), 4.67−4.55 (m, 3H), 4.31 (dd, <i>J =</i> 10.9, 6.7 Hz, 1H), 4.05 (d, <i>J =</i> 11.9 Hz, 1H), 3.75 (dd, <i>J =</i> 11.9, 3.6 Hz, 1H), 3.70−3.65 (m, 1H), 3.12 (d, <i>J =</i> 8.1 Hz, 1H), 2.95−2.85 (m, 1H), 2.80 (br s, 1H), 2.59 (dd, <i>J =</i> 12.9, 6.4 Hz, 1H), 2.40−2.35 (m, 1H), 2.26 (dd, <i>J =</i> 13.4, 6.7 Hz, 1H), 2.19 (q, <i>J =</i> 8.8 Hz, 1H), 2.09 (ddd, <i>J =</i> 13.4, 10.9, 3.6 Hz, 1H), 1.89−1.80 (m, 1H), 1.73 (dd, <i>J =</i> 7.9, 5.1 Hz, 1H), 1.63−1.50 (m, 2H), 1.49−1.33 (m, 6H), 1.31−1.22 (m, 2H), 1.15−0.97 (m, 5H), 0.85 (d, <i>J =</i> 6.7 Hz, 3H), 0.83 (d, <i>J =</i> 6.7 Hz, 3H); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −75.2. Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.81 min (peak area 98%), <i>t</i><sub>R</sub> (conditions D) 4.45 min (peak area 99%); HRMS calculated for C<sub>36</sub>H<sub>49</sub>F<sub>3</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 752.3305, found 752.3306.</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (5<i>R</i>,7<i>S</i>,10<i>R</i>,12<i>R</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-10-(propan-2-yl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>13a</b>)</h3><div class="NLM_p last">Treatment of (<i>R</i>)<b>-10c</b> (192 mg, 0.31 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (22%) as a white powder. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (br s, 1H), 8.73 (br s, 1H), 8.50−8.25 (m, 2H), 7.26 (t, <i>J</i> = 7.4 Hz, 1H), 7.18 (d, <i>J</i> = 7.4 Hz, 1H), 7.14 (d, <i>J</i> = 7.4 Hz, 1H), 5.56 (ddd, <i>J</i> = 17.1, 10.2, 9.2 Hz, 1H), 5.41 (br s, 1H), 5.22 (d, <i>J</i> = 17.1 Hz, 1H), 5.11 (d, <i>J</i> = 10.2 Hz, 1H), 4.67 (m, 2H), 4.62−4.49 (m, 3H), 4.40−4.34 (m, 1H), 4.18 (d, <i>J</i> = 12.2, 1H), 3.74 (dd, <i>J</i> = 12.2, 2.5 Hz, 1H), 2.94−2.82 (m, 2H), 2.52−2.43 (m, 2H, obscured by residual DMSO signal), 2.42−2.34 (m, 1H), 2.23 (m, 1H), 2.15 (q, <i>J</i> = 8.7 Hz, 1H), 2.06 (m, 1H), 1.74 (dd, <i>J</i> = 7.6, 5.5 Hz, 1H), 1.71 (m, 1H), 1.63−1.44 (m, 3H), 1.41−0.97 (m, 20H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.96 min (peak area 97%), <i>t</i><sub>R</sub> (conditions D) 4.31 min (peak area 98%); HRMS calculated for C<sub>36</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 698.3587, found 698.3579.</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (5<i>R</i>,7<i>S</i>,10<i>R</i>,12<i>S</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-10-(propan-2-yl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>13b</b>)</h3><div class="NLM_p last">Treatment of (<i>S</i>)-<b>10c</b> (281 mg, 0.46 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (7%) as a white powder. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (br s, 1H), 8.77 (br s, 1H), 8.39−8.23 (m, 2H), 7.24 (t, <i>J</i> = 7.4 Hz, 1H), 7.18 (d, <i>J</i> = 7.4 Hz, 1H), 7.12 (d, <i>J</i> = 7.4 Hz, 1H), 5.58 (ddd, <i>J</i> = 17.2, 10.3, 9.2 Hz, 1H), 5.34 (br s, 1H), 5.24 (d, <i>J</i> = 17.2 Hz, 1H), 5.12 (d, <i>J</i> = 10.3 Hz, 1H), 4.71 (d, <i>J</i> = 14.6 Hz, 1H), 4.64−4.58 (m, 3H), 4.48 (t, <i>J</i> = 8.8 Hz, 1H), 4.38−4.36 (m, 1H), 4.28 (d, <i>J</i> = 10.6 Hz, 1H), 3.76 (d, <i>J</i> = 10.6 Hz, 1H), 3.07−2.99 (br m, 1H), 2.95−2.89 (m, 1H), 2.58−2.45 (obscured by residual DMSO, 2H), 2.42−2.36 (m, 1H), 2.33−2.25 (m, 1H), 2.17 (q, <i>J</i> = 8.7 Hz, 1H), 2.13−2.05 (m, 1H), 1.78−1.71 (m, 2H), 1.73−1.56 (m, 1H), 1.49−1.19 (m, 9H), 1.28 (d, <i>J</i> = 6.3 Hz, 3H), 1.12 (d, <i>J</i> = 6.7 Hz, 3H), 1.15−0.96 (m, 4H), 0.97 (d, <i>J</i> = 6.8 Hz, 3H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.01 min (peak area 97%), <i>t</i><sub>R</sub> (conditions D) 4.33 min (peak area 96%); HRMS calculated for C<sub>36</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 698.3587, found 698.3580.</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-10-(propan-2-yl)-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>14</b>)</h3><div class="NLM_p last">Treatment of <b>10f</b> (180 mg, 0.35 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (23%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (s, 1H), 8.74 (s, 1H), 8.70−8.56 (m, 2H), 7.25 (t, <i>J</i> = 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.4 Hz, 1H), 7.13 (d, <i>J</i> = 7.4 Hz, 1H), 5.56 (ddd, <i>J</i> = 17.1, 10.3, 9.3 Hz, 1H), 5.39 (br s, 1H), 5.22 (d, <i>J</i> = 17.1 Hz, 1H), 5.11 (d, <i>J</i> = 10.3 Hz, 1H), 4.78−4.48 (m, 5H), 4.27 (br s, 1H), 3.74 (dd, <i>J</i> = 11.6, 2.5 Hz, 1H), 2.95−2.89 (m, 2H), 2.69−2.66 (m, 1H), 2.38−2.32 (m, 1H, partially obscured by residual DMSO signal), 2.21−2.06 (m, 3H), 1.73 (dd, <i>J</i> = 9.7, 6.9 Hz, 2H), 1.69−1.55 (m, 4H), 1.32−1.26 (m, 1H), 4.49−4.62 (m, 7H), 1.15−1.09 (m, 1H), 1.04 (dd, <i>J</i> = 9.7, 6.9 Hz, 9H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.86 min (peak area 99%), <i>t</i><sub>R</sub> (conditions D) 4.24 min (peak area 99%); HRMS calculated for C<sub>35</sub>H<sub>50</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 684.3431, found 698.3431.</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (5<i>R</i>,7<i>S</i>,10<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-13,13-difluoro-10-isopropyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Treatment of <b>10g</b> (22 mg, 0.158 mmol) according to the general procedure described for <b>12a</b> gave the title compound (15%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.66 (s, 1H), 8.97 (br s, 1H), 7.25 (t, <i>J</i> = 7.5 Hz, 1H), 7.17 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 5.61 (ddd, <i>J</i> = 17.2, 10.4, 9.3 Hz, 1H), 5.38 (br s, 1H), 5.25 (d, <i>J</i> = 17.2 Hz, 1H), 5.11 (d, <i>J</i> = 10.4 Hz, 1H), 4.73−4.54 (m, 4H), 4.45 (dd, <i>J</i> = 10.1, 7.3 Hz, 1H), 4.04 (d, <i>J</i> = 12.1 Hz, 1H), 3.75 (dd, <i>J</i> = 12.0, 3.2 Hz, 1H), 3.50−3.02 (m, 3H), 2.96−2.85 (m, 1H), 2.45−2.34 (m, 3H, partially obscured by residual DMSO), 2.24−1.67 (m, 6H), 1.66−1.48 (m, 2H), 1.49−1.20 (m, 5H), 1.14−0.91 (m, 10H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 8.03 min (peak area >99%), <i>t</i><sub>R</sub> (conditions D) 5.60 min (peak area 98%); HRMS calculated for C<sub>35</sub>H<sub>48</sub>F<sub>2</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 720.3243, found 720.3237.</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,17<i>E</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-3,9-dioxo-10-(trifluoromethyl)-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Treatment of <b>10l</b> (17 mg, 0.034 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (35%) as a white powder. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub> + TFA, 294 K) δ 10.98 (bs, 1H), 8.55 (bs, 1H), 7.33 (d, <i>J =</i> 7.6 Hz, 1H), 7.27 (t, <i>J =</i> 7.6 Hz, 1H), 7.21 (d, <i>J =</i> 7.6 Hz, 1H), 6.24 (d, <i>J =</i> 16.4 Hz, 1H), 6.14 (ddd, <i>J =</i> 16.4, 5.5, 5.5 Hz, 1H), 5.61 (m, 1H), 5.51 (ddd, <i>J =</i> 17.1, 10.2, 9.0 Hz, 1H), 5.33 (br t, <i>J =</i> 3.3 Hz, 1H), 5.22 (dd, <i>J =</i> 17.1, 1.5 Hz, 1H), 5.11 (dd, <i>J =</i> 10.2, 1.5 Hz, 1H), 4.71−4.60 (m, 4H), 4.57 (dd, <i>J =</i> 9.7, 8.2 Hz, 1H), 4.36 (d, <i>J =</i> 12.2 Hz, 1H), 3.70 (dd, <i>J =</i> 12.2, 3.3 Hz, 1H), 3.07 (ddd, <i>J =</i> 12.0, 12.0, 4.7 Hz, 1H), 2.96−2.85 (m, 1H), 2.77 (ddd, <i>J =</i> 12.0, 12.0, 5.4 Hz, 1H), 2.56 (dd, <i>J =</i> 14.3, 8.2 Hz, 1H), 2.30−2.15 (m, 2H), 2.14−2.07 (m, 2H), 1.80−1.65 (m, 3H), 1.60−1.45 (m, 2H), 1.42−1.27 (m, 2H), 1.24 (dd, <i>J =</i> 9.3, 5.2 Hz, 1H), 1.10−0.95 (m, 4H); <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −73.0. Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.28 min (peak area 99%), <i>t</i><sub>R</sub> (conditions D) 4.53 min (peak area 99%); HRMS calculated for C<sub>3</sub>H<sub>41</sub>F<sub>3</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 708.2679, found 708.2702.</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>,17<i>E</i>)-10-Cyclopentyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>17a</b>)</h3><div class="NLM_p last">Treatment of (<i>R</i>)<b>-10d</b> (42 mg, 0.068 mmol) as described in the general procedure reported for <b>12a</b> (steps 2 and 3) gave the title compound (37.5 mg, 59%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (br s, 1H), 8.78−8.68 (m, 2H), 8.64 (br s, 1H), 8.57−8.47 (m, 2H), 7.32−7.22 (m, 3H), 6.24 (d, <i>J</i> = 16.3 Hz, 1H), 6.07 (dt, <i>J</i> = 16.3, 5.7 Hz, 1H), 5.56 (ddd, <i>J</i> = 17.1, 10.3, 9.5 Hz, 1H), 5.42−5.38 (m, 1H), 5.21 (d, <i>J</i> = 17.1 Hz, 1H), 5.11 (d, <i>J</i> = 10.3 Hz, 1H), 4.72−4.54 (m, 4H), 4.51 (dd, <i>J =</i> 10.0, 7.7 Hz, 1H), 4.41 (br t, <i>J</i> = 8.3 Hz, 1H), 4.23 (br d, <i>J =</i> 10.7 Hz, 1H), 3.73 (br d, <i>J =</i> 10.7 Hz, 1H), 2.95−2.82 (m, 2H), 2.54−2.01 (m, 6H, partially obscured by residual DMSO signal), 1.96−1.28 (m, 16H), 1.27 (d, <i>J</i> = 6.6 Hz, 3H), 1.13−0.99 (m, 4H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.03 min (peak area 97%), <i>t</i><sub>R</sub> (conditions D) 4.31 min (peak area 98%); HRMS calculated for C<sub>38</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 722.3587, found 722.3599.</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>,17<i>E</i>)-10-Cyclopentyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16-decahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>17b</b>)</h3><div class="NLM_p last">Treatment of (<i>S</i>)<b>-22d</b> (102 mg, 0.160 mmol) as described in the general procedure reported for <b>12a</b> (steps 2 and 3) gave the title compound as a white powder (29.5 mg, 22%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.86 (br s, 1H), 8.66 (br s, 1H), 8.51−8.33 (m, 2H), 7.31−7.18 (m, 3H), 6.38 (d, <i>J</i> = 16.2 Hz, 1H), 6.01 (dt, <i>J</i> = 16.2, 6.1 Hz, 1H), 5.58 (ddd, <i>J</i> = 17.2, 10.4, 9.1 Hz, 1H), 5.22 (d, <i>J</i> = 17.2 Hz, 1H), 5.22−5.16 (m, 1H), 5.12 (d, <i>J</i> = 10.4 Hz, 1H), 4.83 (d, 14.7 Hz, 1H), 4.71 (d, 14.7, 1H), 4.65−4.53 (m, 3H), 4.41 (br t, <i>J</i> = 9.0 Hz, 1H), 4.29 (br d, <i>J</i> = 12.3 Hz, 1H), 3.76 (dd, <i>J</i> = 12.3, 3.4 Hz, 1H), 2.96−2.83 (m, 2H), 2.72−2.64 (m, 1H), 2.46−0.98 (m, 25H), 1.28 (d, <i>J</i> = 6.3 Hz, 3H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.97 min (peak area 99%), <i>t</i><sub>R</sub> (conditions D) 4.41 min (peak area 99%); HRMS calculated for C<sub>38</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 722.3587, found 722.3593.</div></div><div id="sec6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>)-10-Cyclopentyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>17c</b>)</h3><div class="NLM_p last">Treatment of (<i>R</i>)<b>-10d</b> (93.2 mg, 0.146 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (26 mg, 46%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.76 (br s, 1H), 8.72 (br s, 1H), 8.63−8.34 (m, 2H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 5.57 (ddd, <i>J</i> = 17.2, 10.3, 9.1 Hz, 1H), 5.42−5.38 (br s, 1H), 5.22 (d, <i>J</i> = 17.2 Hz, 1H), 5.11 (d, <i>J</i> = 10.3 Hz, 1H), 4.72−4.41 (m, 6H), 4.18 (br d, <i>J</i> = 11.0 Hz, 1H), 3.75 (br d, <i>J</i> = 11.0 Hz, 1H), 2.96−2.79 (m, 2H), 2.54−2.02 (m, 6H, partially obscured by residual DMSO signal), 1.93−0.99 (m, 24H), 1.23 (d, <i>J</i> = 6.4 Hz, 3H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.13 min (peak area 92%), <i>t</i><sub>R</sub> (conditions D) 4.34 min (peak area 93%); HRMS calculated for C<sub>38</sub>H<sub>54</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 724.3744, found 724.3748.</div></div><div id="sec6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (5<i>R</i>,7<i>S</i>, 10<i>S</i>, 12<i>R</i>)-10-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>18a</b>)</h3><div class="NLM_p last">Treatment of (<i>R</i>)<b>-10e</b> (170 mg, 0.26 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (20%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (br s, 1H), 8.73 (br s, 1H), 8.43 (br s, 1H), 8.34−8.20 (m, 1H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 5.58 (ddd, <i>J</i> = 17.3, 10.4, 9.1 Hz, 1H), 5.41 (br s, 1H), 5.21 (d, <i>J</i> = 17.3 Hz, 1H), 5.11 (d, <i>J</i> = 10.4 Hz, 1H), 4.72−4.45 (m, 5H), 4.48−4.39 (m, 1H), 4.17 (d, <i>J</i> = 12.1 Hz, 1H), 3.76 (dd, <i>J</i> = 12.9, 2.3 Hz, 1H), 2.97−2.78 (m, 2H), 2.47−2.34 (partially obscured by residual DMSO, 2H), 2.19−2.03 (m, 2H), 1.99−1.42 (m, 11H), 1.41−0.93 (m, 20H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.39 min (peak area 96%), <i>t</i><sub>R</sub> (conditions D) 4.51 min (peak area 97%); HRMS calculated for C<sub>39</sub>H<sub>56</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 738.3900, found 738.3925.</div></div><div id="sec6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>S</i>)-10-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-12-methyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>18b</b>)</h3><div class="NLM_p last">Treatment of (<i>S</i>)<b>-10e</b> (180 mg, 0.29 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (37%) as a white powder. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.70 (s, 1H), 8.85−8.73 (m, 1H), 8.41 (br s, 1H), 8.15 (br s, 1H), 7.24 (t, <i>J</i> = 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.4 Hz, 1H), 7.12 (d, <i>J</i> = 7.4 Hz, 1H), 5.65−5.55 (m, 1H), 5.36 (br s, 1H), 5.23 (d, <i>J</i> = 17.1 Hz, 1H), 5.12 (d, <i>J</i> = 10.3 Hz, 1H), 4.76−4.53 (m, 4H), 4.48 (t, <i>J</i> = 9.3 Hz, 1H), 4.36−4.21 (m, 2H), 3.81 (d, <i>J</i> = 9.5 Hz, 1H), 3.05 (br s, 1H), 2.91 (m, 1H), 2.60−2.53 (m, 1H, partially obscured by residual DMSO), 2.46−2.38 (m, 1H), 2.22−2.10 (m, 2H), 2.00−1.87 (m, 1H) 1.86−1.71 (m, 5H), 1.70−1.54 (m, 3H), 1.53−1.20 (m, 15H) 1.19−0.98 (m, 6H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.39 min (peak area 94%), <i>t</i><sub>R</sub> (conditions D) 4.52 min (peak area 96%); HRMS calculated for C<sub>39</sub>H<sub>56</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 738.3900, found 738.3915.</div></div><div id="sec6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (5<i>R</i>,7<i>S</i>,10<i>S</i>,12<i>R</i>)-10-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-11,12-dimethyl-3,9-dioxo-6,7,9,10,11,12,13,14,15,16,17,18-dodecahydro-1<i>H</i>,5<i>H</i>-2,22:5,8-dimethano-4,2,8,11-benzoxatriazacycloicosine-7(3<i>H</i>)-carboxamide Trifluoroacetate (<b>19</b>)</h3><div class="NLM_p last">A solution of NaCNBH<sub>3</sub> (5.2 mg, 0.083 mmol) and ZnCl<sub>2</sub> (5.7 mg, 0.042 mmol) in MeOH (4 mL) was added dropwise to a solution of <b>18a</b> (59 mg, 0.069 mmol) and formaldehyde (37% in H<sub>2</sub>O, 0.18 mL, 2.42 mmol) in MeOH (2 mL). The mixture was stirred for 14 h, and then the volatiles were evaporated under reduced pressure. The residue was purified by RP-HPLC (conditions B) to furnish the title compound as a white powder (33 mg, 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.88 (s, 1H), 8.73 (br s, 1H), 8.65 (br s, 1H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 5.60 (ddd, <i>J</i> = 17.2, 10.3, 9.5 Hz, 1H), 5.37 (br s, 1H), 5.20 (d, <i>J</i> = 17.2 Hz, 1H), 5.11 (d, <i>J</i> = 10.3 Hz, 1H), 4.77−5.55 (m, 4H), 4.56−4.39 (m, 2H), 3.92 (d, <i>J</i> = 12.1 Hz, 1H), 3.80 (dd, <i>J</i> = 12.1, 2.5 Hz, 1H), 2.97−2.80 (m, 2H), 2.62 (d, <i>J</i> = 4.0 Hz, 3H), 2.47−2.36 (m, 3H, partially obscured by residual DMSO signal), 2.15 (q, <i>J</i> = 8.9 Hz, 1H), 2.10−1.93 (m, 2H), 1.92−1.41 (m, 12H), 1.40−1.81 (m, 11H), 1.17−0.94 (m, 6H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.24 min (peak area 97%), <i>t</i><sub>R</sub> (conditions D) 4.46 min (peak area 98%); HRMS calculated for C<sub>40</sub>H<sub>58</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 752.4057, found 752.4050.</div></div><div id="sec6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (2<i>R</i>,4<i>S</i>,14<i>E</i>)-7-Cyclopentyl-4-({(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)-6-oxo-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,2-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>20</b>)</h3><div class="NLM_p last">Treatment of <b>10j</b> (408 mg, 0.673 mmol) as described in the general procedure for <b>12a</b> (steps 2 and 3) gave the title compound (92 mg, 17%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (br s, 1H), 8.96−8.69 (m, 2H), 8.59 (br s, 1H), 8.09 (m, 1H), 7.99 (d, <i>J</i> = 5.8 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (br d, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.41 (d, <i>J</i> = 5.8 Hz, 1H), 6.69 (d, <i>J</i> = 15.7 Hz, 1H), 6.02 (dt, <i>J</i> = 15.7, 7.3 Hz, 1H), 5.78 (br s, 1H), 5.56 (ddd, <i>J</i> = 17.2, 10.2, 9.6 Hz, 1H), 5.18 (d, <i>J</i> = 17.2 Hz, 1H), 5.09 (d, <i>J</i> = 10.2 Hz, 1H), 4.60−4.48 (m, 2H), 4.43 (dd, <i>J</i> = 10.3, 7.5 Hz, 1H), 3.85 (dd, <i>J</i> = 12.1, 2.3 Hz, 1H), 3.35−3.23 (m, 1H), 2.95−2.87 (m, 1H), 2.79−2.58 (m, 2H), 2.38−2.06 (m, 5H), 1.96−1.83 (m, 2H), 1.79−1.36 (m, 12H), 1.33−1.20 (m, 2H), 1.15−0.95 (m, 4H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.20 min (peak area 98%), <i>t</i><sub>R</sub> (conditions D) 4.42 min (peak area 98%); HRMS calculated for C<sub>37</sub>H<sub>50</sub>N<sub>5</sub>O<sub>6</sub>S (M + H)<sup>+</sup> 690.3325, found 690.3322.</div></div><div id="sec6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (2<i>R</i>,4<i>S</i>,7<i>S</i>)-7-Cyclopentyl-4-({(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)-6-oxo-3,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,2-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>21</b>)</h3><div class="NLM_p last">Treatment of <b>10j</b> (408 mg, 0.67 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (140 mg, 26%) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.66 (br s, 1H), 8.85 (br s, 1H), 8.85−8.61 (m, 2H), 7.98 (d, <i>J</i> = 5.8 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.85−7.82 (m, 1H), 7.67 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.41 (d, <i>J</i> = 5.8 Hz, 1H), 6.05 (br s, 1H), 5.57 (dt, <i>J</i> = 17.1, 9.9 Hz, 1H), 5.23 (dd, <i>J</i> = 17.1, 1.5 Hz, 1H), 5.12 (dd, <i>J</i> = 9.9, 1.5 Hz, 1H), 4.66 (dd, <i>J</i> = 10.2, 7.6 Hz, 1H), 4.40−4.30 (m, 2H), 3.88 (dd, <i>J</i> = 11.9, 2.9 Hz, 1H), 2.98−2.83 (m, 3H), 2.77−2.58 (m, 3H), 2.28−2.12 (m, 3H), 1.89−0.95 (m, 24H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.40 min (peak area 99%), <i>t</i><sub>R</sub> (conditions D) 4.55 min (peak area 99%); HRMS calculated for C<sub>37</sub>H<sub>50</sub>N<sub>5</sub>O<sub>6</sub>S (M + H)<sup>+</sup> 692.3482, found 692.3475.</div></div><div id="sec6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-23-methoxy-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecine-4-carboxamide Trifluoroacetate (<b>22</b>)</h3><div class="NLM_p last">Treatment of <b>10h</b> (350 mg, 0.55 mmol) as described in the general procedure reported for <b>12a</b> (steps 2 and 3) gave the title compound (43 mg, 35% from <b>9h</b>) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.86 (br s, 1H), 8.83−8.73 (br m, 2H), 8.60 (s, 1H), 8.29−8.22 (m, 2H), 7.92 (s, 1H), 7.65−7.54 (m, 4H), 7.47−7.41 (m, 1H), 6.73 (d, <i>J</i> = 15.5 Hz, 1H), 5.99 (dt, <i>J</i> = 15.5, 7.2 Hz, 1H), 5.76 (br s, 1H), 5.57 (ddd, <i>J</i> = 17.2, 10.3, 9.2 Hz, 1H), 5.16 (d, <i>J</i> = 17.2 Hz, 1H), 5.08 (d, <i>J</i> = 10.3 Hz, 1H), 4.63 (br d, <i>J</i> = 10.9 Hz, 1H), 4.50−4.42 (m, 1H), 4.41 (dd, <i>J</i> = 10.9, 7.9 Hz, 1H), 3.98 (s, 3H), 3.97−3.88 (m, 1H), 3.33−3.19 (m, 1H), 2.94−2.77 (m, 2H), 2.64−0.95 (m, 28H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.70 min (peak area 99%), <i>t</i><sub>R</sub> (conditions D) 3.91 min (peak area 99%); HRMS calculated for C<sub>45</sub>H<sub>56</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 810.3900, found 810.3911.</div></div><div id="sec6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (2<i>R</i>,4<i>S</i>,7<i>S</i>)-7-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-23-methoxy-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecine-4-carboxamide Trifluoroacetate (<b>23</b>)</h3><div class="NLM_p last">Treatment of <b>10h</b> (120 mg, 0.166 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (58 mg, 38% from <b>9h</b>) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (br s, 1H), 8.81−8.58 (m, 3H), 8.27−8.17 (m, 2H), 7.82 (s, 1H), 7.70−7.54 (m, 4H), 7.52−7.44 (m, 1H), 5.86 (br s, 1H), 5.57 (ddd, <i>J</i> = 17.1, 10.2, 9.1 Hz, 1H), 5.21 (d, <i>J</i> = 17.1 Hz, 1H), 5.12 (d, <i>J</i> = 10.2 Hz, 1H), 4.61 (t, <i>J</i> = 8.8 Hz, 1H), 4.49 (br d, <i>J</i> = 12.1 Hz, 1H), 4.40−4.32 (m, 1H), 3.99 (s, 3H), 3.97−3.89 (m, 1H), 3.07−2.82 (m, 3H), 2.80−2.59 (m, 3H), 2.35−2.24 (m, 1H), 2.14 (q, <i>J</i> = 8.7 Hz, 1H), 1.98−1.49 (m, 11H), 1.39−0.97 (m, 16H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.49 min (peak area 97%), <i>t</i><sub>R</sub> (conditions D) 3.92 min (peak area 99%); HRMS calculated for C<sub>45</sub>H<sub>58</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 812.4057, found 812.4067.</div></div><div id="sec6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-23-methoxy-12,12-dimethyl-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecine-4-carboxamide Trifluoroacetate (<b>24</b>)</h3><div class="NLM_p last">Treatment of <b>10i</b> (224 mg, 0.297 mmol) as described in the general procedure reported for <b>12a</b> (steps 2 and 3) gave the title compound (104 mg, 37% from <b>9i</b>) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (br s, 1H), 8.90−8.63 (m, 3H), 8.29−8.22 (m, 2H), 8.11 (s, 1H), 7.66−7.53 (m, 4H), 7.49−7.44 (m, 1H), 6.73 (d, <i>J</i> = 15.8 Hz, 1H), 6.28 (dt, <i>J</i> = 15.8, 7.8 Hz, 1H), 5.76 (br s, 1H), 5.56 (ddd, <i>J</i> = 17.1, 10.5, 9.1 Hz, 1H), 5.18 (d, <i>J</i> = 17.1 Hz, 1H), 5.08 (d, <i>J</i> = 10.5 Hz, 1H), 4.63 (br d, <i>J</i> = 11.9 Hz, 1H), 4.50−4.39 (m, 2H), 4.00 (s, 3H), 3.97−3.90 (m, 1H), 3.22−3.11 (m, 1H), 2.94−2.86 (m, 1H), 2.80−2.67 (m, 2H), 2.27−2.06 (m, 4H), 2.00−1.61 (m, 9H), 1.32−0.96 (m, 12H), 0.92 (s, 3H), 0.91 (s, 3H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.70 min (peak area >99%), <i>t</i><sub>R</sub> (conditions D) 3.92 min (peak area >99%); HRMS calculated for C<sub>47</sub>H<sub>60</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 838.4213, found 838.4221.</div></div><div id="sec6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (2<i>R</i>,4<i>S</i>,7<i>S</i>)-7-Cyclohexyl-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-23-methoxy-12,12-dimethyl-6-oxo-20-phenyl-3,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,4-<i>r</i>][1,5,8]oxadiazacyclononadecine-4-carboxamide Trifluoroacetate (<b>25</b>)</h3><div class="NLM_p last">Treatment of <b>10i</b> (699 mg, 0.93 mmol) as described in the general procedure reported for <b>12a</b> gave the title compound (301 mg, 34% from <b>9i</b>) as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (br s, 1H), 8.79 (s, 1H), 8.65−8.55 (br s, 1H), 8.51−8.41 (br s, 1H), 8.28−8.20 (m, 2H), 7.83 (s, 1H), 7.67−7.54 (m, 5H), 7.47 (s, 1H), 5.85 (br s, 1H), 5.58 (ddd, <i>J</i> = 17.0, 10.3, 9.5 Hz, 1H), 5.22 (d, <i>J</i> = 17.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.3 Hz, 1H), 4.63 (dd, <i>J</i> = 9.2, 8.2 Hz, 1H), 4.41 (d, <i>J</i> = 12.1 Hz, 1H), 4.38−4.31 (br m, 1H), 3.98 (s, 3H), 4.01−3.89 (m, 1H), 2.97−2.84 (m, 3H), 2.80−2.73 (m, 1H), 2.68−2.57 (m, 2H), 2.35−2.25 (m, 1H), 2.14 (q, <i>J</i> = 8.7 Hz, 1H), 2.01−1.90 (m, 1H), 1.81−0.99 (m, 22H), 0.85 (s, 3H), 0.77 (s, 3H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.81 min (peak area >99%), <i>t</i><sub>R</sub> (conditions D) 4.14 min (peak area >99%); HRMS calculated for C<sub>47</sub>H<sub>60</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 840.4370, found 840.4381.</div></div><div id="sec6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (2<i>R</i>,4<i>S</i>,7<i>S</i>,14<i>E</i>)-7-Cyclohexyl-4-({(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)-23-methoxy-6-oxo-3,4,6,7,8,9,10,11,12,13-decahydro-2<i>H</i>-16,18-etheno-2,5-methanopyrido[3,2-<i>r</i>][1,5,8]oxadiazacyclononadecin-8-ium Trifluoroacetate (<b>26</b>)</h3><div class="NLM_p last">Treatment of <b>10k</b> (90 mg, 0.14 mmol) as described in the general procedure reported for <b>12a</b> (steps 2 and 3) gave the title compound (25%) as a white powder. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.12 (s, 1H), 8.90−8.71 (m, 2H), 8.58 (s, 1H), 7.96−7.90 (m, 2H), 7.33 (d, <i>J =</i> 5.9 Hz, 1H), 7.30 (s, 1H), 6.70 (d, <i>J =</i> 15.6 Hz, 1H), 5.92 (dt, <i>J =</i> 15.6, 7.6 Hz, 1H), 5.74 (br s, 1H), 5.58 (ddd, <i>J =</i> 17.0, 10.2, 9.1 Hz, 1H), 5.18 (d, <i>J</i> = 17.0 Hz, 1H), 5.09 (d, <i>J =</i> 10.2 Hz, 1H), 4.52 (d, <i>J =</i> 11.6 Hz, 1H), 4.48−4.38 (m, 2H), 3.91 (s, 3H), 3.70 (dd, <i>J =</i> 12.4, 3.5 Hz, 1H), 3.21 (br s, 1H), 2.91 (m, 1H), 2.74 (dd, <i>J =</i> 14.1, 7.6 Hz, 1H), 2.60 (br s, 1H), 2.36−2.24 (m, 1H), 2.23−2.07 (m, 3H), 1.99−1.60 (m, 9H), 1.57−1.34 (m, 3H), 1.33−0.93 (m, 11H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 6.29 min (peak area 98%), <i>t</i><sub>R</sub> (conditions D) 4.45 min (peak area 98%); HRMS calculated for C<sub>39</sub>H<sub>52</sub>N<sub>5</sub>O<sub>7</sub>S (M + H)<sup>+</sup> 734.3587, found 734.3578.</div></div><div id="sec6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl 3,3,3-Trifluoroalanyl-(4<i>R</i>)-4-{[(4-ethenyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33</b>)</h3><div class="NLM_p last">A solution of <b>4</b> (1.00 g, 2.83 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was treated with (<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Boc-trifluoromethylglycine (827 mg, 3.40 mmol) and NMM (686 μL, 6.24 mmol). HATU (1.51 g, 3.40 mmol) was added, and the mixture was stirred for 14 h. The solution was diluted with EtOAc and aqueous HCl (1 N), and then the layers were separated. The organic layer was washed with saturated aqueous NaHCO<sub>3</sub> and brine and then dried. Removal of the volatiles gave a residue (MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 542 (M + H)<sup>+</sup>) that was taken up in a solution of HCl in dioxane (4 N, 5 mL). The mixture was stirred for 4 h, and then the volatiles were removed in vacuo to afford a residue that was triturated with Et<sub>2</sub>O to furnish the title compound (1.3 g, 59%) as a solid that was used directly in the subsequent step. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 442 (M + H)<sup>+</sup>.</div></div><div id="sec6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (2<i>S</i>)-[(<i>tert</i>-Butoxycarbonyl)(3,3-dimethylbutyl)amino](cyclohexyl)acetic Acid (<b>34</b>)</h3><div class="NLM_p last">Following the general procedure for reductive amination described for <b>10c</b>, treatment of methyl (2<i>S</i>)-amino(cyclohexyl)acetate (400 mg, 1.92 mmol) and 3,3-dimethylbutanal (424 mg, 4.24 mmol) furnished (2<i>S</i>)-cyclohexyl[(3,3-dimethylbutyl)amino]acetate (490 mg, 100%). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 256 (M + H)<sup>+</sup>. This material was taken up in CH<sub>2</sub>Cl<sub>2</sub> (35 mL) and treated with Et<sub>3</sub>N (0.54 mL, 3.84 mmol) and di-<i>tert</i>-butyl dicarbonate (544 mg, 2.49 mmol). The mixture was stirred for 14 h and then diluted with EtOAc and washed with aqueous HCl (1 N) and brine. The dried organic layer was concentrated to afford a residue that was purified by flash chromatography on silica gel (EtOAc/petroleum ether, gradient from 0:100 to 5:95) to give (2S)-[(<i>tert</i>-butoxycarbonyl)(3,3-dimethylbutyl)amino](cyclohexyl)acetate (678 mg, 100%) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 356 (M + H)<sup>+</sup>. This material was dissolved in a 2:1 (v/v) mixture of THF/H<sub>2</sub>O (15 mL) and treated with LiOH·H<sub>2</sub>O (240 mg, 5.74 mmol). The mixture was heated at 50 °C for 3 h and then cooled and diluted with EtOAc. The organic layer was washed with aqueous HCl (1 N) and brine and then dried. Removal of the volatiles in vacuo afforded the title compound (500 mg, 77%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, a mixture of two conformers in a ratio 55:45*) δ 12.51 (br s, 1H), 4.13 and 3.72* (d, <i>J</i> = 9.9 Hz and <i>J</i>* = 8.9 Hz, 1H), 3.24−2.99 (m, 2H), 1.91−1.08 (m, 11H), 1.40 and 1.36* (s, 9H), 0.98−0.83 (m, 2H), 0.87 (s, 9H); MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 342 (M + H)<sup>+</sup>.</div></div><div id="sec6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (4<i>R</i>)-<i>N</i>-{(1<i>R</i>,2<i>S</i>)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>36</b>)</h3><div class="NLM_p last">Treatment of <b>35a</b> (123 mg, 0.16 mmol) according to the general procedure described for <b>12a</b> (step 3, no RP-HPLC purification) gave a residue that was taken up in an 8:2 (v/v) mixture of CH<sub>2</sub>Cl<sub>2</sub>/TFA (10 mL). The mixture was stirred for 2 h, and then the volatiles were removed in vacuo. Trituration of the residue with Et<sub>2</sub>O afforded the title compound (122 mg, 97%) as a solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 641 (M + H)<sup>+</sup>.</div></div><div id="sec6_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl (4<i>R</i>)-1-{(2<i>S</i>)-2-[(<i>tert</i>-Butoxycarbonyl)amino]-2-cyclohexylacetyl}-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>37</b>)</h3><div class="NLM_p last">Treatment of <i>N-</i>Boc-cyclohexylglycine (520 mg, 2.0 mmol) according to the general procedure described for <b>12a</b> (step 3, using <b>35b</b> in place of <b>11</b>, no RP-HPLC purification) gave a residue that was triturated with a 1:2 (v/v) mixture of CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O to furnish the title compound (1.1 g, 84%) as an oily solid that was used without further purification. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 682 (M + H)<sup>+</sup>.</div></div><div id="sec6_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (4<i>R</i>)-1-{(2<i>S</i>)-2-Cyclohexyl-2-[(3,3-dimethylbutyl)amino]acetyl}-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-4-({2-[2-(isopropylamino)-1,3-thiazol-4-yl]-7-methoxyquinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>38</b>)</h3><div class="NLM_p last">Treatment of <b>36</b> (27 mg, 0.08 mmol) according to the general procedure described for <b>12a</b> (step 3 using <b>34</b> in place of <b>11</b>, no RP-HPLC purification) gave a residue that was taken up in a 4:1 (v/v) mixture of CH<sub>2</sub>Cl<sub>2</sub>/TFA (5 mL). The mixture was stirred for 2 h, and then the volatiles were removed. The residue was purified by RP-HPLC to furnish the title compound (7.5 mg, 12%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, mixture of two conformers in a ratio 3:1; only signals for the major conformer are reported) δ 10.86 (s, 1H), 8.90 (s, 1H), 8.64 (br s, 2H), 8.33 (s, 1H), 8.12 (br s, 1H), 8.04 (d, <i>J =</i> 9.2 Hz, 1H), 7.91 (d, <i>J</i> = 2.1 Hz, 1H), 7.82 (s, 1H), 7.31 (dd, <i>J =</i> 9.2, 2.1 Hz, 1H), 5.87 (br s, 1H), 5.61 (ddd, <i>J</i> = 17.1, 11.0, 9.2 Hz, 1H), 5.22 (d, <i>J =</i> 17.1 Hz, 1H), 5.12 (d, <i>J =</i> 11.0 Hz, 1H), 4.64 (dd, <i>J =</i> 9.7, 7.6 Hz, 1H), 4.42 (d, <i>J =</i> 12.0 Hz, 1H), 4.32−4.25 (br s, 1H), 4.22−4.13 (m, 2H), 3.96 (s, 3H), 2.98−2.88 (m, 1H), 2.86−2.70 (m, 2H), 2.63−2.35 (m, 2H, partially obscured by residual DMSO signal), 2.43−2.30 (m, 1H), 2.16 (q, <i>J</i> = 8.8 Hz, 1H), 1.97−1.69 (m, 7H), 1.69−1.60 (m, 1H), 1.50−1.40 (m, 2H), 1.38−1.30 (m, 1H), 1.26 (d, <i>J =</i> 6.3 Hz, 3H), 1.25 (d, <i>J</i> = 6.2 Hz, 3H), 1.21−0.99 (m, 7H), 0.64 (s, 9H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 5.05 min (peak area 95%), <i>t</i><sub>R</sub> (conditions D) 4.14 min (peak area 91%); HRMS calculated for C<sub>44</sub>H<sub>62</sub>N<sub>7</sub>O<sub>7</sub>S<sub>2</sub> (M + H)<sup>+</sup> 864.4152, found 864.4182.</div></div><div id="sec6_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>tert</i>-Butyl {(1<i>S</i>)-1-Cyclohexyl-2-[(2<i>S</i>,4<i>R</i>)-2-({(1<i>R</i>,2<i>S</i>)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)pyrrolidin-1-yl]-2-oxoethyl}carbamate Trifluoroacetate (<b>39</b>)</h3><div class="NLM_p last">Treatment of <b>37</b> (100 mg, 0.15 mmol) as outlined in the general procedure for <b>12a</b> (steps 2 and 3) gave the title compound (100 mg, 80%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 9.05 (s, 1H), 8.21 (br s, 1H), 8.18 (d, <i>J =</i> 9.2 Hz, 1H), 8.04 (br s, 1H), 7.84 (br s, 1H), 7.75 (s, 1H), 7.28 (d, <i>J =</i> 9.2 Hz, 1H), 7.11 (d, <i>J =</i> 6.9 Hz, 1H), 5.77 (br s, 1H), 5.62 (ddd, <i>J =</i> 17.1, 10.9, 9.2 Hz, 1H), 5.25 (d, <i>J =</i> 17.1 Hz, 1H), 5.12 (d, <i>J =</i> 10.9 Hz, 1H), 4.67 (d, <i>J =</i> 12.1 Hz, 1H), 4.41 (t, <i>J =</i> 7.0 Hz, 1H), 4.22−4.08 (m, 1H), 3.98 (s, 3H), 3.97−3.93 (m, 1H), 3.88−3.80 (m, 2H), 2.99−2.89 (m, 1H),2.70−2.56 (m, 1H), 2.40−2.24 (m, 1H), 2.14 (q, <i>J</i> = 8.8 Hz, 1H),1.91−1.48 (m, 7H), 1.34−1.28 (m, 1H), 1.26 (d, <i>J</i> = 5.8 Hz, 6H), 1.16 (s, 9H), 1.13−0.8 (m, 8H). Analytical RP-HPLC <i>t</i><sub>R</sub> (conditions C) 7.19 min (peak area 97%), <i>t</i><sub>R</sub> (conditions D) 5.75 min (peak area 97%); HRMS calculated for C<sub>43</sub>H<sub>58</sub>N<sub>7</sub>O<sub>9</sub>S<sub>2</sub> (M + H)<sup>+</sup> 880.3737, found 880.3731.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/jm900372w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40182" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40182" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and characterization of compounds <b>8a</b>−<b>j</b>, <b>28a</b>,<b>b</b>, and <b>31</b>; rat and dog PK curves and parameters for compound <b>25</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900372w/suppl_file/jm900372w_si_001.pdf">jm900372w_si_001.pdf (112.95 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900372w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Harper</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a696e7f6c7f7445727b686a7f685a777f68797134797577"><span class="__cf_email__" data-cfemail="3142455447545f6e595043415443715c5443525a1f525e5c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Ferrara</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benedetta Crescenzi</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Pompei</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Cecilia Palumbi</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jillian M. DiMuzio</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Donghi</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Fiore</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Koch</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel J. Liverton</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Pesci</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Petrocchi</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Summa</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Gardelli</span> - <span class="hlFld-Affiliation affiliation">IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Vincenzo Pucci and Fabio Bonelli for bioanalytical data and protein binding assays; Claudio Giuliano for HRMS data; Sergio Altamura, Nadia Gennari, Steven S. Carroll, and Mark Stahlhut for cell based assays.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wasley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends</span> <span class="citation_source-journal">Semin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1055%2Fs-2000-9506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=10895428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1-16&issue=1&author=A.+Wasleyauthor=M.+J.+Alter&title=Epidemiology+of+Hepatitis+C%3A+Geographic+Differences+and+Temporal+Trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of hepatitis C: geographic differences and temporal trends</span></div><div class="casAuthors">Wasley A; Alter M J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in liver disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    </div><div class="casAbstract">Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%.  However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection.  Using age-specific prevalence data, at least three distinct transmission patterns can be identified.  In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults.  In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past.  In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection.  In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission.  Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV.  Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSp2wQyhQIHd7HHuJhbyicZfW6udTcc2eaPG6v15siHXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D&md5=7c7736c5229d0104950eace9fa66a3fe</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9506%26sid%3Dliteratum%253Aachs%26aulast%3DWasley%26aufirst%3DA.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DEpidemiology%2520of%2520Hepatitis%2520C%253A%2520Geographic%2520Differences%2520and%2520Temporal%2520Trends%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26issue%3D1%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span> </span><span class="NLM_article-title">National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C 2002</span>.  <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2082</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Institutes+of+Health+Consensus+Development+Conference+Statement%3A+Management+of+Hepatitis+C+2002.+Gastroenterology+2002%2C+123%2C+2082."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DNational%2520Institutes%2520of%2520Health%2520Consensus%2520Development%2520Conference%2520Statement%253A%2520Management%2520of%2520Hepatitis%2520C%25202002%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D123%26spage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Peptidomimetic Therapeutic Agents Targeting the Protease Enzyme of the Human Immunodeficiency Virus and Hepatitis C Virus</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1252-1263&author=Y.+S.+Tsantrizos&title=Peptidomimetic+Therapeutic+Agents+Targeting+the+Protease+Enzyme+of+the+Human+Immunodeficiency+Virus+and+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Far8000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000519%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPeptidomimetic%2520Therapeutic%2520Agents%2520Targeting%2520the%2520Protease%2520Enzyme%2520of%2520the%2520Human%2520Immunodeficiency%2520Virus%2520and%2520Hepatitis%2520C%2520Virus%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1252%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-Nucleoside Inhibitors of the HCV NS5B Polymerase: Progress in the Discovery and Development of Novel Agents for the Treatment of HCV Infections</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-Nucleoside+Inhibitors+of+the+HCV+NS5B+Polymerase%3A+Progress+in+the+Discovery+and+Development+of+Novel+Agents+for+the+Treatment+of+HCV+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-Nucleoside%2520Inhibitors%2520of%2520the%2520HCV%2520NS5B%2520Polymerase%253A%2520Progress%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Novel%2520Agents%2520for%2520the%2520Treatment%2520of%2520HCV%2520Infections%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfí, A.</span><span> </span><span class="NLM_article-title">Advances in the Development of New Therapeutic Agents Targeting the NS3-4A Serine Protease or the NS5B RNA-Dependent RNA Polymerase of the Hepatitis C Virus</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1242</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=1242-1262&author=R.+De+Francescoauthor=A.+Carf%C3%AD&title=Advances+in+the+Development+of+New+Therapeutic+Agents+Targeting+the+NS3-4A+Serine+Protease+or+the+NS5B+RNA-Dependent+RNA+Polymerase+of+the+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DCarf%25C3%25AD%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520Development%2520of%2520New%2520Therapeutic%2520Agents%2520Targeting%2520the%2520NS3-4A%2520Serine%2520Protease%2520or%2520the%2520NS5B%2520RNA-Dependent%2520RNA%2520Polymerase%2520of%2520the%2520Hepatitis%2520C%2520Virus%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2007%26volume%3D59%26spage%3D1242%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 Protease Inhibitor with Antiviral Effects in Humans Infected with Hepatitis C Virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+Boesauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagaceauthor=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llinas-Brunet&title=An+NS3+Protease+Inhibitor+with+Antiviral+Effects+in+Humans+Infected+with+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lhFjsLKwyGPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBoes%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt.%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520Protease%2520Inhibitor%2520with%2520Antiviral%2520Effects%2520in%2520Humans%2520Infected%2520with%2520Hepatitis%2520C%2520Virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+Characteristics+of+the+Hepatitis+C+Virus+NS3%2F4A+Protease+Inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520Characteristics%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%252F4A%2520Protease%2520Inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−Activity Relationship Study on a Novel Series of Cyclopentane-Containing Macrocyclic Inhibitors of the Hepatitis C Virus NS3/4A Protease Leading to the Discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92Activity+Relationship+Study+on+a+Novel+Series+of+Cyclopentane-Containing+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3%2F4A+Protease+Leading+to+the+Discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592Activity%2520Relationship%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Cyclopentane-Containing%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%252F4A%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reesink, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weegink, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forestier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vliet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van De Wetering De Rooij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcnair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purdy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P. L. M.</span><span> </span><span class="NLM_article-title">Rapid Decline of Viral RNA in Hepatitis C Patients Treated with VX-950: A Phase Ib, Placebo-Controlled, Randomized Study</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=997&author=H.+W.+Reesinkauthor=S.+Zeuzemauthor=C.+J.+Weeginkauthor=N.+Forestierauthor=A.+Van+Vlietauthor=J.+Van+De+Wetering+De+Rooijauthor=L.+Mcnairauthor=S.+Purdyauthor=R.+Kauffmanauthor=J.+Alamauthor=P.+L.+M.+Jansen&title=Rapid+Decline+of+Viral+RNA+in+Hepatitis+C+Patients+Treated+with+VX-950%3A+A+Phase+Ib%2C+Placebo-Controlled%2C+Randomized+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReesink%26aufirst%3DH.%2BW.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DWeegink%26aufirst%3DC.%2BJ.%26aulast%3DForestier%26aufirst%3DN.%26aulast%3DVan%2BVliet%26aufirst%3DA.%26aulast%3DVan%2BDe%2BWetering%2BDe%2BRooij%26aufirst%3DJ.%26aulast%3DMcnair%26aufirst%3DL.%26aulast%3DPurdy%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJansen%26aufirst%3DP.%2BL.%2BM.%26atitle%3DRapid%2520Decline%2520of%2520Viral%2520RNA%2520in%2520Hepatitis%2520C%2520Patients%2520Treated%2520with%2520VX-950%253A%2520A%2520Phase%2520Ib%252C%2520Placebo-Controlled%252C%2520Randomized%2520Study%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+Modern+Drug+Discovery%3A+A+Case+Study+of+Boceprevir%2C+an+HCV+Protease+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520Modern%2520Drug%2520Discovery%253A%2520A%2520Case%2520Study%2520of%2520Boceprevir%252C%2520an%2520HCV%2520Protease%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+Modeling+Based+Approach+to+Potent+P2-P4+Macrocyclic+Inhibitors+of+Hepatitis+C+NS3%2F4A+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520Modeling%2520Based%2520Approach%2520to%2520Potent%2520P2-P4%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520NS3%252F4A%2520Protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Bismacrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Bismacrocyclic+Inhibitors+of+Hepatitis+C+NS3%2F4A+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DBismacrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520NS3%252F4A%2520Protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCauley, J. A.; Rudd, M. T.; McIntyre, C. J.; Nguyen, K. T.; Romano, J. J.; Butcher, J. W.; Holloway, M. K.; Wan, B.-L.; Carroll, S. S.; DiMuzio, J. M.; Graham, D. J.; Ludmerer, S. W.; Mao, S.-S.; Stahlhut, M.; Fandozzi, C.; Trainor, N.; Olsen, D. B.; Vacca, J. P.; Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-7009: A Novel Macrocyclic HCV NS3/4A Protease Inhibitor</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 235th National Meeting of the American Chemical Society, New Orleans, LA, April 6−10,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+A.+McCauley&author=M.+T.+Rudd&author=C.+J.+McIntyre&author=K.+T.+Nguyen&author=J.+J.+Romano&author=J.+W.+Butcher&author=M.+K.+Holloway&author=B.-L.+Wan&author=S.+S.+Carroll&author=J.+M.+DiMuzio&author=D.+J.+Graham&author=S.+W.+Ludmerer&author=S.-S.+Mao&author=M.+Stahlhut&author=C.+Fandozzi&author=N.+Trainor&author=D.+B.+Olsen&author=J.+P.+Vacca&author=N.+J.+Liverton&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520MK-7009%253A%2520A%2520Novel%2520Macrocyclic%2520HCV%2520NS3%252F4A%2520Protease%2520Inhibitor%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2008%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">On the Size of the Active Site in Proteases. I. Papain</span> <span class="citation_source-journal">Biochem. Biophy. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+Size+of+the+Active+Site+in+Proteases.+I.+Papain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0lizBq0pNiNs8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520Size%2520of%2520the%2520Active%2520Site%2520in%2520Proteases.%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophy.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mao%2C+S.-S.%3B+DiMuzio%2C+J.%3B+McHale%2C+C.%3B+Burlein%2C+C.%3B+Olsen%2C+D.+B.%3B+Carroll%2C+S.+S.Anal.+Biochem.+2008%2C+373%2C+1%E2%80%938"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassini, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosserman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldrup, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">Characterization of Resistance to Non-Obligate Chain-Terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49164</span><span class="NLM_x">–</span> <span class="NLM_lpage">49170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1074%2Fjbc.M305041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=12966103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49164-49170&author=G.+Migliaccioauthor=J.+E.+Tomassiniauthor=S.+S.+Carrollauthor=L.+Tomeiauthor=S.+Altamuraauthor=B.+Bhatauthor=L.+Bartholomewauthor=M.+R.+Bossermanauthor=A.+Ceccacciauthor=L.+F.+Colwellauthor=R.+Corteseauthor=R.+De+Francescoauthor=A.+B.+Eldrupauthor=K.+L.+Gettyauthor=X.+S.+Houauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmererauthor=M.+MacCossauthor=D.+R.+McMastersauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=O.+A.+Flores&title=Characterization+of+Resistance+to+Non-Obligate+Chain-Terminating+Ribonucleoside+Analogs+That+Inhibit+Hepatitis+C+Virus+Replication+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span></div><div class="casAuthors">Migliaccio, Giovanni; Tomassini, Joanne E.; Carroll, Steven S.; Tomei, Licia; Altamura, Sergio; Bhat, Balkrishen; Bartholomew, Linda; Bosserman, Michele R.; Ceccacci, Alessandra; Colwell, Lawrence F.; Cortese, Riccardo; De Francesco, Raffaele; Eldrup, Anne B.; Getty, Krista L.; Hou, Xiaoli S.; LaFemina, Robert L.; Ludmerer, Steven W.; MacCoss, Malcolm; McMasters, Daniel R.; Stahlhut, Mark W.; Olsen, David B.; Hazuda, Daria J.; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49164-49170</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes.  We demonstrate that 2'-C-Me ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication.  Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compds. in both replicon and isolated polymerase assays.  Biochem. analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog.  Importantly, the combination of these agents with interferon-α results in synergistic inhibition of HCV genome replication in cell culture.  Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses.  These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacol. profile, suggest that this class of compds. may have broad utility in the treatment of HCV and other flavivirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Zeuc5zFmbbVg90H21EOLACvtfcHk0ljtHrneyDkVfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D&md5=a7183ce208fe008e48c7a1a83ef66e85</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305041200%26sid%3Dliteratum%253Aachs%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DBosserman%26aufirst%3DM.%2BR.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DCharacterization%2520of%2520Resistance%2520to%2520Non-Obligate%2520Chain-Terminating%2520Ribonucleoside%2520Analogs%2520That%2520Inhibit%2520Hepatitis%2520C%2520Virus%2520Replication%2520in%2520Vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49164%26epage%3D49170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of Subgenomic Hepatitis C Virus RNA’s in a Hepatoma Cell Line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.+Kochauthor=U.+Henanauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+Subgenomic+Hepatitis+C+Virus+RNA%E2%80%99s+in+a+Hepatoma+Cell+Line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.%26aulast%3DHenan%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520Subgenomic%2520Hepatitis%2520C%2520Virus%2520RNA%25E2%2580%2599s%2520in%2520a%2520Hepatoma%2520Cell%2520Line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wang, X. A.; Sun, L.-Q.; Sit, S. Y.; Sin, Y.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span> US 6,995,174,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wang%2C+X.+A.%3B+Sun%2C+L.-Q.%3B+Sit%2C+S.+Y.%3B+Sin%2C+Y.%3B+Scola%2C+P.+M.%3B+Hewawasam%2C+P.%3B+Good%2C+A.+C.%3B+Chen%2C+Y.%3B+Campbell%2C+J.+A.+US+6%2C995%2C174%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BA.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gosselin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Shea, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R. P.</span><span> </span><span class="NLM_article-title">Oxazolidine Ring Opening and Isomerization to (<i>E</i>)-Imines. Asymmetric Synthesis of Aryl-a-fluoroalkyl Amino Alcohols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol036486g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=641&author=F.+Gosselinauthor=A.+Royauthor=P.+D.+O%27Sheaauthor=C.+Chenauthor=R.+P.+Volante&title=Oxazolidine+Ring+Opening+and+Isomerization+to+%28E%29-Imines.+Asymmetric+Synthesis+of+Aryl-a-fluoroalkyl+Amino+Alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fol036486g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036486g%26sid%3Dliteratum%253Aachs%26aulast%3DGosselin%26aufirst%3DF.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DO%2527Shea%26aufirst%3DP.%2BD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DVolante%26aufirst%3DR.%2BP.%26atitle%3DOxazolidine%2520Ring%2520Opening%2520and%2520Isomerization%2520to%2520%2528E%2529-Imines.%2520Asymmetric%2520Synthesis%2520of%2520Aryl-a-fluoroalkyl%2520Amino%2520Alcohols%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pattenden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span> </span><span class="NLM_article-title">Transannular Cyclization as a Stratagem in Synthesis. Total Synthesis of (±)-Pentalenene</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5637</span><span class="NLM_x">–</span> <span class="NLM_lpage">5652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=5637-5652&author=G.+Pattendenauthor=S.+J.+Teague&title=Transannular+Cyclization+as+a+Stratagem+in+Synthesis.+Total+Synthesis+of+%28%C2%B1%29-Pentalenene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPattenden%26aufirst%3DG.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26atitle%3DTransannular%2520Cyclization%2520as%2520a%2520Stratagem%2520in%2520Synthesis.%2520Total%2520Synthesis%2520of%2520%2528%25C2%25B1%2529-Pentalenene%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D5637%26epage%3D5652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Beeson, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacMillan, D. W. C.</span><span> </span><span class="NLM_article-title">Enantioselective Organocatalytic alpha-Fluorination of Aldehydes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">8826</span><span class="NLM_x">–</span> <span class="NLM_lpage">8828</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja051805f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=8826-8828&author=T.+D.+Beesonauthor=D.+W.+C.+MacMillan&title=Enantioselective+Organocatalytic+alpha-Fluorination+of+Aldehydes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja051805f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja051805f%26sid%3Dliteratum%253Aachs%26aulast%3DBeeson%26aufirst%3DT.%2BD.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.%2BC.%26atitle%3DEnantioselective%2520Organocatalytic%2520alpha-Fluorination%2520of%2520Aldehydes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D8826%26epage%3D8828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; Mccauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.; Mcintyre, C. J.</span><span> </span><span class="NLM_article-title">Preparation of Macrocyclic Compounds as HCV NS3 Protease Inhibitors</span>. U.S. Pat. Appl. Publ. 2007/027071,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+Mccauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&author=C.+J.+Mcintyre&title=Preparation+of+Macrocyclic+Compounds+as+HCV+NS3+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520Macrocyclic%2520Compounds%2520as%2520HCV%2520NS3%2520Protease%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Zhan 1 catalyst, [1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-yl](dichloro)[5-chloro-2-(propan-2-yloxy)benzylidene]ruthenium, is available from Zannan Pharma:<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0019.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">No effort was made to assign the absolute stereochemistry of the diastereoisomers of the ring closing products <b>10c</b>−<b>e</b>. In all cases the first diastereoisomers of <b>10c</b>−<b>e</b> eluted during RP-HPLC purification gave rise to the more active inhibitors. Compounds <b>13a</b>, <b>17a</b>, and <b>18a</b> showed 7- to 89-fold improved enzyme inhibition over <b>13b</b>, <b>17b</b>, and <b>18b</b>, respectively. On the basis of our expectation that (12<i>R</i>)-stereochemistry is favorable for interaction with NS3 (see <a class="ref internalNav" href="#sec4" aria-label="Results and Discussion">Results and Discussion</a> in main text for compounds <b>12a</b> and <b>12b</b>; note the change of Cahn−Ingold−Prelog priorities for the nonfluorinated analogues <b>13</b>, <b>17</b>, and <b>18</b>), the first eluted isomers of <b>10c</b>−<b>e</b> (as well as compounds derived from these intermediates) are depicted and named as the (12<i>R</i>)-diastereoisomers.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Crescenzi, B.; Donghi, M.; Ferrara, M.; Gardelli, C.; Harper, S.; Koch, U.; Rowley, M.; Summa, V.</span><span> </span><span class="NLM_article-title">Preparation of Peptidyl Macrocyclic Compounds as Antiviral Agents</span>. PCT Int. Appl. WO 2007148135,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+Crescenzi&author=M.+Donghi&author=M.+Ferrara&author=C.+Gardelli&author=S.+Harper&author=U.+Koch&author=M.+Rowley&author=V.+Summa&title=Preparation+of+Peptidyl+Macrocyclic+Compounds+as+Antiviral+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCrescenzi%26aufirst%3DB.%26atitle%3DPreparation%2520of%2520Peptidyl%2520Macrocyclic%2520Compounds%2520as%2520Antiviral%2520Agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">NOESY experiments were performed in DMSO-<i>d</i><sub>6</sub> at 600 MHz and 294 K with mixing times varying from 100 to 200 ms. Interproton distances were estimated using the isolated spin−pair approximation (calibration performed on the geminal protons of the vinyl group in P1); NOE intensities were classified as strong, medium, or weak and compared to distances generated by molecular modeling analysis (Monte Carlo simulation). For compound <b>16</b>, modeling clearly indicated different conformational preferences for the proline amide bond of the <i>R</i>- or <i>S</i>-trifluoromethylglycine analogues; the <i>Z</i>-amide is preferred for the 10-<i>R</i> epimer, while the <i>E</i>-amide is preferred for the 10-<i>S</i>. NOESY experiments detected two strong NOEs between H<sub>10</sub> and both H24/24′, while no NOE was detected between H<sub>10</sub> and H<sub>7</sub>. These results are consistent only with <i>Z</i>-conformation around the proline amide bond and support <i>R</i>-configuration at C<sub>10</sub>.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0020.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>Compounds <b>35a</b>,<b>b</b> were available through routine protecting group changes from intermediates described in the following published patent application: <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span><span class="NLM_string-name">Thorstensson, F.</span><span class="NLM_string-name">ohansson, P.-O.</span><span class="NLM_string-name">Kvarnström, I.</span><span class="NLM_string-name">Ayesa, S.</span><span class="NLM_string-name">Classon, B.</span><span class="NLM_string-name">Rakos, L.</span><span class="NLM_string-name">Samuelsson, B.</span></span><span> </span><span class="NLM_article-title">HCV NS-3 Serine Protease Inhibitors</span>. WO 2005/073216,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=+&author=+&author=+&author=+&author=+&author=+&author=+&author=+&title=HCV+NS-3+Serine+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DHCV%2520NS-3%2520Serine%2520Protease%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+Selective%2C+Potent%2C+Orally+Bioavailable+Hepatitis+C+Virus+NS3+Protease+Inhibitor%3A+A+Potential+Therapeutic+Agent+for+the+Treatment+of+Hepatitis+C+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520Selective%252C%2520Potent%252C%2520Orally%2520Bioavailable%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%253A%2520A%2520Potential%2520Therapeutic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800940u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=336-346&author=S.+Venkatramanauthor=F.+Velazquezauthor=W.+Wuauthor=M.+Blackmanauthor=K.+X.+Chenauthor=S.+Bogenauthor=L.+Nairauthor=X.+Tongauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=J.+Pichardoauthor=A.+Prongayauthor=K.-C.+Chengauthor=V.+Girijavallabhanauthor=J.+Piwinskiauthor=N.-Y.+Shihauthor=F.+G.+Njoroge&title=Discovery+and+Structure%E2%88%92Activity+Relationship+of+P1%E2%88%92P3+Ketoamide+Derived+Macrocyclic+Inhibitors+of+Hepatitis+C+Virus+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800940u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800940u%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBlackman%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520P1%25E2%2588%2592P3%2520Ketoamide%2520Derived%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D336%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">For a review on macrocyclic inhibitors of HCV NS3 protease, see the following: </p></div><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.2174%2F156802607781212202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=17627558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1290-1301&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+Inhibitors+of+HCV+NS3-4A+Protease%3A+Design+and+Structure+Activity+Relationship"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3-4A protease: design and structure activity relationship</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1290-1301</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HCV NS3, a serine protease, that when bound to NS-4A cofactor facilitates development of mature virons by catalyzing cleavage of a single polyprotein to form functional and structural proteins of HCV.  X-ray structure of the enzyme reveal a very shallow binding pocket at the catalytic site which makes development of inhibitors a daunting task.  Various novel approaches have been used to design, preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 residues and P1-P3 groups.  The design and structure activity relationship of these macrocyclic inhibitors are reviewed in the following article.  X-ray structure of inhibitor bound to the active site of the enzyme is also discussed.  Macrocyclization proved to be an effective tool for depeptidization of peptidic inhibitors, imparting enhanced metabolic stability and improved pharmacokinetic properties in the resultant mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhDndFaOnLrVg90H21EOLACvtfcHk0lhB5E4EIKdznA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP&md5=da704c17e2ed4f3780d550c1b81348fa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F156802607781212202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212202%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520HCV%2520NS3-4A%2520Protease%253A%2520Design%2520and%2520Structure%2520Activity%2520Relationship%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1290%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>Occasional reports of tripeptide-like inhibitors of the HCV NS3 protease in which the P3-N atom is uncapped (and/or is basic) have appeared in the patent literature, e.g., WO2005/051410. During the preparation of this manuscript two relevant patent applications appeared: WO2008/070733 reports a series of P1−P3 macrocyclic inhibitors containing a basic P3-N atom; WO2008/060927 reports a series of acyclic tripeptide analogues that feature aromatic or heteroaromatic P3-capping groups.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Occasional+reports+of+tripeptide-like+inhibitors+of+the+HCV+NS3+protease+in+which+the+P3-N+atom+is+uncapped+%28and%2For+is+basic%29+have+appeared+in+the+patent+literature%2C+e.g.%2C+WO2005%2F051410.+During+the+preparation+of+this+manuscript+two+relevant+patent+applications+appeared%3A+WO2008%2F070733+reports+a+series+of+P1%E2%88%92P3+macrocyclic+inhibitors+containing+a+basic+P3-N+atom%3B+WO2008%2F060927+reports+a+series+of+acyclic+tripeptide+analogues+that+feature+aromatic+or+heteroaromatic+P3-capping+groups."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Evolution, Synthesis and SAR of Tripeptide α-Ketoacid Inhibitors of the Hepatitis C Virus NS3/NS4A Serine Protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=705-708&author=S.+Colarussoauthor=B.+Gerlachauthor=U.+Kochauthor=E.+Muragliaauthor=I.+Conteauthor=I.+Stansfieldauthor=V.+G.+Matassaauthor=F.+Narjes&title=Evolution%2C+Synthesis+and+SAR+of+Tripeptide+%CE%B1-Ketoacid+Inhibitors+of+the+Hepatitis+C+Virus+NS3%2FNS4A+Serine+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DGerlach%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DEvolution%252C%2520Synthesis%2520and%2520SAR%2520of%2520Tripeptide%2520%25CE%25B1-Ketoacid%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%252FNS4A%2520Serine%2520Protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D705%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volonterio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanda, M.</span><span> </span><span class="NLM_article-title">The Trifluoroethylamine Function as Peptide Bond Replacement</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1002%2Fcmdc.200700156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=17823898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlWlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1693-1700&author=M.+Saniauthor=A.+Volonterioauthor=M.+Zanda&title=The+Trifluoroethylamine+Function+as+Peptide+Bond+Replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">The trifluoroethylamine function as peptide bond replacement</span></div><div class="casAuthors">Sani, Monica; Volonterio, Alessandro; Zanda, Matteo</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693-1700</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Synthesis of peptidomimetics contg. a stereogenic trifluoroethylamine group in place of the peptide bond is discussed.  Peptidomimetics contg. the trifluoroethylamine group in place of amide group have been found to be highly potent and metabolically stable inhibitors of cathepsin K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpycpD6uKgMT7Vg90H21EOLACvtfcHk0li0_qws6V938A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlWlt7c%253D&md5=f319f5ec15482837b159ae6776302717</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700156%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.%26aulast%3DVolonterio%26aufirst%3DA.%26aulast%3DZanda%26aufirst%3DM.%26atitle%3DThe%2520Trifluoroethylamine%2520Function%2520as%2520Peptide%2520Bond%2520Replacement%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1693%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarias, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N:</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span> </span><span class="NLM_article-title">Trifluoroethylamines as Amide Isosteres in Inhibitors of Cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4741</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1016%2Fj.bmcl.2005.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=16154747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4741-4744&author=W.+C.+Blackauthor=C.+I.+Baylyauthor=D.+E.+Davisauthor=S.+Desmariasauthor=J.-P.+Falgueyretauthor=S.+L%C3%A9gerauthor=C.+S.+Liauthor=F.+Mass%C3%A9author=D.+J.+McKayauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=J.+Robichaudauthor=N%3A+Tsouauthor=R.+Zamboni&title=Trifluoroethylamines+as+Amide+Isosteres+in+Inhibitors+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K</span></div><div class="casAuthors">Black, W. Cameron; Bayly, Christopher I.; Davis, Dana E.; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Leger, Serge; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Palmer, James T.; Percival, M. David; Robichaud, Joel; Tsou, Nancy; Zamboni, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4741-4744</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The P2-P3 amide of dipeptide cathepsin K inhibitors can be replaced by the metabolically stable trifluoroethylamine group.  The nonbasic nature of the nitrogen allows the important hydrogen bond to Gly66 to be made.  The resulting compds. are 10- to 20-fold more potent than the corresponding amide derivs.  Compd. (I) is a 5 pM inhibitor of human cathepsin K with >10,000-fold selectivity over other cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJDCfyMa_crVg90H21EOLACvtfcHk0li0_qws6V938A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE&md5=c2ffc9bde9fbee7bb432d3c2485cfc62</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DDesmarias%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DTsou%26aufirst%3DN%253A%26aulast%3DZamboni%26aufirst%3DR.%26atitle%3DTrifluoroethylamines%2520as%2520Amide%2520Isosteres%2520in%2520Inhibitors%2520of%2520Cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4741%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">The conformational analysis of <b>12a</b> and <b>12b</b> was performed in the absence of the protein using Macromodel and MMFFs as implemented in Maestro7.5. Low energy conformations were sampled, and the backbone atoms of each were first superimposed to a covalent inhibitor from a cocrystal structure and subsequently minimized.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">Full details of this compound class will be published elsewhere.</p></div><span class="NLM_contrib-group">McCauley, J. A.; McIntyre, C. M.; Rudd, M. T.; Nguyen, K. T.; Romano, J. J.; Butcher, J. W.; Gilbert, K. F.; Bush, K. J.; Holloway, K.; Swestock, J.; Wan, B.-L.; Carroll, S. S.; DiMuzio, J. M.; Graham, D. J.; Ludmerer, S. W.; Mao, S.-S.; Stahlhut, M. W.; Fandozzi, C. M.; Trainor, N.; Olsen, D. B.; Vacca, J. P.; Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery and Characterisation of MK-7009, a Macrocyclic Hepatitis C NS3/4a Protease Inhibitor</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Full+details+of+this+compound+class+will+be+published+elsewhere.McCauley%2C+J.+A.%3B+McIntyre%2C+C.+M.%3B+Rudd%2C+M.+T.%3B+Nguyen%2C+K.+T.%3B+Romano%2C+J.+J.%3B+Butcher%2C+J.+W.%3B+Gilbert%2C+K.+F.%3B+Bush%2C+K.+J.%3B+Holloway%2C+K.%3B+Swestock%2C+J.%3B+Wan%2C+B.-L.%3B+Carroll%2C+S.+S.%3B+DiMuzio%2C+J.+M.%3B+Graham%2C+D.+J.%3B+Ludmerer%2C+S.+W.%3B+Mao%2C+S.-S.%3B+Stahlhut%2C+M.+W.%3B+Fandozzi%2C+C.+M.%3B+Trainor%2C+N.%3B+Olsen%2C+D.+B.%3B+Vacca%2C+J.+P.%3B+Liverton%2C+N.+J.+Discovery+and+Characterisation+of+MK-7009%2C+a+Macrocyclic+Hepatitis+C+NS3%2F4a+Protease+Inhibitor.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520and%2520Characterisation%2520of%2520MK-7009%252C%2520a%2520Macrocyclic%2520Hepatitis%2520C%2520NS3%252F4a%2520Protease%2520Inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Predicted p<i>K</i><sub>a</sub> values were calculated using Advanced Chemistry Development ACD Laboratories p<i>K</i><sub>a</sub> DB software, version 11.01.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Predicted+pKa+values+were+calculated+using+Advanced+Chemistry+Development+ACD+Laboratories+pKa+DB+software%2C+version+11.01."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klabe, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacheler, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span> </span><span class="NLM_article-title">Design and Selection of DMP 850 and DMP 851: The Next Generation of Cyclic Urea HIV Protease Inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1016%2FS1074-5521%2898%2990117-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=9818151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADyaK1cXntVSgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=597-608&author=J.+D.+Rodgersauthor=P.+Y.+S.+Lamauthor=B.+L.+Johnsonauthor=H.+Wangauthor=S.+S.+Koauthor=S.+P.+Seitzauthor=G.+L.+Trainorauthor=P.+S.+Andersonauthor=R.+M.+Klabeauthor=L.+T.+Bachelerauthor=B.+Cordovaauthor=S.+Garberauthor=C.+Reidauthor=M.+R.+Wrightauthor=+Changauthor=S.+Erickson-Viitanen&title=Design+and+Selection+of+DMP+850+and+DMP+851%3A+The+Next+Generation+of+Cyclic+Urea+HIV+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors</span></div><div class="casAuthors">Rodgers, James D.; Lam, Patrick Y. S.; Johnson, Barry L.; Wang, Haisheng; Ko, Soo S.; Seitz, Steven P.; Trainor, George L.; Anderson, Paul S.; Klabe, Ronald M.; Bacheler, Lee T.; Cordova, Beverly; Garber, Sena; Reid, Carol; Wright, Matthew R.; Chang, Chong-Hwan; Erickson-Viitanen, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Recent clin. trials have demonstrated that HIV protease inhibitors are useful in the treatment of AIDS.  It is necessary, however, to use HIV protease inhibitors in combination with other antiviral agents to inhibit the development of resistance.  The daunting ability of the virus to rapidly generate resistant mutants suggests that there is an ongoing need for new HIV protease inhibitors with superior pharmacokinetic and efficacy profiles.  In our attempts to design and select improved cyclic urea HIV protease inhibitors, we have simultaneously optimized potency, resistance profile, protein binding and oral bioavailability.  We have discovered that nonsym. cyclic ureas contg. a 3-aminoindazole P2 group are potent inhibitors of HIV protease with excellent oral bioavailability.  Furthermore, the 3-aminoindazole group forms four hydrogen bonds with the enzyme and imparts a good resistance profile.  The nonsym. 3-aminoindazoles DMP 850 and DMP 851 were selected as our next generation of cyclic urea HIV protease inhibitors because they achieve 8 h trough blood levels in dog, with a 10 mg/kg dose, at or above the protein-binding-adjusted IC90 value for the worst single mutant - that contg. the lle84→Val mutation.  In selecting our next generation of cyclic urea HIV protease inhibitors, we established a rigorous set of criteria designed to maximize chances for a sustained antiviral effect in HIV-infected individuals.  As DMP 850 and DMP 851 provide plasma levels of free drug that are sufficient to inhibit wild-type HIV and several mutant forms of HIV, they could show improved ability to decrease viral load for clin. significant time periods.  The ultimate success of DMP 850 and DMP 851 in clin. trials might depend on achieving or exceeding the oral bioavailability seen in dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomrtg2uGkdrbVg90H21EOLACvtfcHk0li0_qws6V938A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntVSgtLk%253D&md5=84e17f6e56985037bf7fd9251ddc0358</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2898%2990117-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252898%252990117-X%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DJohnson%26aufirst%3DB.%2BL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DS.%2BS.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DKlabe%26aufirst%3DR.%2BM.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DCordova%26aufirst%3DB.%26aulast%3DGarber%26aufirst%3DS.%26aulast%3DReid%26aufirst%3DC.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DChang%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Selection%2520of%2520DMP%2520850%2520and%2520DMP%2520851%253A%2520The%2520Next%2520Generation%2520of%2520Cyclic%2520Urea%2520HIV%2520Protease%2520Inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1998%26volume%3D5%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><div class="note"><p class="first last">For further examples in which cell-based potency is notably enhanced by generation of zwitterionic inhibitors, see the following. </p></div><span class="NLM_contrib-group">Ikegashira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruha</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6950</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6950&author=K.+Ikegashiraauthor=T.+Okaauthor=S.+Hirashimaauthor=S.+Nojiauthor=H.+Yamanakaauthor=Y.+Haraauthor=T.+Adachiauthor=+Tsuruhaauthor=S.+Doiauthor=Y.+Haseauthor=T.+Noguchiauthor=I.+Andoauthor=N.+Oguraauthor=S.+Ikedaauthor=H.+Hashimoto&title=Discovery+of+Conformationally+Constrained+Tetracyclic+Compounds+as+Potent+Hepatitis+C+Virus+NS5B+RNA+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span></div><div class="casAuthors">Ikegashira, Kazutaka; Oka, Takahiro; Hirashima, Shintaro; Noji, Satoru; Yamanaka, Hiroshi; Hara, Yoshinori; Adachi, Tsuyoshi; Tsuruha, Jun-Ichiro; Doi, Satoki; Hase, Yasunori; Noguchi, Toru; Ando, Izuru; Ogura, Naoki; Ikeda, Satoru; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6950-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a new series of hepatitis C virus NS5B RNA polymerase inhibitors contg. a conformationally constrained tetracyclic scaffold.  SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (I and II) bearing a basic pendent group with high biochem. and cellular potencies.  These compds. displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0S142h4FZLVg90H21EOLACvtfcHk0lhjvli-LGxufg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF&md5=18234c5535779cf60484899c6e63770f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0610245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610245%26sid%3Dliteratum%253Aachs%26aulast%3DIkegashira%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DTsuruha%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DOgura%26aufirst%3DN.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Conformationally%2520Constrained%2520Tetracyclic%2520Compounds%2520as%2520Potent%2520Hepatitis%2520C%2520Virus%2520NS5B%2520RNA%2520Polymerase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">The evaluation of rat liver concentrations 4 h postdose is based on liver time-course studies from previous work (see ref <a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">10b</a>). Plasma <i>T</i><sub>max</sub> values for all compounds reported are below 4 h and are typically in the 0.5−1 h time range.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollazzo, M.</span><span> </span><span class="NLM_article-title">Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">7152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=7152&author=S.+Di+Marcoauthor=M.+Rizziauthor=C.+Volpariauthor=M.+A.+Walshauthor=F.+Narjesauthor=S.+Colarussoauthor=R.+De+Francescoauthor=V.+G.+Matassaauthor=M.+Sollazzo&title=Inhibition+of+the+hepatitis+C+virus+NS3%2F4A+protease.+The+crystal+structures+of+two+protease-inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DWalsh%26aufirst%3DM.%2BA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DSollazzo%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease.%2520The%2520crystal%2520structures%2520of%2520two%2520protease-inhibitor%2520complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D7152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldivar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlbrenner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W. M.</span><span> </span><span class="NLM_article-title">Hepatitis C NS3 Protease Inhibition by Peptidyl-α-ketoamide Inhibitors: Kinetic Mechanism and Structure</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2004&pages=207-216&author=Y.+Liuauthor=V.+S.+Stollauthor=P.+L.+Richardsonauthor=A.+Saldivarauthor=J.+L.+Klausauthor=A.+Mollaauthor=W.+Kohlbrennerauthor=W.+M.+Kati&title=Hepatitis+C+NS3+Protease+Inhibition+by+Peptidyl-%CE%B1-ketoamide+Inhibitors%3A+Kinetic+Mechanism+and+Structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DSaldivar%26aufirst%3DA.%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKohlbrenner%26aufirst%3DW.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DHepatitis%2520C%2520NS3%2520Protease%2520Inhibition%2520by%2520Peptidyl-%25CE%25B1-ketoamide%2520Inhibitors%253A%2520Kinetic%2520Mechanism%2520and%2520Structure%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D421%26spage%3D207%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koch, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Determinants of Substrate Specificity in the NS3 Serine Proteinase of the Hepatitis C Virus</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1997&pages=78&author=J.+O.+Kochauthor=R.+Bartenschlager&title=Determinants+of+Substrate+Specificity+in+the+NS3+Serine+Proteinase+of+the+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DJ.%2BO.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DDeterminants%2520of%2520Substrate%2520Specificity%2520in%2520the%2520NS3%2520Serine%2520Proteinase%2520of%2520the%2520Hepatitis%2520C%2520Virus%26jtitle%3DVirology%26date%3D1997%26volume%3D237%26spage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tsantrizos, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1355&author=T.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+Inhibitors+of+the+NS3+Protease+as+Potential+Therapeutic+Agents+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DT.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520the%2520NS3%2520Protease%2520as%2520Potential%2520Therapeutic%2520Agents%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':[],'ref21':[],'ref22':['cit22'],'ref23':[],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':[],'ref37':['cit37a','cit37b','cit37c','cit37d']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Keith D.  Combrink</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Jan  Thuring</span>, <span class="hlFld-ContribAuthor ">Jianqing  Li</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Min S.  Lee</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Wenying  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Santone</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Eric  Hughes</span>, <span class="hlFld-ContribAuthor ">Caly  Chien</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1708-1729. <a href="https://doi.org/10.1021/jm401840s" title="DOI URL">https://doi.org/10.1021/jm401840s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401840s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BEvaluation%252Bof%252BBMS-605339%25252C%252Ba%252BPotent%252Band%252BOrally%252BEfficacious%252BTripeptidic%252BAcylsulfonamide%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27112013%26date%3D20022014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1708%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1730-1752. <a href="https://doi.org/10.1021/jm500297k" title="DOI URL">https://doi.org/10.1021/jm500297k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500297k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252BAn%252BOrally%252BEfficacious%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24022014%26date%3D05032014%26date%3D13032014%26date%3D24022014%26volume%3D57%26issue%3D5%26spage%3D1730%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Simon</span>, <span class="hlFld-ContribAuthor ">Evelyne  Chelain</span>, and <span class="hlFld-ContribAuthor ">Thierry  Brigaud</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Diastereoselective Synthesis of Enantiopure β-Trifluoromethyl β-Amino Alcohols from Chiral Trifluoromethyl Oxazolidines (Fox). </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (2)
                                     , 604-607. <a href="https://doi.org/10.1021/ol2032174" title="DOI URL">https://doi.org/10.1021/ol2032174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol2032174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol2032174%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DHighly%252BDiastereoselective%252BSynthesis%252Bof%252BEnantiopure%252B%2525CE%2525B2-Trifluoromethyl%252B%2525CE%2525B2-Amino%252BAlcohols%252Bfrom%252BChiral%252BTrifluoromethyl%252BOxazolidines%252B%252528Fox%252529%26aulast%3DSimon%26aufirst%3DJulien%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D02122011%26date%3D22122011%26date%3D20012012%26volume%3D14%26issue%3D2%26spage%3D604%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrien  Quintard</span>. </span><span class="cited-content_cbyCitation_article-title">Copper Catalyzed Decarboxylative Functionalization of Ketoacids. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1002/tcr.202100045" title="DOI URL">https://doi.org/10.1002/tcr.202100045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.202100045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.202100045%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DCopper%252BCatalyzed%252BDecarboxylative%252BFunctionalization%252Bof%252BKetoacids%26aulast%3DQuintard%26aufirst%3DAdrien%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Ricucci</span>, <span class="hlFld-ContribAuthor ">Jean  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Adrien  Quintard</span>. </span><span class="cited-content_cbyCitation_article-title">Organo- and Copper-Multi-Catalyzed Pseudo Four-Component Access to
              gem
              -Difluorohydrins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (27-28)
                                     , 3697-3700. <a href="https://doi.org/10.1002/ejoc.201701459" title="DOI URL">https://doi.org/10.1002/ejoc.201701459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701459%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOrgano-%252Band%252BCopper-Multi-Catalyzed%252BPseudo%252BFour-Component%252BAccess%252Bto%252Bgem%252B-Difluorohydrins%26aulast%3DRicucci%26aufirst%3DAngela%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D27-28%26spage%3D3697%26epage%3D3700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Fischer</span>, <span class="hlFld-ContribAuthor ">Nikolas  Huwyler</span>, <span class="hlFld-ContribAuthor ">Susanne  Wolfrum</span>, <span class="hlFld-ContribAuthor ">Erick M.  Carreira</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Bromo- and Fluorodanicalipin A. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (7)
                                     , 2601-2604. <a href="https://doi.org/10.1002/ange.201510608" title="DOI URL">https://doi.org/10.1002/ange.201510608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201510608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201510608%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BBromo-%252Band%252BFluorodanicalipin%2525E2%252580%252585A%26aulast%3DFischer%26aufirst%3DStefan%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D7%26spage%3D2601%26epage%3D2604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Fischer</span>, <span class="hlFld-ContribAuthor ">Nikolas  Huwyler</span>, <span class="hlFld-ContribAuthor ">Susanne  Wolfrum</span>, <span class="hlFld-ContribAuthor ">Erick M.  Carreira</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Bromo- and Fluorodanicalipin A. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (7)
                                     , 2555-2558. <a href="https://doi.org/10.1002/anie.201510608" title="DOI URL">https://doi.org/10.1002/anie.201510608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201510608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201510608%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BBromo-%252Band%252BFluorodanicalipin%2525E2%252580%252585A%26aulast%3DFischer%26aufirst%3DStefan%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D7%26spage%3D2555%26epage%3D2558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Shi</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5539-5545. <a href="https://doi.org/10.1016/j.bmc.2015.07.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bcompounds%252Bwith%252Bmoderate%252Banti-hepatitis%252BC%252Bvirus%252BNS3%252Bprotease%252Bactivity%252Bin%252Bvitro%26aulast%3DShi%26aufirst%3DFangyuan%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5539%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver R.  Thiel</span>. </span><span class="cited-content_cbyCitation_article-title">Metathesis Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 215-255. <a href="https://doi.org/10.1002/9781118309872.ch5" title="DOI URL">https://doi.org/10.1002/9781118309872.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118309872.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118309872.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DMetathesis%252BReactions%26aulast%3DThiel%26aufirst%3DOliver%2BR.%26date%3D2012%26date%3D2012%26spage%3D215%26epage%3D255%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DApplications%252Bof%252BTransition%252BMetal%252BCatalysis%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DCrawley%26aufirst%3DMatthew%2BL.%26date%3D2012%26volume%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Stephane  Bogen</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Kevin  Chen</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Weing  Yang</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Doll</span>, <span class="hlFld-ContribAuthor ">N.-Y.  Shih</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel fluoro amino acids: synthons for potent macrocyclic HCV NS3 protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (23)
                                     , 3057-3061. <a href="https://doi.org/10.1016/j.tetlet.2010.04.010" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bfluoro%252Bamino%252Bacids%25253A%252Bsynthons%252Bfor%252Bpotent%252Bmacrocyclic%252BHCV%252BNS3%252Bprotease%252Binhibitors%26aulast%3DNair%26aufirst%3DLatha%2BG.%26date%3D2010%26volume%3D51%26issue%3D23%26spage%3D3057%26epage%3D3061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Stephane  Bogen</span>, <span class="hlFld-ContribAuthor ">Sumei  Ruan</span>, <span class="hlFld-ContribAuthor ">Weidong  Pan</span>, <span class="hlFld-ContribAuthor ">Russel  Pike</span>, <span class="hlFld-ContribAuthor ">Xiao  Tong</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhuyan  Guo</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Doll</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 1689-1692. <a href="https://doi.org/10.1016/j.bmcl.2010.01.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTowards%252Bthe%252Bsecond%252Bgeneration%252Bof%252BBoceprevir%25253A%252BDithianes%252Bas%252Ban%252Balternative%252BP2%252Bsubstituent%252Bfor%252B2%25252C2-dimethyl%252Bcycloproyl%252Bproline%252Bin%252BHCV%252BNS3%252Bprotease%252Binhibitors%26aulast%3DNair%26aufirst%3DLatha%2BG.%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D1689%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Pompei</span>, <span class="hlFld-ContribAuthor ">Maria Emilia Di  Francesco</span>, <span class="hlFld-ContribAuthor ">Silvia  Pesci</span>, <span class="hlFld-ContribAuthor ">Uwe  Koch</span>, <span class="hlFld-ContribAuthor ">Sue Ellen  Vignetti</span>, <span class="hlFld-ContribAuthor ">Maria  Veneziano</span>, <span class="hlFld-ContribAuthor ">Paola  Pace</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Novel P2–P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 168-174. <a href="https://doi.org/10.1016/j.bmcl.2009.11.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BP2%2525E2%252580%252593P4%252Bmacrocyclic%252Binhibitors%252Bof%252BHCV%252BNS3%25252F4A%252Bprotease%252Bby%252BP3%252Bsuccinamide%252Bfragment%252Bdepeptidization%252Bstrategy%26aulast%3DPompei%26aufirst%3DMarco%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D168%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Mousumi  Sannigrahi</span>, <span class="hlFld-ContribAuthor ">Stephane  Bogen</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Andrew  Prongay</span>, <span class="hlFld-ContribAuthor ">Xiao  Tong</span>, <span class="hlFld-ContribAuthor ">K.-C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Viyyoor  Girijavallabhan</span>, <span class="hlFld-ContribAuthor ">F.  George Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 567-570. <a href="https://doi.org/10.1016/j.bmcl.2009.11.094" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.094%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DP4%252Bcapped%252Bamides%252Band%252Blactams%252Bas%252BHCV%252BNS3%252Bprotease%252Binhibitors%252Bwith%252Bimproved%252Bpotency%252Band%252BDMPK%252Bprofile%26aulast%3DNair%26aufirst%3DLatha%2BG.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D567%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. P2−P4 Macrocyclic Inhibitors of the HCV NS3 Protease Enzyme</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General retrosynthetic analysis of P2−P4 macrocyclic amine inhibitors <b>12</b>−<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) 6-bromohex-1-ene, Mg, Et<sub>2</sub>O; (ii) RP-HPLC; (iii) Jones reagent, Me<sub>2</sub>CO; (iv) NaBH<sub>3</sub>CN, ZnCl<sub>2</sub>, MeOH; (v) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (vi) (PhSO<sub>2</sub>)<sub>2</sub>NF, <span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>-proline, THF.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) TBTU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA then RP-HPLC; (iii) H<sub>2</sub>(g), Pd/C; (iv) LiOH.H<sub>2</sub>O, THF/H<sub>2</sub>O; (v) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) TBTU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA, then RP-HPLC; (iii) RP-HPLC; (iv) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (v) H<sub>2</sub>(g), Pd/C; (vi) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC; (vii) HCHO, NaBH<sub>3</sub>CN, ZnCl<sub>2</sub>, MeOH, then RP-HPLC.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) TBTU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA, then RP-HPLC; (iii) H<sub>2</sub>(g), Pd/C; (iv) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (v) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) HATU, CH<sub>2</sub>Cl<sub>2</sub>, DIEA; (ii) Zhan I, DCE, TFA; (iii) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (iv) H<sub>2</sub>(g), Pd/C; (v) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) (<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Boc-trifluoromethylglycine, HATU, NMM; (ii) 4 N HCl in 1,4-dioxane; (iii) <b>30</b>, NaBH<sub>3</sub>CN, then RP-HPLC; (iv) Zhan I, DCE, TFA; (v) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O; (vi) TBTU, <b>11</b>, DIEA, DMAP, then RP-HPLC.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) NaBH<sub>3</sub>CN, ZnCl<sub>2</sub>, MeOH; (ii) Boc<sub>2</sub>O, Et<sub>3</sub>N, MeOH; (iii) LiOH·H<sub>2</sub>O, THF/dioxane/H<sub>2</sub>O; (iv) TBTU, DIEA, DMAP; (v) TFA/CH<sub>2</sub>Cl<sub>2</sub>, then RP-HPLC; (vi) Boc-Chg-OH, HATU, Et<sub>3</sub>N; (vii) <b>11</b>, TBTU, DIEA, DMAP.</p></p></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Superposition of urethane inhibitor <b>3</b> (green) with trifluoroethylamine analogues <b>12a</b> (cyan, A) and <b>12b</b> (pink, B) and the proposed binding orientation for compound <b>12a</b> (cyan, C). Inhibitors were minimized and docked into the active site of the genotype 1b NS3/peptide4A crystal structure. The enzyme surface and individual amino acid residues are shown in white (with the exception of the side chain of residue D168 which is shown in red in parts A and B). Potential hydrogen bonding interactions between the ligand and enzyme are shown as broken lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0008.jpeg" id="rightTab-fx1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacokinetic data for P2−P4 macrocyclic compounds measured following oral administration to Sprague−Dawley rats at doses between 3 and 5 mg/kg. Plasma exposure (<i>x</i>-axis, μM·h) was measured as the area under the plasma concentration/time curve between 0 and 4 h; liver concentrations (<i>y</i>-axis, μM) were measured at 4 h. Data are colored according to the heterocycle attached to the P2-hydroxyproline residue, as indicated below the graph. Exposure values and liver concentrations for compounds that were administered at doses below 5 mg/kg are normalized by linear adjustment to 5 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/large/jm-2009-00372w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900372w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wasley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends</span> <span class="citation_source-journal">Semin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1055%2Fs-2000-9506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=10895428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1-16&issue=1&author=A.+Wasleyauthor=M.+J.+Alter&title=Epidemiology+of+Hepatitis+C%3A+Geographic+Differences+and+Temporal+Trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of hepatitis C: geographic differences and temporal trends</span></div><div class="casAuthors">Wasley A; Alter M J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in liver disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    </div><div class="casAbstract">Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%.  However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection.  Using age-specific prevalence data, at least three distinct transmission patterns can be identified.  In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults.  In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past.  In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection.  In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission.  Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV.  Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSp2wQyhQIHd7HHuJhbyicZfW6udTcc2eY4OVnfax_6lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D&md5=7c7736c5229d0104950eace9fa66a3fe</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9506%26sid%3Dliteratum%253Aachs%26aulast%3DWasley%26aufirst%3DA.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DEpidemiology%2520of%2520Hepatitis%2520C%253A%2520Geographic%2520Differences%2520and%2520Temporal%2520Trends%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26issue%3D1%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span> </span><span class="NLM_article-title">National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C 2002</span>.  <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">2082</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Institutes+of+Health+Consensus+Development+Conference+Statement%3A+Management+of+Hepatitis+C+2002.+Gastroenterology+2002%2C+123%2C+2082."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DNational%2520Institutes%2520of%2520Health%2520Consensus%2520Development%2520Conference%2520Statement%253A%2520Management%2520of%2520Hepatitis%2520C%25202002%26jtitle%3DGastroenterology%26date%3D2002%26volume%3D123%26spage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span> </span><span class="NLM_article-title">Peptidomimetic Therapeutic Agents Targeting the Protease Enzyme of the Human Immunodeficiency Virus and Hepatitis C Virus</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1252-1263&author=Y.+S.+Tsantrizos&title=Peptidomimetic+Therapeutic+Agents+Targeting+the+Protease+Enzyme+of+the+Human+Immunodeficiency+Virus+and+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Far8000519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000519%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPeptidomimetic%2520Therapeutic%2520Agents%2520Targeting%2520the%2520Protease%2520Enzyme%2520of%2520the%2520Human%2520Immunodeficiency%2520Virus%2520and%2520Hepatitis%2520C%2520Virus%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1252%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-Nucleoside Inhibitors of the HCV NS5B Polymerase: Progress in the Discovery and Development of Novel Agents for the Treatment of HCV Infections</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-Nucleoside+Inhibitors+of+the+HCV+NS5B+Polymerase%3A+Progress+in+the+Discovery+and+Development+of+Novel+Agents+for+the+Treatment+of+HCV+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-Nucleoside%2520Inhibitors%2520of%2520the%2520HCV%2520NS5B%2520Polymerase%253A%2520Progress%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Novel%2520Agents%2520for%2520the%2520Treatment%2520of%2520HCV%2520Infections%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfí, A.</span><span> </span><span class="NLM_article-title">Advances in the Development of New Therapeutic Agents Targeting the NS3-4A Serine Protease or the NS5B RNA-Dependent RNA Polymerase of the Hepatitis C Virus</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1242</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=1242-1262&author=R.+De+Francescoauthor=A.+Carf%C3%AD&title=Advances+in+the+Development+of+New+Therapeutic+Agents+Targeting+the+NS3-4A+Serine+Protease+or+the+NS5B+RNA-Dependent+RNA+Polymerase+of+the+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DCarf%25C3%25AD%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520Development%2520of%2520New%2520Therapeutic%2520Agents%2520Targeting%2520the%2520NS3-4A%2520Serine%2520Protease%2520or%2520the%2520NS5B%2520RNA-Dependent%2520RNA%2520Polymerase%2520of%2520the%2520Hepatitis%2520C%2520Virus%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2007%26volume%3D59%26spage%3D1242%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 Protease Inhibitor with Antiviral Effects in Humans Infected with Hepatitis C Virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+Boesauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagaceauthor=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llinas-Brunet&title=An+NS3+Protease+Inhibitor+with+Antiviral+Effects+in+Humans+Infected+with+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0licAtCrFgqzEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBoes%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt.%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520Protease%2520Inhibitor%2520with%2520Antiviral%2520Effects%2520in%2520Humans%2520Infected%2520with%2520Hepatitis%2520C%2520Virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+Characteristics+of+the+Hepatitis+C+Virus+NS3%2F4A+Protease+Inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520Characteristics%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%252F4A%2520Protease%2520Inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−Activity Relationship Study on a Novel Series of Cyclopentane-Containing Macrocyclic Inhibitors of the Hepatitis C Virus NS3/4A Protease Leading to the Discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92Activity+Relationship+Study+on+a+Novel+Series+of+Cyclopentane-Containing+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3%2F4A+Protease+Leading+to+the+Discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592Activity%2520Relationship%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Cyclopentane-Containing%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%252F4A%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reesink, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weegink, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forestier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vliet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van De Wetering De Rooij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcnair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purdy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P. L. M.</span><span> </span><span class="NLM_article-title">Rapid Decline of Viral RNA in Hepatitis C Patients Treated with VX-950: A Phase Ib, Placebo-Controlled, Randomized Study</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=997&author=H.+W.+Reesinkauthor=S.+Zeuzemauthor=C.+J.+Weeginkauthor=N.+Forestierauthor=A.+Van+Vlietauthor=J.+Van+De+Wetering+De+Rooijauthor=L.+Mcnairauthor=S.+Purdyauthor=R.+Kauffmanauthor=J.+Alamauthor=P.+L.+M.+Jansen&title=Rapid+Decline+of+Viral+RNA+in+Hepatitis+C+Patients+Treated+with+VX-950%3A+A+Phase+Ib%2C+Placebo-Controlled%2C+Randomized+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReesink%26aufirst%3DH.%2BW.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DWeegink%26aufirst%3DC.%2BJ.%26aulast%3DForestier%26aufirst%3DN.%26aulast%3DVan%2BVliet%26aufirst%3DA.%26aulast%3DVan%2BDe%2BWetering%2BDe%2BRooij%26aufirst%3DJ.%26aulast%3DMcnair%26aufirst%3DL.%26aulast%3DPurdy%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DJansen%26aufirst%3DP.%2BL.%2BM.%26atitle%3DRapid%2520Decline%2520of%2520Viral%2520RNA%2520in%2520Hepatitis%2520C%2520Patients%2520Treated%2520with%2520VX-950%253A%2520A%2520Phase%2520Ib%252C%2520Placebo-Controlled%252C%2520Randomized%2520Study%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+Modern+Drug+Discovery%3A+A+Case+Study+of+Boceprevir%2C+an+HCV+Protease+Inhibitor+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520Modern%2520Drug%2520Discovery%253A%2520A%2520Case%2520Study%2520of%2520Boceprevir%252C%2520an%2520HCV%2520Protease%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+Modeling+Based+Approach+to+Potent+P2-P4+Macrocyclic+Inhibitors+of+Hepatitis+C+NS3%2F4A+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520Modeling%2520Based%2520Approach%2520to%2520Potent%2520P2-P4%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520NS3%252F4A%2520Protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Bismacrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Bismacrocyclic+Inhibitors+of+Hepatitis+C+NS3%2F4A+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DBismacrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520NS3%252F4A%2520Protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McCauley, J. A.; Rudd, M. T.; McIntyre, C. J.; Nguyen, K. T.; Romano, J. J.; Butcher, J. W.; Holloway, M. K.; Wan, B.-L.; Carroll, S. S.; DiMuzio, J. M.; Graham, D. J.; Ludmerer, S. W.; Mao, S.-S.; Stahlhut, M.; Fandozzi, C.; Trainor, N.; Olsen, D. B.; Vacca, J. P.; Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-7009: A Novel Macrocyclic HCV NS3/4A Protease Inhibitor</span>.  <span class="citation_source-book">Abstracts of Papers</span>, 235th National Meeting of the American Chemical Society, New Orleans, LA, April 6−10,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span><span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+A.+McCauley&author=M.+T.+Rudd&author=C.+J.+McIntyre&author=K.+T.+Nguyen&author=J.+J.+Romano&author=J.+W.+Butcher&author=M.+K.+Holloway&author=B.-L.+Wan&author=S.+S.+Carroll&author=J.+M.+DiMuzio&author=D.+J.+Graham&author=S.+W.+Ludmerer&author=S.-S.+Mao&author=M.+Stahlhut&author=C.+Fandozzi&author=N.+Trainor&author=D.+B.+Olsen&author=J.+P.+Vacca&author=N.+J.+Liverton&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520MK-7009%253A%2520A%2520Novel%2520Macrocyclic%2520HCV%2520NS3%252F4A%2520Protease%2520Inhibitor%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2008%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">On the Size of the Active Site in Proteases. I. Papain</span> <span class="citation_source-journal">Biochem. Biophy. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+Size+of+the+Active+Site+in+Proteases.+I.+Papain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0liAHUCxhO5gLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520Size%2520of%2520the%2520Active%2520Site%2520in%2520Proteases.%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophy.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mao%2C+S.-S.%3B+DiMuzio%2C+J.%3B+McHale%2C+C.%3B+Burlein%2C+C.%3B+Olsen%2C+D.+B.%3B+Carroll%2C+S.+S.Anal.+Biochem.+2008%2C+373%2C+1%E2%80%938"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassini, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosserman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldrup, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">Characterization of Resistance to Non-Obligate Chain-Terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49164</span><span class="NLM_x">–</span> <span class="NLM_lpage">49170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1074%2Fjbc.M305041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=12966103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49164-49170&author=G.+Migliaccioauthor=J.+E.+Tomassiniauthor=S.+S.+Carrollauthor=L.+Tomeiauthor=S.+Altamuraauthor=B.+Bhatauthor=L.+Bartholomewauthor=M.+R.+Bossermanauthor=A.+Ceccacciauthor=L.+F.+Colwellauthor=R.+Corteseauthor=R.+De+Francescoauthor=A.+B.+Eldrupauthor=K.+L.+Gettyauthor=X.+S.+Houauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmererauthor=M.+MacCossauthor=D.+R.+McMastersauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=O.+A.+Flores&title=Characterization+of+Resistance+to+Non-Obligate+Chain-Terminating+Ribonucleoside+Analogs+That+Inhibit+Hepatitis+C+Virus+Replication+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span></div><div class="casAuthors">Migliaccio, Giovanni; Tomassini, Joanne E.; Carroll, Steven S.; Tomei, Licia; Altamura, Sergio; Bhat, Balkrishen; Bartholomew, Linda; Bosserman, Michele R.; Ceccacci, Alessandra; Colwell, Lawrence F.; Cortese, Riccardo; De Francesco, Raffaele; Eldrup, Anne B.; Getty, Krista L.; Hou, Xiaoli S.; LaFemina, Robert L.; Ludmerer, Steven W.; MacCoss, Malcolm; McMasters, Daniel R.; Stahlhut, Mark W.; Olsen, David B.; Hazuda, Daria J.; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49164-49170</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes.  We demonstrate that 2'-C-Me ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication.  Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compds. in both replicon and isolated polymerase assays.  Biochem. analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog.  Importantly, the combination of these agents with interferon-α results in synergistic inhibition of HCV genome replication in cell culture.  Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses.  These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacol. profile, suggest that this class of compds. may have broad utility in the treatment of HCV and other flavivirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Zeuc5zFmbbVg90H21EOLACvtfcHk0liAHUCxhO5gLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D&md5=a7183ce208fe008e48c7a1a83ef66e85</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305041200%26sid%3Dliteratum%253Aachs%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DBosserman%26aufirst%3DM.%2BR.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DCharacterization%2520of%2520Resistance%2520to%2520Non-Obligate%2520Chain-Terminating%2520Ribonucleoside%2520Analogs%2520That%2520Inhibit%2520Hepatitis%2520C%2520Virus%2520Replication%2520in%2520Vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49164%26epage%3D49170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of Subgenomic Hepatitis C Virus RNA’s in a Hepatoma Cell Line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.+Kochauthor=U.+Henanauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+Subgenomic+Hepatitis+C+Virus+RNA%E2%80%99s+in+a+Hepatoma+Cell+Line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.%26aulast%3DHenan%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520Subgenomic%2520Hepatitis%2520C%2520Virus%2520RNA%25E2%2580%2599s%2520in%2520a%2520Hepatoma%2520Cell%2520Line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wang, X. A.; Sun, L.-Q.; Sit, S. Y.; Sin, Y.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span> US 6,995,174,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wang%2C+X.+A.%3B+Sun%2C+L.-Q.%3B+Sit%2C+S.+Y.%3B+Sin%2C+Y.%3B+Scola%2C+P.+M.%3B+Hewawasam%2C+P.%3B+Good%2C+A.+C.%3B+Chen%2C+Y.%3B+Campbell%2C+J.+A.+US+6%2C995%2C174%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BA.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gosselin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Shea, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R. P.</span><span> </span><span class="NLM_article-title">Oxazolidine Ring Opening and Isomerization to (<i>E</i>)-Imines. Asymmetric Synthesis of Aryl-a-fluoroalkyl Amino Alcohols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol036486g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=641&author=F.+Gosselinauthor=A.+Royauthor=P.+D.+O%27Sheaauthor=C.+Chenauthor=R.+P.+Volante&title=Oxazolidine+Ring+Opening+and+Isomerization+to+%28E%29-Imines.+Asymmetric+Synthesis+of+Aryl-a-fluoroalkyl+Amino+Alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fol036486g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036486g%26sid%3Dliteratum%253Aachs%26aulast%3DGosselin%26aufirst%3DF.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DO%2527Shea%26aufirst%3DP.%2BD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DVolante%26aufirst%3DR.%2BP.%26atitle%3DOxazolidine%2520Ring%2520Opening%2520and%2520Isomerization%2520to%2520%2528E%2529-Imines.%2520Asymmetric%2520Synthesis%2520of%2520Aryl-a-fluoroalkyl%2520Amino%2520Alcohols%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pattenden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teague, S. J.</span><span> </span><span class="NLM_article-title">Transannular Cyclization as a Stratagem in Synthesis. Total Synthesis of (±)-Pentalenene</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5637</span><span class="NLM_x">–</span> <span class="NLM_lpage">5652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=5637-5652&author=G.+Pattendenauthor=S.+J.+Teague&title=Transannular+Cyclization+as+a+Stratagem+in+Synthesis.+Total+Synthesis+of+%28%C2%B1%29-Pentalenene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPattenden%26aufirst%3DG.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26atitle%3DTransannular%2520Cyclization%2520as%2520a%2520Stratagem%2520in%2520Synthesis.%2520Total%2520Synthesis%2520of%2520%2528%25C2%25B1%2529-Pentalenene%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D5637%26epage%3D5652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Beeson, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacMillan, D. W. C.</span><span> </span><span class="NLM_article-title">Enantioselective Organocatalytic alpha-Fluorination of Aldehydes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">8826</span><span class="NLM_x">–</span> <span class="NLM_lpage">8828</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja051805f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=8826-8828&author=T.+D.+Beesonauthor=D.+W.+C.+MacMillan&title=Enantioselective+Organocatalytic+alpha-Fluorination+of+Aldehydes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja051805f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja051805f%26sid%3Dliteratum%253Aachs%26aulast%3DBeeson%26aufirst%3DT.%2BD.%26aulast%3DMacMillan%26aufirst%3DD.%2BW.%2BC.%26atitle%3DEnantioselective%2520Organocatalytic%2520alpha-Fluorination%2520of%2520Aldehydes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D8826%26epage%3D8828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; Mccauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.; Mcintyre, C. J.</span><span> </span><span class="NLM_article-title">Preparation of Macrocyclic Compounds as HCV NS3 Protease Inhibitors</span>. U.S. Pat. Appl. Publ. 2007/027071,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+Mccauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&author=C.+J.+Mcintyre&title=Preparation+of+Macrocyclic+Compounds+as+HCV+NS3+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DPreparation%2520of%2520Macrocyclic%2520Compounds%2520as%2520HCV%2520NS3%2520Protease%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Zhan 1 catalyst, [1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-yl](dichloro)[5-chloro-2-(propan-2-yloxy)benzylidene]ruthenium, is available from Zannan Pharma:<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0019.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">No effort was made to assign the absolute stereochemistry of the diastereoisomers of the ring closing products <b>10c</b>−<b>e</b>. In all cases the first diastereoisomers of <b>10c</b>−<b>e</b> eluted during RP-HPLC purification gave rise to the more active inhibitors. Compounds <b>13a</b>, <b>17a</b>, and <b>18a</b> showed 7- to 89-fold improved enzyme inhibition over <b>13b</b>, <b>17b</b>, and <b>18b</b>, respectively. On the basis of our expectation that (12<i>R</i>)-stereochemistry is favorable for interaction with NS3 (see <a class="ref internalNav" href="#sec4" aria-label="Results and Discussion">Results and Discussion</a> in main text for compounds <b>12a</b> and <b>12b</b>; note the change of Cahn−Ingold−Prelog priorities for the nonfluorinated analogues <b>13</b>, <b>17</b>, and <b>18</b>), the first eluted isomers of <b>10c</b>−<b>e</b> (as well as compounds derived from these intermediates) are depicted and named as the (12<i>R</i>)-diastereoisomers.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Crescenzi, B.; Donghi, M.; Ferrara, M.; Gardelli, C.; Harper, S.; Koch, U.; Rowley, M.; Summa, V.</span><span> </span><span class="NLM_article-title">Preparation of Peptidyl Macrocyclic Compounds as Antiviral Agents</span>. PCT Int. Appl. WO 2007148135,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+Crescenzi&author=M.+Donghi&author=M.+Ferrara&author=C.+Gardelli&author=S.+Harper&author=U.+Koch&author=M.+Rowley&author=V.+Summa&title=Preparation+of+Peptidyl+Macrocyclic+Compounds+as+Antiviral+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCrescenzi%26aufirst%3DB.%26atitle%3DPreparation%2520of%2520Peptidyl%2520Macrocyclic%2520Compounds%2520as%2520Antiviral%2520Agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">NOESY experiments were performed in DMSO-<i>d</i><sub>6</sub> at 600 MHz and 294 K with mixing times varying from 100 to 200 ms. Interproton distances were estimated using the isolated spin−pair approximation (calibration performed on the geminal protons of the vinyl group in P1); NOE intensities were classified as strong, medium, or weak and compared to distances generated by molecular modeling analysis (Monte Carlo simulation). For compound <b>16</b>, modeling clearly indicated different conformational preferences for the proline amide bond of the <i>R</i>- or <i>S</i>-trifluoromethylglycine analogues; the <i>Z</i>-amide is preferred for the 10-<i>R</i> epimer, while the <i>E</i>-amide is preferred for the 10-<i>S</i>. NOESY experiments detected two strong NOEs between H<sub>10</sub> and both H24/24′, while no NOE was detected between H<sub>10</sub> and H<sub>7</sub>. These results are consistent only with <i>Z</i>-conformation around the proline amide bond and support <i>R</i>-configuration at C<sub>10</sub>.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900372w/production/images/medium/jm-2009-00372w_0020.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>Compounds <b>35a</b>,<b>b</b> were available through routine protecting group changes from intermediates described in the following published patent application: <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span><span class="NLM_string-name">Thorstensson, F.</span><span class="NLM_string-name">ohansson, P.-O.</span><span class="NLM_string-name">Kvarnström, I.</span><span class="NLM_string-name">Ayesa, S.</span><span class="NLM_string-name">Classon, B.</span><span class="NLM_string-name">Rakos, L.</span><span class="NLM_string-name">Samuelsson, B.</span></span><span> </span><span class="NLM_article-title">HCV NS-3 Serine Protease Inhibitors</span>. WO 2005/073216,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=+&author=+&author=+&author=+&author=+&author=+&author=+&author=+&title=HCV+NS-3+Serine+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DHCV%2520NS-3%2520Serine%2520Protease%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+Selective%2C+Potent%2C+Orally+Bioavailable+Hepatitis+C+Virus+NS3+Protease+Inhibitor%3A+A+Potential+Therapeutic+Agent+for+the+Treatment+of+Hepatitis+C+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520Selective%252C%2520Potent%252C%2520Orally%2520Bioavailable%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%253A%2520A%2520Potential%2520Therapeutic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800940u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=336-346&author=S.+Venkatramanauthor=F.+Velazquezauthor=W.+Wuauthor=M.+Blackmanauthor=K.+X.+Chenauthor=S.+Bogenauthor=L.+Nairauthor=X.+Tongauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=J.+Pichardoauthor=A.+Prongayauthor=K.-C.+Chengauthor=V.+Girijavallabhanauthor=J.+Piwinskiauthor=N.-Y.+Shihauthor=F.+G.+Njoroge&title=Discovery+and+Structure%E2%88%92Activity+Relationship+of+P1%E2%88%92P3+Ketoamide+Derived+Macrocyclic+Inhibitors+of+Hepatitis+C+Virus+NS3+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800940u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800940u%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBlackman%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520P1%25E2%2588%2592P3%2520Ketoamide%2520Derived%2520Macrocyclic%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D336%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">For a review on macrocyclic inhibitors of HCV NS3 protease, see the following: </p></div><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.2174%2F156802607781212202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=17627558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1290-1301&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+Inhibitors+of+HCV+NS3-4A+Protease%3A+Design+and+Structure+Activity+Relationship"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3-4A protease: design and structure activity relationship</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1290-1301</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HCV NS3, a serine protease, that when bound to NS-4A cofactor facilitates development of mature virons by catalyzing cleavage of a single polyprotein to form functional and structural proteins of HCV.  X-ray structure of the enzyme reveal a very shallow binding pocket at the catalytic site which makes development of inhibitors a daunting task.  Various novel approaches have been used to design, preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 residues and P1-P3 groups.  The design and structure activity relationship of these macrocyclic inhibitors are reviewed in the following article.  X-ray structure of inhibitor bound to the active site of the enzyme is also discussed.  Macrocyclization proved to be an effective tool for depeptidization of peptidic inhibitors, imparting enhanced metabolic stability and improved pharmacokinetic properties in the resultant mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhDndFaOnLrVg90H21EOLACvtfcHk0lgBfrLNJi5Eng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP&md5=da704c17e2ed4f3780d550c1b81348fa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F156802607781212202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212202%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520HCV%2520NS3-4A%2520Protease%253A%2520Design%2520and%2520Structure%2520Activity%2520Relationship%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1290%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>Occasional reports of tripeptide-like inhibitors of the HCV NS3 protease in which the P3-N atom is uncapped (and/or is basic) have appeared in the patent literature, e.g., WO2005/051410. During the preparation of this manuscript two relevant patent applications appeared: WO2008/070733 reports a series of P1−P3 macrocyclic inhibitors containing a basic P3-N atom; WO2008/060927 reports a series of acyclic tripeptide analogues that feature aromatic or heteroaromatic P3-capping groups.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Occasional+reports+of+tripeptide-like+inhibitors+of+the+HCV+NS3+protease+in+which+the+P3-N+atom+is+uncapped+%28and%2For+is+basic%29+have+appeared+in+the+patent+literature%2C+e.g.%2C+WO2005%2F051410.+During+the+preparation+of+this+manuscript+two+relevant+patent+applications+appeared%3A+WO2008%2F070733+reports+a+series+of+P1%E2%88%92P3+macrocyclic+inhibitors+containing+a+basic+P3-N+atom%3B+WO2008%2F060927+reports+a+series+of+acyclic+tripeptide+analogues+that+feature+aromatic+or+heteroaromatic+P3-capping+groups."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Evolution, Synthesis and SAR of Tripeptide α-Ketoacid Inhibitors of the Hepatitis C Virus NS3/NS4A Serine Protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=705-708&author=S.+Colarussoauthor=B.+Gerlachauthor=U.+Kochauthor=E.+Muragliaauthor=I.+Conteauthor=I.+Stansfieldauthor=V.+G.+Matassaauthor=F.+Narjes&title=Evolution%2C+Synthesis+and+SAR+of+Tripeptide+%CE%B1-Ketoacid+Inhibitors+of+the+Hepatitis+C+Virus+NS3%2FNS4A+Serine+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DGerlach%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DEvolution%252C%2520Synthesis%2520and%2520SAR%2520of%2520Tripeptide%2520%25CE%25B1-Ketoacid%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%252FNS4A%2520Serine%2520Protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D705%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volonterio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanda, M.</span><span> </span><span class="NLM_article-title">The Trifluoroethylamine Function as Peptide Bond Replacement</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1002%2Fcmdc.200700156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=17823898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlWlt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1693-1700&author=M.+Saniauthor=A.+Volonterioauthor=M.+Zanda&title=The+Trifluoroethylamine+Function+as+Peptide+Bond+Replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">The trifluoroethylamine function as peptide bond replacement</span></div><div class="casAuthors">Sani, Monica; Volonterio, Alessandro; Zanda, Matteo</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693-1700</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Synthesis of peptidomimetics contg. a stereogenic trifluoroethylamine group in place of the peptide bond is discussed.  Peptidomimetics contg. the trifluoroethylamine group in place of amide group have been found to be highly potent and metabolically stable inhibitors of cathepsin K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpycpD6uKgMT7Vg90H21EOLACvtfcHk0lgNNYEasYgdTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlWlt7c%253D&md5=f319f5ec15482837b159ae6776302717</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700156%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.%26aulast%3DVolonterio%26aufirst%3DA.%26aulast%3DZanda%26aufirst%3DM.%26atitle%3DThe%2520Trifluoroethylamine%2520Function%2520as%2520Peptide%2520Bond%2520Replacement%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1693%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarias, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N:</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span> </span><span class="NLM_article-title">Trifluoroethylamines as Amide Isosteres in Inhibitors of Cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4741</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1016%2Fj.bmcl.2005.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=16154747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4741-4744&author=W.+C.+Blackauthor=C.+I.+Baylyauthor=D.+E.+Davisauthor=S.+Desmariasauthor=J.-P.+Falgueyretauthor=S.+L%C3%A9gerauthor=C.+S.+Liauthor=F.+Mass%C3%A9author=D.+J.+McKayauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=J.+Robichaudauthor=N%3A+Tsouauthor=R.+Zamboni&title=Trifluoroethylamines+as+Amide+Isosteres+in+Inhibitors+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K</span></div><div class="casAuthors">Black, W. Cameron; Bayly, Christopher I.; Davis, Dana E.; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Leger, Serge; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Palmer, James T.; Percival, M. David; Robichaud, Joel; Tsou, Nancy; Zamboni, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4741-4744</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The P2-P3 amide of dipeptide cathepsin K inhibitors can be replaced by the metabolically stable trifluoroethylamine group.  The nonbasic nature of the nitrogen allows the important hydrogen bond to Gly66 to be made.  The resulting compds. are 10- to 20-fold more potent than the corresponding amide derivs.  Compd. (I) is a 5 pM inhibitor of human cathepsin K with >10,000-fold selectivity over other cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJDCfyMa_crVg90H21EOLACvtfcHk0lgNNYEasYgdTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE&md5=c2ffc9bde9fbee7bb432d3c2485cfc62</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DDesmarias%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DTsou%26aufirst%3DN%253A%26aulast%3DZamboni%26aufirst%3DR.%26atitle%3DTrifluoroethylamines%2520as%2520Amide%2520Isosteres%2520in%2520Inhibitors%2520of%2520Cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4741%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">The conformational analysis of <b>12a</b> and <b>12b</b> was performed in the absence of the protein using Macromodel and MMFFs as implemented in Maestro7.5. Low energy conformations were sampled, and the backbone atoms of each were first superimposed to a covalent inhibitor from a cocrystal structure and subsequently minimized.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">Full details of this compound class will be published elsewhere.</p></div><span class="NLM_contrib-group">McCauley, J. A.; McIntyre, C. M.; Rudd, M. T.; Nguyen, K. T.; Romano, J. J.; Butcher, J. W.; Gilbert, K. F.; Bush, K. J.; Holloway, K.; Swestock, J.; Wan, B.-L.; Carroll, S. S.; DiMuzio, J. M.; Graham, D. J.; Ludmerer, S. W.; Mao, S.-S.; Stahlhut, M. W.; Fandozzi, C. M.; Trainor, N.; Olsen, D. B.; Vacca, J. P.; Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery and Characterisation of MK-7009, a Macrocyclic Hepatitis C NS3/4a Protease Inhibitor</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Full+details+of+this+compound+class+will+be+published+elsewhere.McCauley%2C+J.+A.%3B+McIntyre%2C+C.+M.%3B+Rudd%2C+M.+T.%3B+Nguyen%2C+K.+T.%3B+Romano%2C+J.+J.%3B+Butcher%2C+J.+W.%3B+Gilbert%2C+K.+F.%3B+Bush%2C+K.+J.%3B+Holloway%2C+K.%3B+Swestock%2C+J.%3B+Wan%2C+B.-L.%3B+Carroll%2C+S.+S.%3B+DiMuzio%2C+J.+M.%3B+Graham%2C+D.+J.%3B+Ludmerer%2C+S.+W.%3B+Mao%2C+S.-S.%3B+Stahlhut%2C+M.+W.%3B+Fandozzi%2C+C.+M.%3B+Trainor%2C+N.%3B+Olsen%2C+D.+B.%3B+Vacca%2C+J.+P.%3B+Liverton%2C+N.+J.+Discovery+and+Characterisation+of+MK-7009%2C+a+Macrocyclic+Hepatitis+C+NS3%2F4a+Protease+Inhibitor.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520and%2520Characterisation%2520of%2520MK-7009%252C%2520a%2520Macrocyclic%2520Hepatitis%2520C%2520NS3%252F4a%2520Protease%2520Inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Predicted p<i>K</i><sub>a</sub> values were calculated using Advanced Chemistry Development ACD Laboratories p<i>K</i><sub>a</sub> DB software, version 11.01.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Predicted+pKa+values+were+calculated+using+Advanced+Chemistry+Development+ACD+Laboratories+pKa+DB+software%2C+version+11.01."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klabe, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacheler, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span> </span><span class="NLM_article-title">Design and Selection of DMP 850 and DMP 851: The Next Generation of Cyclic Urea HIV Protease Inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm900372w&amp;key=10.1016%2FS1074-5521%2898%2990117-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm900372w&amp;key=9818151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADyaK1cXntVSgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=597-608&author=J.+D.+Rodgersauthor=P.+Y.+S.+Lamauthor=B.+L.+Johnsonauthor=H.+Wangauthor=S.+S.+Koauthor=S.+P.+Seitzauthor=G.+L.+Trainorauthor=P.+S.+Andersonauthor=R.+M.+Klabeauthor=L.+T.+Bachelerauthor=B.+Cordovaauthor=S.+Garberauthor=C.+Reidauthor=M.+R.+Wrightauthor=+Changauthor=S.+Erickson-Viitanen&title=Design+and+Selection+of+DMP+850+and+DMP+851%3A+The+Next+Generation+of+Cyclic+Urea+HIV+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors</span></div><div class="casAuthors">Rodgers, James D.; Lam, Patrick Y. S.; Johnson, Barry L.; Wang, Haisheng; Ko, Soo S.; Seitz, Steven P.; Trainor, George L.; Anderson, Paul S.; Klabe, Ronald M.; Bacheler, Lee T.; Cordova, Beverly; Garber, Sena; Reid, Carol; Wright, Matthew R.; Chang, Chong-Hwan; Erickson-Viitanen, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Recent clin. trials have demonstrated that HIV protease inhibitors are useful in the treatment of AIDS.  It is necessary, however, to use HIV protease inhibitors in combination with other antiviral agents to inhibit the development of resistance.  The daunting ability of the virus to rapidly generate resistant mutants suggests that there is an ongoing need for new HIV protease inhibitors with superior pharmacokinetic and efficacy profiles.  In our attempts to design and select improved cyclic urea HIV protease inhibitors, we have simultaneously optimized potency, resistance profile, protein binding and oral bioavailability.  We have discovered that nonsym. cyclic ureas contg. a 3-aminoindazole P2 group are potent inhibitors of HIV protease with excellent oral bioavailability.  Furthermore, the 3-aminoindazole group forms four hydrogen bonds with the enzyme and imparts a good resistance profile.  The nonsym. 3-aminoindazoles DMP 850 and DMP 851 were selected as our next generation of cyclic urea HIV protease inhibitors because they achieve 8 h trough blood levels in dog, with a 10 mg/kg dose, at or above the protein-binding-adjusted IC90 value for the worst single mutant - that contg. the lle84→Val mutation.  In selecting our next generation of cyclic urea HIV protease inhibitors, we established a rigorous set of criteria designed to maximize chances for a sustained antiviral effect in HIV-infected individuals.  As DMP 850 and DMP 851 provide plasma levels of free drug that are sufficient to inhibit wild-type HIV and several mutant forms of HIV, they could show improved ability to decrease viral load for clin. significant time periods.  The ultimate success of DMP 850 and DMP 851 in clin. trials might depend on achieving or exceeding the oral bioavailability seen in dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomrtg2uGkdrbVg90H21EOLACvtfcHk0lj7sGLuIngsgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntVSgtLk%253D&md5=84e17f6e56985037bf7fd9251ddc0358</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2898%2990117-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252898%252990117-X%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DJohnson%26aufirst%3DB.%2BL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DS.%2BS.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DKlabe%26aufirst%3DR.%2BM.%26aulast%3DBacheler%26aufirst%3DL.%2BT.%26aulast%3DCordova%26aufirst%3DB.%26aulast%3DGarber%26aufirst%3DS.%26aulast%3DReid%26aufirst%3DC.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DChang%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Selection%2520of%2520DMP%2520850%2520and%2520DMP%2520851%253A%2520The%2520Next%2520Generation%2520of%2520Cyclic%2520Urea%2520HIV%2520Protease%2520Inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1998%26volume%3D5%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><div class="note"><p class="first last">For further examples in which cell-based potency is notably enhanced by generation of zwitterionic inhibitors, see the following. </p></div><span class="NLM_contrib-group">Ikegashira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruha</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6950</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900372w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6950&author=K.+Ikegashiraauthor=T.+Okaauthor=S.+Hirashimaauthor=S.+Nojiauthor=H.+Yamanakaauthor=Y.+Haraauthor=T.+Adachiauthor=+Tsuruhaauthor=S.+Doiauthor=Y.+Haseauthor=T.+Noguchiauthor=I.+Andoauthor=N.+Oguraauthor=S.+Ikedaauthor=H.+Hashimoto&title=Discovery+of+Conformationally+Constrained+Tetracyclic+Compounds+as+Potent+Hepatitis+C+Virus+NS5B+RNA+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span></div><div class="casAuthors">Ikegashira, Kazutaka; Oka, Takahiro; Hirashima, Shintaro; Noji, Satoru; Yamanaka, Hiroshi; Hara, Yoshinori; Adachi, Tsuyoshi; Tsuruha, Jun-Ichiro; Doi, Satoki; Hase, Yasunori; Noguchi, Toru; Ando, Izuru; Ogura, Naoki; Ikeda, Satoru; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6950-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a new series of hepatitis C virus NS5B RNA polymerase inhibitors contg. a conformationally constrained tetracyclic scaffold.  SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (I and II) bearing a basic pendent group with high biochem. and cellular potencies.  These compds. displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0S142h4FZLVg90H21EOLACvtfcHk0lj7sGLuIngsgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF&md5=18234c5535779cf60484899c6e63770f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0610245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610245%26sid%3Dliteratum%253Aachs%26aulast%3DIkegashira%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DTsuruha%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DOgura%26aufirst%3DN.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Conformationally%2520Constrained%2520Tetracyclic%2520Compounds%2520as%2520Potent%2520Hepatitis%2520C%2520Virus%2520NS5B%2520RNA%2520Polymerase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">The evaluation of rat liver concentrations 4 h postdose is based on liver time-course studies from previous work (see ref <a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">10b</a>). Plasma <i>T</i><sub>max</sub> values for all compounds reported are below 4 h and are typically in the 0.5−1 h time range.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollazzo, M.</span><span> </span><span class="NLM_article-title">Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">7152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=7152&author=S.+Di+Marcoauthor=M.+Rizziauthor=C.+Volpariauthor=M.+A.+Walshauthor=F.+Narjesauthor=S.+Colarussoauthor=R.+De+Francescoauthor=V.+G.+Matassaauthor=M.+Sollazzo&title=Inhibition+of+the+hepatitis+C+virus+NS3%2F4A+protease.+The+crystal+structures+of+two+protease-inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DWalsh%26aufirst%3DM.%2BA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DSollazzo%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease.%2520The%2520crystal%2520structures%2520of%2520two%2520protease-inhibitor%2520complexes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D7152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldivar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlbrenner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W. M.</span><span> </span><span class="NLM_article-title">Hepatitis C NS3 Protease Inhibition by Peptidyl-α-ketoamide Inhibitors: Kinetic Mechanism and Structure</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2004&pages=207-216&author=Y.+Liuauthor=V.+S.+Stollauthor=P.+L.+Richardsonauthor=A.+Saldivarauthor=J.+L.+Klausauthor=A.+Mollaauthor=W.+Kohlbrennerauthor=W.+M.+Kati&title=Hepatitis+C+NS3+Protease+Inhibition+by+Peptidyl-%CE%B1-ketoamide+Inhibitors%3A+Kinetic+Mechanism+and+Structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DSaldivar%26aufirst%3DA.%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKohlbrenner%26aufirst%3DW.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DHepatitis%2520C%2520NS3%2520Protease%2520Inhibition%2520by%2520Peptidyl-%25CE%25B1-ketoamide%2520Inhibitors%253A%2520Kinetic%2520Mechanism%2520and%2520Structure%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D421%26spage%3D207%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koch, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Determinants of Substrate Specificity in the NS3 Serine Proteinase of the Hepatitis C Virus</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1997&pages=78&author=J.+O.+Kochauthor=R.+Bartenschlager&title=Determinants+of+Substrate+Specificity+in+the+NS3+Serine+Proteinase+of+the+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DJ.%2BO.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DDeterminants%2520of%2520Substrate%2520Specificity%2520in%2520the%2520NS3%2520Serine%2520Proteinase%2520of%2520the%2520Hepatitis%2520C%2520Virus%26jtitle%3DVirology%26date%3D1997%26volume%3D237%26spage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tsantrizos, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1355&author=T.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+Inhibitors+of+the+NS3+Protease+as+Potential+Therapeutic+Agents+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DT.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520the%2520NS3%2520Protease%2520as%2520Potential%2520Therapeutic%2520Agents%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/jm900372w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68058"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and characterization of compounds <b>8a</b>−<b>j</b>, <b>28a</b>,<b>b</b>, and <b>31</b>; rat and dog PK curves and parameters for compound <b>25</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900372w/suppl_file/jm900372w_si_001.pdf">jm900372w_si_001.pdf (112.95 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900372w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm900372w" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900372w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1be14e9c24b2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
